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Zusammenfassung 
 
Fibroblast Growth Factor 2 (FGF2) ist ein proangiogener Wachstumsfaktor, der eine 
entscheidende Rolle bei der Tumor-induzierten Angiogenese spielt. FGF2 wird über 
einen bisher nicht bekannten Mechanismus von Säugetierzellen sezerniert, der auch 
nach Blockierung des ER/Golgi Systems durch Brefeldin A vollständig funktionell 
bleibt. Da FGF2 auch biomedizinisch ein sehr interessantes Targetprotein darstellt, 
ist die molekulare Aufklärung des Sekretionsweges von ausserordentlich grosser 
Bedeutung. 
 
In dieser Arbeit wurde ein experimentelles Modellsystem etabliert, dass mittels 
Durchflusszytometrie eine exakte Quantifizierung der FGF2 Expressionsrate unter 
verschiedenen experimentellen Bedingungen erlaubt. Darüber hinaus wurden 
Testsysteme entwickelt, die den Exportvorgang sowohl mittels konfokaler 
Laserscanmikroskopie als auch durch biochemische Methoden wie die 
Zelloberflächenbiotinylierung rekonstituieren. 
 
Eine wesentliche Fragestellung bei der Aufklärung des molekularen Mechanismus 
der FGF2 Sekretion bestand in der Analyse des Faltungszustandes von FGF2 
während des Exportvorganges. Auf der Basis der oben beschriebenen 
Modellsysteme wurde FGF2 als DHFR Fusionsprotein exprimiert, so dass der 
Faltungszustand durch einen exogenen Liganden kontrolliert werden konnte. Es 
konnte gezeigt werden, dass unter Bedingungen, die die Entfaltung des Moleküls 
nicht erlauben, die FGF2 Sekretionsrate nicht beeinflusst wird. Darüber hinaus 
konnten mit Hilfe eines sogenannten Piggyback Exportsystems Hinweise dafür 
gewonnen werden, dass eine Interaktion eines zweiten Reportermoleküls mit FGF2 
während des Exportvorganges erhalten bleibt. Jedoch war die Effizienz dieses 
Piggyback Transportes gering, so dass diese Ergebnisse schwer interpretierbar 
blieben. Dennoch sind diese Beobachtungen konsistent mit den Ergebnissen, die mit 
Hilfe des DHFR Systems erhalten wurden. Weiterhin stimmen die in dieser Arbeit 
geschilderten Experimente in überein mit neueren Befunden aus unserem Labor, die 
auf eine Rolle von Heparansulfatproteoglykanen als Exportrezeptoren bei der 
Sekretion von FGF2 hinweisen. Diese Daten deuten ebenfalls auf einen 
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Exportvorgang hin, während dessen FGF2 vollständig gefaltet bleibt. Die Summe der 
Daten hat wichtige Implikationen für den Mechanismus der FGF2 Sekretion, der nach 
heutigem Kenntnisstand durch eine direkte Translokation über die Plasmamembran 
erfolgt. Eine Verknüpfung des Exportvorgangs mit dem FGF2 Faltungszustand 
könnte somit Qualitätskontrolle gewährleisten, die die Sekretion von nicht 
funktionellen Molekülen ausschliesst. 
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Summary 
 
Fibroblast growth factor 2, a mediator of tumor-associated angiogenesis, is a 
mitogenic growth factor involved in various cellular processes. It is released by an 
unconventional secretory pathway independent of the ER/Golgi system. Due to its 
strong biomedical relevance it is of great interest to elucidate the molecular 
machinery involved in non-classical export. 
 
To analyze unconventional secretion, different model systems were established 
during this study including a FACS-based system which allows for a quantitative 
analysis of exported material bound to the cell surface and an analysis system 
employing confocal microscopy to analyze non-classical export qualitatively 
employing specific antibodies. Additionally, various biochemical analysis methods 
employing immobilized antibodies, as well as labelling of cell surface proteins using a 
membrane-impermeable biotinylation reagent to quantify exported FGF2 reporter 
molecules were established. 
 
In the second part of this thesis, these systems were used to analyze the folding 
state of FGF2 during unconventional secretion. The first experimental approach, 
termed DHFR fusion protein system, prevents unfolding during membrane 
translocation by aminopterin-dependent stabilization of a DHFR domain fused to 
FGF2. It could be shown that export of FGF2 is not affected under conditions where 
protein unfolding is prevented, although, based on the same system, mitochondrial 
import could be blocked. These findings suggest that export of FGF2 does not 
require unfolding. 
The second strategy, termed piggyback export analysis system, monitors the folding 
state of FGF2 and investigates potential means of quality control associated with 
unconventional secretion. The system is based on the export of non-covalent 
cytosolic complexes formed between two interacting domains, one fused to FGF2 
and the other to non-exported GFP. To this end, a certain degree of piggyback 
export, could be detected, however, the efficiency was found to be low. In any case, 
the results are consistent with those obtained with the DHFR system in that it 
appears likely that FGF2 remains folded during membrane translocation. These 
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findings are also supported by recent observations made in our laboratory pointing to 
a role of heparan sulfate proteoglycans as export receptors requiring FGF2 to be 
folded during export. 
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1 Introduction 
 
One of the basic principles of living organisms is to separate the interior from the 
surrounding environment by a barrier. At the level of cells this barrier is formed by an 
amphipathic lipid bilayer termed plasma membrane which separates the cytosol from 
the cell exterior. Additionally, eukaryotic cells possess a highly evolved 
endomembrane system which allows the formation of specialized compartments 
known as organelles (Palade, 1975). Organelles create enclosed cavities which 
provide specialized surroundings for different biological processes. They function in 
distribution of nutrients and metabolites, storage of substances, assembly and 
degradation of macromolecules and export of material to the extracellular space. To 
fulfill these functions transport between organelles and exchange with the cell 
exterior is essential. The most important processes in this regard are endo- and 
exocytosis (Besterman and Low, 1983; Bloom and Puszkin, 1981; Sollner, 2003; 
Stahl and Barbieri, 2002), intracellular transport and secretion. They are mediated by 
membrane-coated vesicles, which release their content upon fusion with an acceptor 
membrane (Harter and Wieland, 1996; Rothman, 1994; Rothman and Wieland, 1996; 
Schmid, 1997). In eukaryotic cells a number of independent organelles functions 
sequentially to form a network known as the secretory pathway (Lee et al., 2004). It 
is a specialized transport route which is highly regulated and directly involved in 
protein biogenesis, modification, sorting, quality control and secretion. The secretory 
pathway mediates the transport of lipids, proteins and other cargo molecules to 
intracellular organelles or to the plasma membrane where export occurs. Besides, a 
number of proteins are known which are exported independently of the secretory 
pathway by a process termed unconventional secretion (Cleves, 1997; Nickel, 2003; 
Nickel, 2005). 
 
1.1 Classical Protein Secretion 
 
Classical protein secretion begins with the binding of the signal recognition particle 
(SRP) to an N-terminal, hydrophobic signal sequence of a nascent polypeptide chain 
synthesized at a free ribosome in the cytosol (Blobel and Dobberstein, 1975b; Walter 
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et al., 1984). SRP also binds to the large subunit of the ribosome which causes an 
arrest in elongation (Walter and Blobel, 1981). This ternary complex is directed to the 
membrane of the endoplasmatic reticulum (ER) where SRP binds to its receptor 
(Meyer et al., 1982; Rapoport, 1992a). The SRP receptor is an integral membrane 
protein consisting of an α- and a smaller β-subunit (Tajima et al., 1986). Once bound 
to the α-subunit of the SRP receptor the complex is transferred to the translocon, an 
integral membrane protein complex which forms the protein conducting channel 
(Rapoport, 1992a). It consists of Sec61α, a protein with 10 membrane spanning α-
helices, Sec61β and Sec61γ, which are smaller in size (High et al., 1993; Rapoport, 
1992a). When the ribosome is transferred to the translocon SRP is released 
accompanied by GTP hydrolysis, and elongation continues (Gilmore et al., 1982). 
The growing polypeptide chain is directly synthesized into the pore formed by the 
translocon and enters the lumen of the ER in a co-translational manner (Brodsky, 
1998; Gilmore, 1993; Walter et al., 1984). The signal peptide is cleaved off by an 
integral, translocon-associated signal-peptidase (Blobel and Dobberstein, 1975a; 
Dalbey and Von Heijne, 1992) and the polypeptide chain associates with ER resident 
chaperones which ensure correct folding (Bukau and Horwich, 1998) and facilitate 
translocation by functioning as molecular ratchets (Matlack et al., 1999). The 
translocation from the cytosol to the lumen of the ER is the only step during export 
where a secretory protein is transported across a membrane. The cytosolic and the 
luminal face of the membrane, the latter being topologically equivalent to the 
extracellular space, do not change during further transport steps since they are 
mediated by membrane-coated vesicles which are generated at a donor 
compartment and fuse with a downstream acceptor compartment (Lee et al., 2004).  
After insertion into the ER the protein can be modified by formation of intramolecular 
disulfide bonds (Gething and Sambrook, 1992), specific proteolytic cleavage, 
hydroxylation of proline residues (Lee et al., 2004) as well as N- and O-linked 
glycosylation. N-linked glycosylation involves the transfer of pre-assembled 
oligosaccharide precursors to asparagine residues by oligosaccharyl-protein 
transferases (Sharma et al., 1981). The oligosaccharide precursors are subsequently 
trimmed by glucosidases which remove glucose and mannose moieties (Hebert et 
al., 1995). When all modifications are completed and the protein obtained its correct 
conformation it is packaged into small membrane-coated vesicles with a size of about 
50 nm in diameter. These vesicles transport the protein to the Golgi apparatus 
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eventually passing through the ER-Golgi intermediate compartment (ERGIC) which is 
formed by fusion of transport vesicles and is involved in sorting processes (Lee et al., 
2004). 
The Golgi apparatus is organized as a network of cisternal stacks consisting of the 
cis-, medial- and trans-Golgi (Dunphy and Rothman, 1985; Morre, 1987; Rothman, 
1981). Vesicles fuse with an existing cis-Golgi cisterna or a number of vesicles fuse 
with each other to form a new cis-Golgi stack (Lee et al., 2004). ER-resident proteins 
transported to the Golgi are retrieved to the ER via retrograde transport (Lee et al., 
2004). Additionally, misfolded proteins can be transported back to the ER to undergo 
ER-associated degradation (ERAD) (McCracken and Brodsky, 1996; Tsuda et al., 
2005). Transport through the Golgi is likely to occur according to the cisternal 
progression model or mediated by transport vesicles. In the cisternal progression 
model a cis-Golgi stack moves spatially towards the trans-Golgi face thereby 
undergoing a maturing process in which the enzymatic content and the membrane 
composition change (Becker et al., 1995). In the vesicular transport model small 
transport vesicles mediate transport between the Golgi cisternae which are defined 
compartments with a specific protein and lipid composition (Beckers and Rothman, 
1992; Rothman and Orci, 1990). In the Golgi cargo proteins undergo further 
modifications which have influence on their structure and functional properties. N-
linked oligosaccharides transferred in the ER are further trimmed (Zuber et al., 2000), 
O-linked glycosylation takes place (Ernst and Prill, 2001; Sadeghi and Birnbaumer, 
1999) and proteins are modified by sulfatation (Baeuerle and Huttner, 1987; Hille et 
al., 1984). Once secretory proteins reach the trans-Golgi face they are packaged into 
specific vesicles to be transported to the plasma membrane. This can occur by bulk 
flow which mediates incorporation of cargo proteins into vesicle for constitutive 
secretion (Keller and Simons, 1997; Wieland et al., 1987) or by association with 
cargo-receptors and adaptor proteins (Pearse and Robinson, 1990; Seeger and 
Payne, 1992; Tooze and Tooze, 1986). The secretory vesicles are transported to the 
plasma membrane by movement along the microtubular network (Henley and 
McNiven, 1996; Hirschberg et al., 1998; Martin-Verdeaux et al., 2003; Wacker et al., 
1997) and release their content in a controlled fusion event with the membrane to the 
extracellular space . 
Vesicles mediating the various transport steps are characterized by their protein coat 
and membrane origin. Known types are clathrin-coated vesicles, COPI and COPII 
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vesicles (Salama and Schekman, 1995; Schekman and Orci, 1996). Clathrin-coated 
vesicles are formed at the plasma membrane or the trans-Golgi. They mediate 
transport to the endosomal/lysosomal compartment. COPI vesicles function in 
retrograde transport from the Golgi to the ER and mediate intra-Golgi transport 
between the cisternae (Lippincott-Schwartz, 1993; Lippincott-Schwartz et al., 1989). 
It is further hypothesized that they might also play a role in transport to the 
endosomal compartment (Nickel et al., 1998; Rothman and Wieland, 1996). COPII 
vesicles mediate the anterograde transport of proteins from the ER to the Golgi or the 
ERGIC (Aridor et al., 1998; Barlowe et al., 1994; Kuehn and Schekman, 1997). All 
vesicles are formed by polymerization of coat proteins on the cytosolic surface of a 
donor membrane. Small GTP-binding proteins of the ras-GTPase superfamily 
function as molecular switches to initiate and control polymerization (ARF for COPI- 
and clathrin-coated vesicles and Sar1 for COPII vesicles) (Balch, 1990; Boman and 
Kahn, 1995; Nakano and Muramatsu, 1989; Nickel et al., 2002; Orci et al., 1993; 
Ostermann et al., 1993; Palmer et al., 1993; Shaywitz et al., 1997). Assembly of the 
coat results in local membrane deformation which contributes to vesicle shaping and 
drives the budding process. To select cargo molecules for packaging into vesicles a 
sorting signal, e.g. in the cytosolic domain of membrane proteins, is required. The 
sorting signal interacts directly with polymerized coat proteins (Allan et al., 2000; 
Campbell and Schekman, 1997; Gimeno et al., 1996; Kuehn et al., 1998). Luminal 
proteins bind to membrane spanning cargo receptors prior to packaging which, in 
turn, interact with coat proteins. A well characterized example is the binding of the 
KDEL retrieval sequence of soluble ER resident proteins to the KDEL receptor 
mediating retrograde transport from the Golgi to the ER (Lewis and Pelham, 1992; 
Tang et al., 1993). Following vesicle pinch off from the donor membrane the coat is 
disassembled triggered by hydrolysis of ARF- or Sar1-bound GTP and proteins 
required for targeting and fusion with the acceptor membrane are exposed 
(Goldberg, 1999; Reinhard et al., 2003; Tanigawa et al., 1993). 
Transport specifity is mediated by a combination of fusion assembly proteins known 
as SNAREs (Soluble N-ethylmaleimide sensitive factor attachment protein receptor) 
(Rothman and Warren, 1994; Söllner et al., 1993b), small GTPases of the Rab family 
(Balch, 1990; Clague, 1999; Novick and Zerial, 1997) and a diverse group of 
tethering factors (Waters and Pfeffer, 1999). The initial interaction with the acceptor 
membrane is the assembly of tethering complexes. The mechanistical details of this 
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process remain elusive but it is likely that loose tethering anchors the vesicle to the 
target membrane and primes SNAREs for fusion by rearranging SNARE complexes 
or increasing the probability of SNARE encounters. Tethering factors which mediate 
the primary interaction can be classified into a group of multi-subunit complexes and 
a group of coiled-coil proteins (Pfeffer, 2001; Suvorova et al., 2001). Rab proteins 
mediate docking of the vesicle by interactions with specific coiled-coil Rab effectors 
on the acceptor membrane. The set of Rab proteins and Rab effectors present on 
different membranes thereby provide the compartmental identity of an organelle 
(Christoforidis et al., 1999; Gonzalez and Scheller, 1999; Jahn and Sudhof, 1999; 
Novick and Zerial, 1997). After docking the interaction of complementary SNAREs 
present on the vesicle (v-SNARE) and the target membrane (t-SNARE) leads to the 
formation of the trans-SNARE complex (Rothman and Söllner, 1997; Söllner et al., 
1993a; Söllner and Rothman, 1996). This brings the membranes into close proximity 
and directly drives the fusion process (Nickel et al., 1999; Weber et al., 1998). Upon 
formation of the trans-SNARE complex the SNARE proteins undergo a 
conformational change form an unstructured, high-energetic state to an ordered, low-
energetic four-helical bundle (Sollner, 2004). The energy provided by this step may 
be directly used to catalyze the fusion of the two opposing membranes by 
destabilizing the lipid/water interface and initiating lipid mixing (Jahn et al., 2003). 
After fusion the SNARE assembly is present as a cis-SNARE complex at the 
membrane of the target organelle. This complex is disassembled for subsequent 
rounds of docking and fusion by the combined action of SNAP (soluble N-
ethylmaleimide sensitive factor attachment protein) and NSF (N-ethylmaleimide 
sensitive factor) (Hanson et al., 1997a; Hanson et al., 1997b). The energy required 
for this process is provided by NSF-mediated ATP-hydrolysis (Jahn et al., 2003). 
After disassembly t-SNAREs remain in the target membrane and v-SNAREs are 
recycled to their donor membrane by retrograde transport (Ballensiefen et al., 1998) 
or maybe by an independent mechanism as proposed by Dietrich et al. based on 
yeast vacuole studies on homotypic membrane fusion (Dietrich et al., 2005). After 
this last step the machinery is ready for the next round of vesicle docking and 
membrane fusion. 
The classical secretory pathway involving the ER and the Golgi apparatus can be 
blocked by certain inhibitors. The fungal metabolite brefeldin A (BFA) inhibits ARF 
recycling by disrupting the interaction of ARF with its guanine exchange factor (GEF) 
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which, in turn, impairs COPI vesicles formation (Mossessova et al., 2003), (Robineau 
et al., 2000). This results in fusion of the cis- and medial-Golgi with the ER and 
compromises ER/Golgi-dependent protein secretion reversibly (Misumi et al., 1986), 
(Lippincott-Schwartz et al., 1989). The drug monensin irreversibly blocks transport 
from the trans-Golgi face leading to Golgi dilatation (Hashieh et al., 1989) which in 
turn also disrupts the secretory pathway (Tartakoff, 1983). 
 
1.2 Unconventional Protein Secretion 
 
The ER/Golgi-dependent or classical secretory pathway is the main export route for 
proteins in eukaryotic cells. Soluble secretory proteins typically contain a N-terminal, 
hydrophobic signal sequence to enter the pathway which transports them through the 
ER to the Golgi and finally to the extracellular space (see section 1.1). 
About 15 years ago proteins were discovered that do not fulfill this requirement but 
are exported from cells (Muesch et al., 1990). Furthermore, protein secretion was 
observed in the absence of a functional ER/Golgi system as shown for interleukin 1β 
(IL-1β) and galectin-1 (Cooper and Barondes, 1990; Hughes, 1999; Nickel, 2003; 
Nickel, 2005; Rubartelli et al., 1990). These findings were the starting point to unravel 
the phenomenon of unconventional protein secretion also known as non-classical 
protein export (Cooper and Barondes, 1990; Florkiewicz et al., 1995; Muesch et al., 
1990). Further characterization of unconventionally exported proteins uncovered 
common features of these different, functionally and structurally unrelated proteins. 
They do not contain a classical, N-terminal, hydrophobic signal sequence (Rubartelli 
et al., 1990). They are excluded from the lumen of the ER or the Golgi apparatus. 
They do not show ER/Golgi-dependent posttranslational modifications, e.g. N-linked 
glycosylation, despite bearing numerous consensus sites (Hughes, 1999). Their 
export is not affected by inhibitors like BFA or monensin which compromise the 
classical secretory pathway (Florkiewicz et al., 1995; Muesch et al., 1990). Various 
experimental strategies, like measurements of unrelated cytosolic proteins in cellular 
supernatants, have been applied to exclude unspecific release originating from 
injured or dead cells (Cleves, 1997; Engling et al., 2002; Hughes, 1999). 
Furthermore, non-classical export of the proangiogenic growth factor FGF2 was 
shown to be energy and temperature dependent in vivo (Florkiewicz et al., 1995) and 
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can be influenced by stimulating or inhibiting agents (Cleves, 1997; Hughes, 1999). 
Additionally, different experimental approaches provided evidence that 
unconventional secretion of galectins is regulated during cell differentiation (Cooper 
and Barondes, 1990; Lutomski et al., 1997), release of FGF2 is controlled by NF-κB-
mediated signalling (Wakisaka et al., 2002) and that post-translational modifications, 
e.g. phosphorylation, regulate the release of the non-classically exported 
homeodomain protein Engrailed (Maizel et al., 2002). Taken together, these findings 
demonstrate that unconventional secretion is not based on unspecific release by 
sublethal injury or cell death as proposed formerly (McNeil et al., 1989). It is rather a 
highly regulated process involving protein-based molecular machineries. 
 
1.2.1 Current Models of Unconventional Export Mechanisms 
 
Although unconventionally secreted proteins share the features described in section 
1.2 it is unlikely that they make use of a common unconventional export pathway. 
Instead, they seem to be released by mechanistically distinct export routes consisting 
of vesicular and non-vesicular membrane translocation processes (Nickel, 2005). 
The potential export mechanisms are summarized in the following figure (Fig 1.1). 
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Fig. 1.1 Vesicular and non-vesicular pathways potentially involved in unconventional secretion. 
1, export by secretory lysosomes; 2, export mediated by plasma membrane-resident transporters; 3, 
export through the release of exosomes derived from multivesicular bodies; 4, export mediated by 
shedding of microvesicles. For details, see main text. (Courtesy of Walter Nickel (Nickel, 2005)) 
 
The first model depicted in Fig. 1.1 shows unconventional export mediated by 
secretory lysosomes. Under certain conditions, lysosomal contents gain access to 
the exterior of cells when specialized endocytic structures such as secretory 
lysosomes of cytotoxic T lymphocytes or melanosomes of melanocytes fuse with the 
plasma membrane (Stinchcombe et al., 2004). An example of a non-classically 
exported protein using this pathway is IL-1β (Rubartelli et al., 1990). In the second 
model displayed in Fig. 1.1 a direct translocation of unconventionally secreted 
proteins by plasma membrane-resident transporters such as adenosine triphosphate-
binding cassette (ABC) transporters is proposed (Cleves and Kelly, 1996). Proteins 
probably exported by this mechanism are FGF-1 (Prudovsky et al., 2002), FGF2 
(Schäfer et al., 2004) and the hydrophilic acylated surface protein B (HASPB) of 
Leishmania (Denny et al., 2000; Stegmayer et al., 2005). In the third model, depicted 
in Fig. 1.1, non-classical export is mediated by the release of exosomes derived from 
multivesicular bodies. Exosomes are released from cells upon fusion of 
multivesicular bodies with the plasma membrane (Stoorvogel et al., 2002). The cargo 
has to be packaged into the exosomal structures prior to the fusion event. An 
unconventionally secreted protein reported to use this pathway is galectin-3 (Thery et 
al., 2001). The fourth model presented in Fig 1.2 explains unconventional membrane 
Introduction  13 
 
 
 
translocation by the release of microvesicles in a process termed membrane 
blebbing (Freyssinet, 2003; Hugel et al., 2005; Martinez et al., 2005). As proposed by 
Hughes et al. the export of unconventionally secreted members of the galectin family 
is mediated by this mechanism (Hughes, 1999). 
 
1.3 Non-classically Secreted Proteins 
 
Since the discovery of unconventional secretion (Cooper and Barondes, 1990; 
Florkiewicz et al., 1995; Muesch et al., 1990) the number of proteins released by 
non-classical means is increasing steadily. The discovered proteins represent a 
highly diverse group not sharing structural or functional similarities. In general they 
have only in common their ER/Golgi-independent export route, but the underlying 
mechanistical details of membrane translocation differ strongly (Nickel, 2003). A 
summary of unconventionally secreted cellular, viral and parasitic proteins and the 
proposed mechanisms of how they exit the cell is presented in the following figure 
(Fig. 1.2). 
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Fig. 1.2 Unconventionally secreted proteins and putative export pathways. 
Four different plasma membrane translocation processes involved in non-classical export can be 
distinguished. They represent the mechanisms described in section 1.2.1. IL-1β, En2 and HMGB1 exit 
the cell packaged into intracellular vesicle originating form multivesicular endosomes or secretory 
lysosomes. FGF1 and FGF2 are directly translocated using plasma membrane resident transporters. 
HASPB of Leishmania is also directly translocated across the plasma membrane probably involving a 
flip-flop mechanism since it is membrane anchored at the inner leaflet due to its dual acylation at the 
N-terminus. Galectins are exported by membrane blebbing involving the formation of exosomes which 
are labile structures and release their content to the extracellular space once released. (Courtesy of 
Walter Nickel (Nickel, 2003)) 
 
One group of unconventionally secreted proteins are proangiogenic growth factors 
such as FGF1 and FGF2. Others are lectins of the extracellular matrix (ECM) such 
as galectin-1 (Cleves et al., 1996) and galectin-3 (Menon and Hughes, 1999). 
Additionally, cytokines like IL-1β (Rubartelli et al., 1990), macrophage inhibiting factor 
(MIF) (Flieger et al., 2003) and thioredoxin (Rubartelli and Sitia, 1991) have been 
reported to be secreted by unconventional means. Also viral proteins such as Herpes 
simplex tegument protein VP22 (Elliott and O'Hare, 1997), Human immunodeficiency 
virus (HIV) Tat protein (Ensoli et al., 1993) and Foamy virus Bet protein (Lecellier et 
al., 2002) are released by non-classical export. Other proteins sharing 
unconventional export are HASPB of Leishmania (Denny et al., 2000), the 
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homeodomain-containing transcription factor Engrailed homeoprotein isoform 2 (En2) 
(Joliot et al., 1998) and high mobility group chromatin-binding protein 1 (HMGB1) 
(Gardella et al., 2002). Selected proteins from this group are described in more detail 
in the following sections. 
 
1.3.1 Fibroblast Growth Factors 
 
The protein family of heparin-binding fibroblast growth factors (FGFs) consists of 23 
members exhibiting 13-71% amino acid identity (Ornitz and Itoh, 2001). They range 
in molecular mass form 17 to 34 kDa and are highly conserved among vertebrates in 
both gene structure and amino acid sequence. Their gene loci are scattered 
throughout the genome but several genes appear in clusters on different 
chromosomes. Evolutionary the family was probably generated by gene- and 
chromosome-duplication accompanied by gene translocation events (Ornitz and Itoh, 
2001).  
FGFs mediate a variety of functions and are involved in numerous biological 
processes including angiogenesis, embryonic development, mitogenic activity, 
cellular chemotaxis, proliferation and differentiation (Bikfalvi et al., 1995; Bikfalvi et 
al., 1997; Powers et al., 2000; Rogelj et al., 1989). They also function in adult 
organisms as homeostatic factors, in tissue repair and response to injury (Bikfalvi et 
al., 1997). Additionally FGFs contribute to pathogenesis of cancer mediating tumor-
associated angiogenesis (Liekens et al., 2001) and a subset is involved in neuronal 
signal transduction in the central and peripheral nervous system (Lou et al., 2005). 
As a structural feature FGFs share a central core region of 140 amino acids with 28 
highly conserved and six identical amino acids (Ornitz, 2000). Ten of the highly 
conserved amino acids are thought to mediate the interaction with FGF receptors 
(FGFRs) (Plotnikov et al., 2000). The central core folds into twelve antiparallel β-
strands that form a cylindrical barrel closed by the variable N- and C-terminal regions 
which is structurally identical to IL-1β (Ago et al., 1991; Zhang et al., 1991). The 
heparin binding site is formed by basic amino acids residing in the β-strands 10 and 
11 and in the loop region between the two β-strands. These regions are believed to 
be distinct from regions mediating FGFR-binding (Faham et al., 1998). 
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In addition to receptor binding FGFs interact with heparin, heparan sulfate or 
herparan sulfate proteoglycans (HSPGs) which are abundant ECM components 
(Gleizes et al., 1995). These low affinity interactions stabilize FGFs and prevent 
uncontrolled diffusion and release from the ECM after secretion thereby inducing 
dimer-formation and the assembly of higher-ordered oligomers (Caldwell et al., 2004; 
Flaumenhaft et al., 1990; Herr et al., 1997). Furthermore, they mediate clustering and 
guidance to the actual FGFRs and a concerted mechanism of HSPG- and FGFR-
binding is required for the biological activity of FGFs (Pellegrini et al., 2000). FGFRs 
are transmembrane tyrosine kinase receptors with two to three immunoglobulin (Ig)-
like domains which mediate the association with FGFs. Additionally, they contain a 
heparin binding domain (McKeehan et al., 1998). Four FGFRs are known which 
result from alternative splicing by which the specifity of FGF-recognizing Ig-like 
domains is modulated (Johnson et al., 1991; Johnson and Williams, 1993). 
Most FGFs contain an N-terminal signal sequence which directs them to the classical 
secretory pathway (FGFs 3-8, 10, 15, 17-19 and 21-23). FGFs 9, 16 and 20 do not 
have a classical signal peptide but are nevertheless exported via the ER/Golgi-
dependent pathway (Miyakawa et al., 1999; Miyake et al., 1998; Miyamoto et al., 
1993). Another group of FGFs (11-14) also lack a signal sequence and remain 
intracellularly, their function is unknown (Munoz-Sanjuan et al., 2000; Smallwood et 
al., 1996). 
The group of unconventially secreted FGFs is comprised of FGF1 (Burgess et al., 
1994; Jackson et al., 1992; Prudovsky et al., 1994), FGF2 (the 18 kDa isoform) 
(Engleka and Maciag, 1992; Engling et al., 2002; Florkiewicz et al., 1995; Nickel, 
2005) and FGF20, the latter being discovered recently and its export mechanism and 
biological role is currently not known (Hajihosseini and Heath, 2002; Jeffers et al., 
2001; Kirikoshi et al., 2000). Non-classically exported FGFs do not contain N-terminal 
signal sequences and their export occurs independently of the ER/Golgi-pathway. 
The characteristics of FGF1 and especially FGF2 are discussed in more detail in the 
following sections since FGF2 is the main focus of the present study. 
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1.3.1.1 Fibroblast Growth Factor 1 
 
Fibroblast growth factor 1 (FGF1), also known as acidic FGF, is one of the prototype 
members of the FGF family. It was initially isolated from bovine pituitary extracts in 
1974 (Gospodarowicz et al., 1974). FGF1 is known to be unconventionally secreted 
exhibiting features like the lack of a classical signal sequence and BFA-insensitive 
export (Tarantini et al., 1995). It was observed that FGF1 release is induced in 
response to stress conditions such as heat shock (Jackson et al., 1992; Jackson et 
al., 1995; Tarantini et al., 1998) and serum starvation (Shin et al., 1996). FGF1 forms 
homodimers in the presence of Cu2+ ions mediated by a cysteine residue at position 
30 (Engleka and Maciag, 1992; Jackson et al., 1995; Tarantini et al., 1995) which is a 
prerequisite for secretion. Additionally, dimerized FGF1 binds to S100A13, a member 
of the S100 family of calcium-binding proteins (Carreira et al., 1998; Landriscina et 
al., 2001b), and to the p40 extravesicular domain of p65 synaptotagmin 1 (p40) prior 
to export (Carreira et al., 1998; Landriscina et al., 2001a; Landriscina et al., 2001b). 
The hetero-oligomeric complex requires the oxidative function of Cu2+ ions as an 
essential post-translational intracellular modifier (Landriscina et al., 2001a). Upon 
heat shock FGF1 is transported to the plasma membrane as analyzed by real-time 
confocal microscopy. Based on these observations it was proposed that the 
assembly of the release complex occurs underneath the plasma membrane. 
Additionally, this process was shown to be dependent on actin filaments since it can 
be inhibited by amlexanox, a compound that is known to attenuate actin stress fiber 
formation (Prudovsky et al., 2002).  
Extracellular FGF1 binds to FGFRs 1 to 4 and is internalized by receptor-mediated 
endocytosis, in a clathrin-dependent and clathrin-independent way. Receptor 
activation and internalization are required to induce FGF1-dependent proliferation 
(Wiedlocha and Sorensen, 2004). Externally added FGF1 was found to translocate to 
early endosomes after 15 min at 37°C. Following association with the respective 
receptor isoform FGF1 is sorted to the lysosomal compartment for degradation 
(FGFR 1-3) or to the recycling compartment (FGFR 4) probably dependent on the 
ubiquitination status of the receptor (Haugsten et al., 2005). FGF1 not destined for 
degradation is able to cross intracellular membranes to reach the cytosol and the 
nucleus (Wiedlocha and Sorensen, 2004) mediated by a nuclear localization signal 
(NLS) which is also crucial for its mitogenic activity (Imamura et al., 1990). FGF1 
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contains a bipartite NLS localized in the N- and the C-terminal regions of the protein 
which causes FGF1 translocation from the cytosol to the nucleus (Wesche et al., 
2005). FGF1 is thought to stimulate DNA synthesis and is phosphorylated in the 
nucleus by protein kinase C delta. Phosphorylated FGF1 is exported from the 
nucleus probably serving as an activity-regulating mechanism (Wiedlocha et al., 
2005). 
 
1.3.1.2 Fibroblast Growth Factor 2 
 
Fibroblast growth factor 2 (FGF2) or basic FGF is a mitogenic growth factor which 
was, like FGF1, first discovered in 1974 by isolation from bovine pituitary extracts 
(Gospodarowicz et al., 1974). It is a protein of high biomedical relevance with 
multiple functions as a signalling factor. FGF2 displays pleiotropic effects on different 
cell types and tissues such as stimulation of proliferation (Rogelj et al., 1989) and 
migration (Mignatti et al., 1992) or induction of differentiation, e.g. in primary neurons 
(Williams et al., 1994) and embryogenesis (Poole et al., 2001). It further plays a role 
in organ biogenesis like cardiogenesis (Sugi et al., 1993) and liver development 
(Jung et al., 1999) and also acts in wound healing (Bikfalvi et al., 1997). Most 
importantly, it is a strong mediator of neovascularization and angiogenesis during 
developmental processes and in association with solid tumor outgrowth (Liekens et 
al., 2001; Poole et al., 2001). This effect is directly visible in a chicken chorioallantoic 
membrane assay (CAM) where external FGF2 addition leads to the formation of new 
capillaries (Wilting et al., 1991). During tumor-associated blood vessel formation 
FGF2 acts as an initializing factor by stimulating the production and release of 
vascular endothelial growth factor (VEGF). Released FGF2 and VEGF directly 
stimulate endothelial cells to proliferate and release extracellular proteases such as 
urokinase-type plasminogen activator (uPA) that proteolytically activates plasmin 
which, in turn, degrades components of the ECM. Following ECM-degradation, 
proliferating endothelial cells can migrate towards the tumor to form new blood 
vessels (Mignatti and Rifkin, 1996a; Mignatti and Rifkin, 1996b; Rifkin et al., 1990). 
FGF2 is found in five isoforms with molecular masses of 18, 22, 22.5, 24 and 34 kDa. 
The higher molecular weight forms are N-terminally prolonged transcripts of the 18 
kDa form which arise by translation-initiation from upstream CUG codons (Arnaud et 
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al., 1999; Florkiewicz and Sommer, 1989; Prats et al., 1989). The additional N-
terminal sequence contains a NLS which causes the higher molecular weight forms 
to localize predominantly to the nucleus (Renko et al., 1990). 
In contrast, the 18 kDa form of FGF2 is a cytosolic protein which is secreted by 
unconventional means. It does not contain disulfide bonds which are formed in the 
ER although cysteine residues are present. Mutation of the four intrinsic cysteine 
residues at position 26, 70, 88 and 93 to serines results in a protein with the same 
secondary structure and equally mitogenic effects on 3T3 cells as the wild-type FGF2 
(Fox et al., 1988). This finding suggests that the formation of disulfide bonds is not 
necessary for FGF2 functionality (Arakawa et al., 1989). 
 
 
Fig. 1.3 Molecular structure of FGF2 associated with a HSPG side chain. 
The HSPG side chain (indicated by the green circle) is arranged to the β-sheets S1, S2, and S3 (in 
red) of a β-trefoil scaffold of FGF2 in such a way that the pseudoaxis of threefold symmetry is roughly 
perpendicular to the plane of the paper. The oligosaccharides of HSPGs interact with basic residues 
(in blue) in the loop regions numbered 1-3. (Picture from Raman et al. (Raman et al., 2003)) 
 
Structural characteristics of the FGF2 molecule are the organization of 12 β-strands 
into a β-trefoil fold. The β-trefoil scaffold is comprised of three antiparallel β-sheets, 
S1, S2, and S3 that are stacked in a triangular fashion to form a trigonal pyramid-like 
structure. Each of the antiparallel β-sheets contains four β-strands (Raman et al., 
2003). This three-dimensional structure is topologically equivalent to IL-1β (Ago et al., 
1991; Eriksson et al., 1991) but only 25% amino acid homology can be observed 
(Gimenez-Gallego et al., 1985). 
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FGF2 contains different binding sites for the FGFR and HSPGs. FGFR binding is 
mediated by a primary and a secondary FGFR binding site which are directly 
opposed to each other on the molecule. A cluster of hydrophobic residues form the 
primary receptor binding site (Y24, E96, N101, Y103, L140, and M142) while the 
secondary receptor binding site is formed by a linear stretch of amino acid residues 
(K110, Y111, and W114). The primary binding site is conserved among members of 
the FGF family whereas the secondary binding site varies due to amino acid 
deletions and mutations (Venkataraman et al., 1999). The binding sites are described 
as low and high affinity sites depending on their capability to bind to their respective 
binding site in FGFR. The HSPG-binding site of FGF2 is comprised of three surface 
exposed loop regions, including one large loop (loop3) between S1 and S3 sheets 
and two small loops in S1 (loop1) and S3 (loop2) of the β-trefoil scaffold (Raman et 
al., 2003). It is spatially spread throughout the molecule and only functional upon 
folding into the correct three-dimensional structure (Seddon et al., 1991). 
Extracellular FGF2 binds to heparan sulfates present in the carbohydrate side chains 
of HSPGs in the ECM. HSPGs are abundant components of the ECM and organized 
into a core protein backbone, normally a perlecan, glypican or syndecan, and 
glyosaminoglycan (GAG) side chains. The GAG side chain in HSPGs is an anionic 
polysaccharide consisting of repetitive disaccharides units (Esko, 1991; Esko and 
Selleck, 2002). HSPG binding is crucial for FGF2 since it mediates protection against 
degradation, serves as an FGF2 reservoir for storage of secreted FGF2, and 
facilitates the formation of the ternary complex of FGF2, HSPG and FGFR. FGF2 
bound to HSPGs within the ECM of secreting cells is released upon a stimulus by 
proteolysis of the HSPG core protein (Rifkin et al., 1990) or GAG side chain cleavage 
by heparanase (Moscatelli, 1992). It was further proposed that an extracellular FGF-
binding protein competes with heparan sulfates for FGF2 causing its release and 
acting as a carrier molecule (Wu et al., 1991). 
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Fig. 1.4 Ternary complex of FGF2, FGFR and HSPG in the ECM. 
FGF2 binds to heparan sulfate side chains of HSPG in the ECM. The complex of FGF2 molecules and 
HSPG binds to the FGFR and induces dimerization. This leads to trans-phosphorylation between the 
two receptor molecules, which, in turn, activates different signalling pathways of the cell. (Picture from 
Powers et al. (Powers et al., 2000)) 
 
Receptor mediated signalling requires binding of FGF2 to HSPGs and tyrosine 
kinase FGFRs. Binding of soluble FGF2 to heparan sulfate side chains induces 
oligomerization and increases the local concentration on the cell surface. As shown 
by Spivak-Kroizman et al., FGF1 and FGFRs interact with 1:1 stoichiometry (Spivak-
Kroizman et al., 1994). The oligomerization of FGFs triggered by binding to heparan 
sulfates promotes the recruitment of several FGFRs leading to receptor dimerization 
and activation (Powers et al., 2000). Dimerization of FGFRs induces 
autophosphorylation of cytosolic tyrosine residues which, in turn, activates 
phospholipase Cγ (PLCγ), a protein found to be associated with FGFRs (Burgess et 
al., 1990). PLCγ cleaves phophatidyl-inositol-4,5-bisphosphate to inositol 
triphosphate (IP3) and diacylglycerol (DAG) which leads to an increase of the 
intracellular concentration of Ca2+ ions by release from the ER reservoir in response 
to the stimulus by IP3. Ca2+ ions function as second messengers which induce 
numerous cellular responses and additionally DAG together with the released Ca2+ 
ions activates phosphokinase C (PKC). 
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Another signalling pathway which can be activated by FGFR dimerization is 
Ras/MAP-kinase signalling. It was shown that dimerized FGFRs can phosphorylate a 
90 kDa-signalling factor known as SNT-1 or FRS2 (Kouhara et al., 1997; Wang et al., 
1996) which links FGF2 induced FGFR dimerization to MAP-kinase signalling. 
Regarding the export of FGF2 it was initially supposed that the protein is released by 
cell damage to induce blood vessel formation in regenerating tissues following injury 
(McNeil et al., 1989). However, in 1991 it was reported that FGF2 is released from 
intact cells by a controlled mechanism although it lacks a classical signal sequence 
(Mignatti and Rifkin, 1991) similar to IL-1β. A milestone was the discovery that FGF2 
is selectively exported from COS cells being transiently transfected with the 18 kDa 
form cDNA (Florkiewicz et al., 1995). Additionally it was discovered that BFA does 
not inhibit FGF2 secretion and that export is energy-dependent since ATP-depletion 
abolished FGF2 secretion. First experiments analyzing the kinetics of FGF2 export 
revealed that it is a relatively slow process since pulse-labelled FGF2 was found 
extracellularly only after 120 min (Florkiewicz et al., 1995). Taken together these 
findings showed that the release of FGF2 does not occur in an uncontrolled manner 
but rather that it is a regulated process dependent on a molecular machinery. 
Another finding to confirm this hypothesis came again from Florkiewicz et al. who 
could show that ouabain, a plant-derived alkaloid (cardiac glycoside) from 
Strophantus gratus interferes with FGF2 secretion in a time- and dose-dependent 
manner (Florkiewicz et al., 1998). Ouabain is a known inhibitor of the Na+/K+-ATPase 
(Lingrel and Kuntzweiler, 1994) and co-purification experiments showed that FGF2 
directly interacts with the α-subunit of the Na+/K+-ATPase (Florkiewicz et al., 1998). 
In addition, cells transfected with a rodent α-subunit, insensitive to ouabain, showed 
no inhibition of FGF2 secretion by ouabain (Dahl et al., 2000). These findings 
demonstrated the involvement of a proteinaceous machinery and linked FGF2 
secretion indirectly to the functionality of the α-subunit of the Na+/K+-ATPase without 
providing evidence for a direct role in FGF2 export. Moreover, Trudel et al. could 
show that FGF2 is not released into the medium of transfected COS cells but stored 
extracellularly bound to HSPGs. These findings demonstrated that FGF2 secretion 
and release are not coupled processes and extracellular FGF2 activity is regulated 
by controlled release from the ECM giving an explanation why FGF2 is absent from 
most body fluids and conditioned media (Trudel et al., 2000). Investigating the details 
of non-classical FGF2 export a study by Gloe et al. provided evidence that FGF2 is 
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released from shear stress-exposed endothelial cells. They further reported that the 
release is tightly controlled by cell-matrix interactions mediated by the αVβ3 integrin 
(Gloe et al., 2002). Taverna et al. provided information that three isoforms of FGF2, 
the 18, 22 and 24 kDa form, can be found in vesicles released from the plasma 
membrane of serum-starved cells after serum re-addition (Taverna et al., 2003). 
Linking these two observations it was reported that shear stress induces the 
shedding of microvesicles (Martinez et al., 2005). Although these observations sound 
quite reasonable one has to take into consideration that re-addition of serum to 
previously serum-starved cells is known to induce apoptosis (Hasan et al., 1999). 
This would lead to unspecific release of cellular content in apoptotic vesicles which 
could explain the appearance of the 22 and 24 kDa isoform of FGF2 that are not 
released under normal conditions (Arese et al., 1999; Monzat et al., 1996). 
Further analysis of the mechanistical details of FGF2 secretion provided evidence for 
a microvesicle-independent release. An in vitro assay employing plasma membrane-
derived inside-out vesicles was exploited to study FGF2 plasma membrane 
translocation (Schäfer et al., 2004). The lumen of these vesicles is topologically 
equivalent to the extracellular space and the performed import studies reconstitute 
the export process. Using this assay it was shown by Schäfer et al. that FGF2 is 
translocated across the plasma membrane in a temperature- and time-dependent 
manner (Schäfer et al., 2004). Additionally, treatment with high salt or protease which 
removes membrane-associated proteins prior to FGF2 addition abolished FGF2 
translocation. Moreover, protein translocation occurred selectively as FGF2 and 
galectin-1 were imported into inside-out vesicles but the unconventionally secreted 
protein MIF (see section 1.3.4) and classically secreted FGF4 were rejected (Schäfer 
et al., 2004). These findings gave rise to the proposal of a plasma membrane 
resident transporter which directly mediates FGF2 secretion. 
 
1.3.2 Galectins 
 
The family of galectins consists of 15 members which are abundant β-galactoside-
binding lectins of the ECM (Barondes et al., 1994). All members of the galectin family 
contain one or two highly conserved carbohydrate recognition domains (CRD) which 
mediate binding to glycoproteins containing oligosaccharide side chains with terminal 
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β-galactoside sugar moieties (Hughes, 1999; Perillo et al., 1998) and glycolipids like 
GM1 (Kopitz et al., 1998; Perillo et al., 1998). Galectins function in different intra- and 
extracellular processes including cell growth, proliferation, apoptosis, differentiation, 
migration and adhesion (Liu et al., 2002; Pace et al., 1999; Perillo et al., 1998; Perillo 
et al., 1995). The best characterized galectins are galectin-1 and galectin-3 which are 
unconventionally secreted (Hughes, 1999). 
Galectin-1 is a low molecular weight protein with a size of 14 kDa containing one 
CRD. It is mostly found in a homodimeric state with the CRDs located at the opposed 
ends which results in increased binding properties and crosslinking functions (Lopez-
Lucendo et al., 2004). Galectin-1 is synthesized on free ribosomes in the cytosol 
where it is in an active state due to the reducing environment (Cho and Cummings, 
1995). To remain active after secretion into the oxidative extracellular milieu it rapidly 
binds to β-galactoside-containing ligands. Secretion of galectin-1 is insensitive to 
BFA (Sato et al., 1993) and it lacks a classical signal sequence (Couraud et al., 
1989). Additionally, it is not modified by intramolecular disulfide bond formation 
although free sulfhydryl groups are present (Hirabayashi and Kasai, 1991). 
Extracellular galectin-1 binds to counter receptors on the plasma membrane such as 
laminin (Zhou and Cummings, 1990), T-cell specific CD43 and CD45 (Pace et al., 
1999) and fibronectin (Ozeki et al., 1995). Moreover, it is bound by CA125, a tumor-
specific cell surface antigen (Seelenmeyer et al., 2003), which points to a role in 
tumor cell interaction with the ECM (Liu and Rabinovich, 2005). 
Galectin-3 is a 30 kDa protein also synthesized on free ribosomes. Its secretion is not 
affected by BFA and it is does not contain a classical signal sequence (Hughes, 
1997). It can form homodimers like galectin-1 and its secretion from breast 
carcinoma cells is stimulated by the fetal serum protein fetuin (Zhu and Ochieng, 
2001). Like galectin-1 it binds to counter receptors localized to the cell surface like 
laminin (Hughes, 1997; Mehul and Hughes, 1997). 
It is assumed that galectin-1 and galectin-3 exit the cell by a process known as 
membrane blebbing. This process consists of an accumulation of the molecules 
underneath the plasma membrane and release by shedding of plasma membrane-
derived vesicles (Hughes, 1999; Mehul and Hughes, 1997; Sato et al., 1993). 
Opposed to this model it was recently shown that counter receptor binding, which 
was thought to occur in the extracellular space after secretion, is essential for the 
overall release mechanism. Cells devoid of counter receptors do not secrete galectin-
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1 and mutated forms of the protein which are deficient in β-galactoside binding are 
not exported from cells which normally secrete the wt form of the protein 
(Seelenmeyer et al., 2005). Additionally, Schäfer et al. provided evidence that 
membrane translocation seems to occur directly from the cytosol to the extracellular 
space since galectin-1 is imported into the lumen of inside-out vesicles in an in vitro 
assay which mimics secretion, as the lumen of these vesicles is topologically 
equivalent to the extracellular space (Schäfer et al., 2004).  
 
1.3.3 Leishmania HASPB 
 
An example of a parasitic protein exported by unconventional means is the cell 
surface molecule HASPB of Leishmania (Denny et al., 2000). HASPB is expressed 
only in infectious stages of the parasite’s lifecycle and found associated with the 
outer leaflet of the plasma membrane (Alce et al., 1999; Flinn et al., 1994; Pimenta et 
al., 1994). The primary structure differs from all unconventionally secreted proteins 
known as it contains an N-terminal SH4 domain commonly found in src-kinases 
(Resh, 2004). It is synthesized on free ribosomes in the cytosol, co-translationally 
myristoylated followed by a palmitoylation step which occurs at the outer leaflet of the 
Golgi apparatus mediated by a putative Golgi-resident palmitoylacyltransferase 
(Denny et al., 2000). These acylation modifications occur at amino acid residues of 
the SH4 domain. Following these modifications the protein is transported to the inner 
leaflet of the plasma membrane which was shown to be the membrane translocation 
site of the molecule (Stegmayer et al., 2005). The 18 N-terminal amino acids of 
HASPB are both required and sufficient to target the protein to the plasma 
membrane. As shown by mutational analysis a protein lacking this sequence is 
redistributed to the cytosol (Denny et al., 2000). Also, the myristoylation site is 
essential for membrane targeting since a myristoylation mutant is also found to be 
cytosolic (Denny et al., 2000). A palmitoylation mutant is retained at the level of the 
Golgi suggesting that the outer leaflet of the Golgi membrane is the putative site of 
palmitoylation in the HASPB biogenesis pathway (Stegmayer et al., 2005). An 
interesting feature of HASPB is that, upon heterologous expression, it is also 
exported from mammalian cells, an observation which points to a conserved pathway 
of non-classical plasma membrane translocation among lower and higher eukaryotes 
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(Denny et al., 2000). Based on heterologous expression of a HASPB-N18-GFP 
fusion protein in CHO cells a somatic mutation analysis was performed by Stegmayer 
et al. resulting in the isolation of a clonal cell line deficient with regard to HASPB 
secretion. In this mutant, the protein accumulates at the inner leaflet of the plasma 
membrane suggesting the existence of a plasma membrane-resident transporter 
which has been compromised by the retroviral mutagenesis (Stegmayer et al., 2005). 
 
1.3.4 Cytokines 
 
Different cytokines were found to exit the cell by non-classical export. The best 
characterized example is interleukin 1 (IL-1) which was also one of the first proteins 
discovered to be released by an unconventional mechanism (Rubartelli et al., 1990). 
It exists in two isoforms IL-1α and IL-1β which are proteolytically processed from two 
related, but distinct precursors (Dinarello, 1997). Interleukin-1 mediates several 
biological functions related to inflammatory or infectious immune response and host 
defense mechanisms (Dinarello, 1985). IL-α is myristoylated, inserted into the 
plasma membrane and released to the extracellular space by calpain-dependent 
cleavage independent of the ER/Golgi-pathway (Kobayashi et al., 1990; Stevenson 
et al., 1993; Watanabe and Kobayashi, 1994). IL-1β is synthesized as a 33 kDa 
precursor and processed by an interleukin-converting enzyme (ICE) (Black et al., 
1988). Only the mature form is then localized to intracellular vesicles which are not 
related to the ER/Golgi system but rather originate from the endolysosomal 
compartment (Andrei et al., 1999). IL-1β is not glycosylated despite bearing 
corresponding consensus sites and its export involves the ABC transporter ABC1 
based on inhibition studies using sulfonylurea glyburide (Hamon et al., 1997) and 
antisense expression inhibition (Zhou et al., 2002). Moreover, studies by MacKenzie 
et al. suggested that IL-1β is rapidly released from activated monocytes by shedding 
of microvesicles since bioactive IL-1β was found extracellularly inside microvesicles 2 
min after stimulation (MacKenzie et al., 2001). 
The unconventional secretion of the pro-inflammatory cytokine macrophage inhibiting 
factor (MIF) is also dependent on functional ABC transporters (Flieger et al., 2003). 
The protein mediates pleiotropic functions upon release from monocytes, 
macrophages and lymphocytes in response to bacterial endo- and exotoxins and 
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cytokines (Calandra and Bucala, 1997). MIF lacks a classical signal sequence, does 
not enter the ER and its export from monocytes is not inhibited by BFA (Flieger et al., 
2003). Additionally it was reported that MIF can be found in vesicles being released 
from the plasma membrane of specialized epithelial cells (Eickhoff et al., 2001). 
Thioredoxin, another protein exhibiting cytokine functions was found to be exported 
in an unconventional manner as well. It is an ubiquitous enzyme catalyzing thiol-
disulfide exchange reactions (Holmgren, 1989). Certain isoforms act extracellularly 
as mitogenic cytokines although they lack a classical signal sequence (Rubartelli et 
al., 1992). Its release is not affected by BFA (Rubartelli and Sitia, 1991; Tanudji et al., 
2003). Furthermore, it could be shown that non-classical export of thioredoxin is not 
dependent on the redox-state of the cell or the protein (Tanudji et al., 2003). The 
release mechanism remains elusive but secretion is not dependent on ABC 
transporters and the protein can not be found in intracellular vesicles. 
 
1.3.5 Viral Proteins 
 
Unconventionally secreted proteins of strong biomedical relevance are virus-encoded 
factors which play a role in the viral replication cycle. The HIV-Tat protein is an 
auxiliary factor required for replication in addition to structural and enzymatic proteins 
(Goldstein, 1996). It is an early transactivator protein which is released from intact 
HIV-infected cells and from cells transfected with HIV-Tat cDNA although it lacks a 
classical signal sequence (Chang et al., 1997; Ensoli et al., 1993). Furthermore, it 
contains a region termed the basic transduction domain which is involved in 
membrane translocation (Becker-Hapak et al., 2001). The basic transduction domain 
also mediates binding of released Tat to HSPGs in the ECM for storage similar to 
FGF2 (Chang et al., 1997). Since the release of Tat from cultured cells is 
temperature sensitive whereas its uptake is not, it was proposed that unconventional 
secretion occurs in a different way as the protein machinery-independent uptake 
related to the basic transduction domain (Chang et al., 1997). 
Another viral protein exhibiting non-classical export is the Herpes simplex tegument 
protein VP22. It is expressed as a cytosolic factor lacking a signal sequence and 
exported by an unknown BFA-insensitive pathway (Elliott and O'Hare, 1997). 
Additionally its export is sensitive to cytochalasin D which inhibits actin 
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polymerization. This observation suggests an involvement of the cytoskeleton being 
consistent with findings that VP22 binds to microfilaments and induces microtubular 
bundle formation rendering these nocodazole-insensitive (Elliott and O'Hare, 1998). 
A third viral protein exiting host cells via unconventional secretion is the Foamy virus 
protein Bet. It is expressed as a cytosolic protein, secreted by an unknown 
mechanism and can spread between cultured cells (Giron et al., 1998; Lecellier et al., 
2002). Evidence for the secretion via an ER/Golgi-independent pathway came from 
the finding that Bet lacks a classical signal sequence and its export is not affected by 
BFA (Lecellier et al., 2002). 
 
1.3.6 Homeodomain Containing Transcription Factors and Chromatin-
binding Proteins 
 
Further examples of unconventionally secreted proteins are the transcription factor 
engrailed homeoprotein isoform 2 (En2) and the high mobility group chromatin-
binding protein 1 (HMGB1). These proteins are involved in the process of regulated 
gene transcription and normally localize to the nucleus. 
HMGB1 is secreted in response to inflammation from a limited number of cell types 
including monocytes and macrophages. Bacterial lipopolysaccharides stimulate 
monocytes to release HMBG1 which is devoid of a conventional signal peptide. 
Activated monocytes show a redistribution of HMBG1 from the nucleus to the 
cytoplasm where it localizes to the endolysosomal compartment. Export occurs by 
lysosomal exocytosis triggered by an unknown stimulus showing similarities to IL-1β 
secretion (Gardella et al., 2002). 
Analyzing the intracellular distribution of En2 a subpopulation was reported to 
localize to caveolae-like structures at the plasma membrane. Moreover, a significant 
portion is present in membrane-bound vesicles as determined by protease protection 
assays (Joliot et al., 1997). These findings provided first evidence that the protein 
might be secreted to a certain extent although it does not contain a classical signal 
sequence. It was further observed that En2 can spread between co-cultured COS 
cells expressing the chicken orthologue and rat primary neurons. About 5% of the 
protein are externalized and an 11 amino acid sequence within the homeodomain 
has been identified which is probably involved in En2 release since deletion of this 
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sequence abolished export of En2 to the extracellular space (Joliot et al., 1998). 
Later this sequence was identified as a NES sequence targeting nuclear En2 to the 
cytoplasm. Furthermore, intercellular transport seems to be regulated by 
phosphorylation of a serine-rich domain by protein kinase CK2 (Maizel et al., 2002) 
suggesting that En2 export is a controlled process. 
 
1.4 Quality Control in Unconventional Secretion 
 
If proteins are exported independently of the ER/Golgi-pathway the question arises 
how quality control is ensured to avoid release of non-functional proteins. During 
classical secretion quality control measures are applied especially at the level of the 
ER. Insertion into the ER requires the binding to ER-resident chaperones which 
facilitate the folding process and misfolded polypeptide chains are removed by 
dislocation to the cytosol where they are degraded by the proteasome (Rubin and 
Finley, 1995; Trombetta and Parodi, 2003). An accumulation of misfolded proteins in 
the ER also induces the unfolded protein response mechanism which leads to 
transcription of chaperones (Sidrauski and Walter, 1997). Post-translational 
modifications contribute to functional characteristics of the protein and enzymes like 
protein disulfide isomerase (PDI) which accomplishes correct formation of disulfide 
bonds (Freedman et al., 1984; Hillson et al., 1984; Noiva and Lennarz, 1992; Walker 
and Gilbert, 1997) or oligosaccharyl-protein transferases which mediate N-linked 
glycosylation by attachment of oligosaccharide alter the protein structure (Abeijon 
and Hirschberg, 1992; Sharma et al., 1981). The attachment of sugar moieties by N-
linked glycosylation serves as another point of quality control. Calnexin or calreticulin, 
two homologous lectins which require Ca2+ for their activity, bind to incorrectly 
modified glycoproteins or protein segments which expose a terminal glucose which is 
normally removed during glycosylation (Hebert et al., 1995; Helenius et al., 1997; 
Tatu and Helenius, 1997). They retain these proteins in the ER and allow another 
round of glycosylation to correctly complete this modification step. After a protein has 
achieved its correct conformation and is correctly modified it is recognized by cargo 
adaptors and packaged into transport vesicles which travel to the Golgi (Helenius 
and Aebi, 2004; Lee et al., 2004).  
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For other membrane translocation processes unfolding is a prerequisite. When 
proteins are imported into mitochondria they have to be unfolded to pass the outer 
and inner membrane translocation complexes. In the mitochondrial matrix the 
translocated polypeptide chain is immediately bound by mitochondrial chaperones 
which ensure correct folding (Schatz and Dobberstein, 1996). Taken together these 
elaborate mechanisms demonstrate the importance of quality control for membrane 
translocation processes and secretion. It is therefore rather unlikely that quality 
control measures do not apply for unconventional secretion. 
Non-classical export starts with synthesis of polypeptide chains on free ribosomes in 
the cytosol. The proteins do not enter the ER or the Golgi and are therefore excluded 
from the post-translational modifications which can serve as quality control measures 
like in the case of N-linked glycosylation in combination with the calnexin/calreticulin 
chaperone system. It could be possible that cytosolic chaperones mediate correct 
folding although no evidence contributing to this hypothesis was found so far. If a 
direct plasma membrane translocation step is involved, as proposed for FGF1, FGF2 
and HASPB, unconventional secretion would be mechanistically similar to ER-
mediated membrane translocation with the difference that quality control measures 
can not be applied anymore once a protein is released to the extracellular space. 
Release of non-functional proteins could be a consequence. As shown by Schäfer et 
al. in an in vitro plasma membrane transport assay FGF2 seems to be translocated 
by a plasma membrane resident transporter (Schäfer et al., 2004). One could 
imagine that the transporter only recognizes correctly folded molecules as a 
substrate. A proposed feature of non-classically exported FGF2 could be that the 
targeting motif which mediates secretion is formed by amino acid residues spread 
throughout the molecule and not by linear export sequence (Nickel, 2005). 
Comparable to the HSPG-binding site (see section 1.3.1.2) (Raman et al., 2003) this 
motif would be inseparably linked to a correct three-dimensional conformation of the 
molecule. Quality control could be mediated by rejection of misfolded molecules. This 
scenario is similar to protein import into peroxisomes, a process by which fully folded 
proteins are translocated into the peroxisomal lumen without the existence of a 
chaperone system (Titorenko et al., 2002). 
Evidence contributing to the plasma membrane-resident transporter quality control 
hypothesis comes from protein import into chloroplasts and bacterial transporters 
involved in protein secretion. These system also mediate transport of fully folded 
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cargo molecules (Robinson and Bolhuis, 2004). In the case of the bacterial twin-
arginine translocation (Tat) system it was observed that the transporter even 
mediates export of oligomeric, co-factor containing complexes and can sense the 
folding state of the cargo as a quality control measure (DeLisa et al., 2003) 
 
1.5 Use of Dihydrofolate Reductase in Protein Folding Analysis 
 
Dihydrofolate Reductase (DHFR) is an enzyme of the nucleotide synthesis pathway 
involved in thymidylate synthesis (Hartman, 1993). It catalyzes the NADPH-
dependent regeneration of tetrahydrofolate from dihydrofolate. Tetrahydrofolate is the 
carrier of the activated methylene group that is added to dUMP to form dTMP. DHFR 
can be inhibited by methotrexate or aminopterin which bind competitively to the 
active center with a Ki < 10-9 M. Methotrexate and aminopterin are analogues of 
folate and inhibit the reaction cycle that generates thymidylate for DNA synthesis. 
These Inhibitors are used in cancer treatment as antimetabolites because actively 
proliferating cells need large amounts of nucleotides for DNA replication. They are 
known since the middle of last century (Hertz et al., 1956; Hunter and Carroll, 1949).  
DHFR can be used in experimental systems to investigate protein folding because 
the protein is highly stabilized in its folded conformation upon binding of i.e. 
methotrexate or aminopterin. Chaperones or membrane translocation machineries 
like pore-complexes are not able to unfold DHFR in the presence of aminopterin or 
methotrexate. Under these conditions, DHFR is even resistant to protease digestion 
(Salvador et al., 2000). Therefore, it is possible to generate fusion constructs of cargo 
proteins linked to DHFR whose export or membrane translocation is dependent on 
unfolding. Another important feature is that the system can be used for in vivo studies 
since aminopterin or methotrexate can pass cellular membranes probably involving a 
folate transporter and bind to intracellular DHFR. The system is well known and 
different studies were performed to analyze import into organelles or transport 
machineries in general. Examples are mitochondrial protein import (Eilers and 
Schatz, 1986; Rassow et al., 1989; Verner and Schatz, 1987; Wienhues et al., 1991), 
chloroplast membrane translocation (Endo et al., 1994; Guera et al., 1993), substrate 
specificity of the GroEL system (Braig et al., 1993; Mayhew et al., 1996), protein 
import into lysosomes (Salvador et al., 2000), glycosomal protein import in 
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trypanosomes (Häusler et al., 1996), uptake of bacterial toxins by cells (Haug et al., 
2003) or bacterial protein export (Arkowitz et al., 1993). Even questions addressing 
classical secretion processes were investigated using the DHFR system (Kida et al., 
2005). 
 
1.6 Aim of the Present Study 
 
The aim of the present study was to analyze the folding state of FGF2 during 
unconventional secretion. For this purpose two experimental systems were applied. 
The first analyzes whether FGF2 has to be unfolded for non-classical export. The 
second investigates whether correct folding is maintained during unconventional 
export of FGF2 or whether the conformation of the cargo molecule is changed. 
Moreover, the second approach investigates the existence of quality control 
measures for unconventional export processes. To experimentally address these 
questions cell lines were generated using a retroviral transduction system, which 
express different FGF2 fusion-proteins in a doxicycline-dependent manner (Engling 
et al., 2002). 
For the first experimental approach an in vivo system which reconstitutes non-
classical FGF2 export in CHO cells was established. An advantage of CHO cells is 
that they do not possess FGFRs which excludes induction of differentiation 
processes mediated by exported FGF2. To generate reporter cell lines a construct 
consisting of FGF2 fused to the fluorescent reporter molecule GFP and DHFR 
(FGF2-GFP-DHFR) was stably integrated into the genome of the target cell line 
CHOMCAT-TAM2. The GFP tag facilitates the detection of exported material which 
rebinds to HSPGs on the cell surface by flow cytometry and confocal microscopy 
using its intrinsic fluorescence activity or by specific antibody staining (Engling et al., 
2002). Furthermore, it allows the analysis of the intracellular distribution of the fusion 
protein accessible by confocal microscopy. The addition of the DHFR domain 
integrates a unit which mediates control of the folding state in an aminopterin-
dependent manner (see section 1.5) (Eilers and Schatz, 1986). As a control a 
mitochondrial targeting sequence was fused to GFP and DHFR (MTS-GFP-DHFR) to 
verify the functionality of the aminopterin-dependent translocation arrest by inhibition 
of unfolding of the reporter construct during mitochondrial import. To investigate 
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whether FGF2 needs to be unfolded for export, flow cytometry and confocal 
microscopy analyses were performed in the absence and presence of aminopterin. 
Specific antibodies directed against the N- and extreme C-terminus of the molecule 
were used to analyze whether translocation of the reporter construct occurs 
completely. 
The second experimental approach makes use of a so called piggyback export 
analysis system. It consists of FGF2 fused to the Fc-part of the mouse 
immunoglobulin 2α (IgG2α). A second reporter construct was generated which is 
comprised of GFP fused to bacterial Protein A. IgG2α and Protein A are known to 
form a stable complex if both molecules are folded correctly. The two reporter 
constructs were introduced into CHO cells using a bicistronic expression vector which 
allows expression of two distinct proteins from one mRNA in a doxicycline-dependent 
manner. The system was used to investigate whether FGF2 maintains its folding 
state during membrane translocation. As a read-out the extracellular appearance of 
the complex consisting of FGF2-IgG2α and GFP-Protein A was monitored. Additional 
cell lines were generated which contain conventionally exported FGF4 with a signal 
sequence (FGF4-S), unconventionally secreted FGF1 instead of FGF2 or no FGF 
moiety at all to be used as controls. The system addresses the question whether the 
machinery mediating FGF2 plasma membrane translocation is capable of exporting 
oligomeric complexes like the bacterial Tat-system and whether, therefore, putative 
means of quality control could apply during the export process (see section 1.4) 
(DeLisa et al., 2003). 
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2 Material and Methods 
 
2.1 Material 
 
2.1.1 Chemicals 
 
Agar  Becton Dickinson, Le Pont de Claix, France 
Agarose electrophoresis grade Invitrogen, Paisley, UK 
Aminopterin Sigma-Aldrich Chemie GmbH, Steinheim 
Ammonium chloride Carl Roth GmbH, Karlsruhe 
Ampicillin sodium salt Gerbu Biotechnik GmbH, Gaiberg 
APS (Ammonium peroxo disulfate) Carl Roth GmbH, Karlsruhe 
αMEM Biochrom AG, Berlin 
Bromphenol Blue Na-salt Serva Electrophoresis GmbH, Heidelberg 
BSA (Bovine serum albumine, Albumin fraction V) Carl Roth GmbH, Karlsruhe 
β-Mercaptoethanol  Merck, Darmstadt 
Calcium chloride dihydrate Applichem, Darmstadt 
Cell dissociation buffer (CDB) Invitrogen, Paisley, UK 
Chloroquine Sigma-Aldrich Chemie GmbH, Steinheim 
CL-4B Sepharose (Beads) Amersham Biosciences AB, Uppsala, Sweden 
Clear Nail Protector Wet’n Wild USA, North Arlington, USA 
Complete Mini (Protease Inhibitor Cocktail Tablets) Roche Diagnostics, Mannheim 
Deoxycholic acid sodium salt Sigma-Aldrich Chemie GmbH, Steinheim 
DMEM Biochrom AG, Berlin 
DMSO (Dimethyl sulfoxide) J.T. Baker, Deventer, USA 
dNTP-Mix Peqlab, Erlangen 
Doxicycline Clontech, Palo Alto, USA 
ECL Western Blotting Detection Reagent Amersham Biosciences AB, Uppsala, Sweden 
EDTA (Ethylene diamine tetraacetic acid) Merck, Darmstadt 
Ethanol pro analysi Riedel-de Haën, Seelze 
EZ-Link Sulfo-NHS-SS-Biotin Pierce, Perbio Sciences, Bonn 
FCS (Fetal Calf Serum) PAA Laboratories GmbH, Linz, Austria 
Fluoromount G Southern Biotechnologies Inc., Birmingham, USA 
Glacial acidic acid Carl Roth GmbH, Karlsruhe 
Glycerol Carl Roth GmbH, Karlsruhe 
Glycine  Applichem, Darmstadt 
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Hepes Carl Roth GmbH, Karlsruhe 
Isopropanol Merck, Darmstadt 
Kanamycin sulfate Gerbu Biotechnik GmbH, Gaiberg 
L-Glutamine Biochrom AG, Berlin 
Magnesium chloride hexahydrate Applichem, Darmstadt 
Methanol pro analysi Merck, Darmstadt 
Milk Powder Carl Roth GmbH, Karlsruhe 
Nonidet P40 (NP-40) Roche, Mannheim 
Paraformaldehyde Electron Microscope Sciences, Hatfield, UK 
Penicillin/Streptomycin for cell culture Biochrom AG, Berlin 
Ponceau S Serva Electrophoresis GmbH, Heidelberg 
Potassium dihydrogen carbonate Carl Roth GmbH, Karlsruhe 
Potassium hydroxide J.T.Baker, Deventer, USA 
Protein A-Sepharose (Beads) Amersham Biosciences AB, Uppsala, Sweden 
PVDF Membrane Immobilon FL Millipore Corporation, Bedford 
PVDF Membrane Immobilon P Millipore Corporation, Bedford 
Rotiphorese Gel 30 (37.5:1) Carl Roth GmbH, Karlsruhe 
Sodium chloride J.T. Baker, Deventer, USA 
Sodium dodecyl sulfate  Serva Electrophoreis GmbH, Heidelberg 
Sodium hydrogen carbonate J.T. Baker, Deventer, USA 
Sodium hydroxide  J.T. Baker, Deventer, USA 
Superdex 200 Beads Amersham Biosciences AB, Uppsala, Sweden 
Temed (N,N,N',N'-tetramethylethylenediamine) Bio-Rad, München 
Trichloroacetic acid Carl Roth GmbH, Karlsruhe 
Tris Carl Roth GmbH, Karlsruhe 
Trition X-100 Roche, Mannheim 
Trypsin Sigma-Aldrich Chemie GmbH, Steinheim 
Trypsin / EDTA for cell culture Biochrom AG, Berlin 
Tryptone Becton Dickinson, Le Pont de Claix, France 
Tween 20 (Polyoxyethylenesorbitan monolaurate) Carl Roth GmbH, Karlsruhe 
UltraLink immobilized streptavidin (Beads) Pierce, Perbio Sciences, Bonn 
Whatman MM  Whatman AG, Würzburg 
Xylencyanol FF Serva Electrophoresis GmbH, Heidelberg 
Yeast Extract Becton Dickinson, Le Pont de Claix, France 
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2.1.2 Technical Devices 
 
Agaros Gel Electrophoresis  
Anthos 2001 Microplate Photometer Anthos, Hombrechtikon, Switzerland 
Bacterial Incubator Infors HT ITE Infors AG, Einsbach 
Bacterial Shaker Centromat R Braun, Melsungen 
Centrifuge 5415 R Eppendorf, Hamburg 
Centrifuge 5417 R Eppendorf, Hamburg 
Centrifuge Avanti J-25 Beckman Coulter, Krefeld 
Centrifuge Megafuge 1.0 R Kendro, Langenselbold 
Centrifuge Optima TLX Ultracentrifuge Beckman Coulter, Krefeld 
Centrifuge Rotor Sorvall SS-34 Kendro, Langenselbold 
Centrifuge Sorvall Evolution RC Kendro, Langenselbold 
Centrifuge Sorvall RC 6 Kendro, Langenselbold 
Ultracentrifuge Rotor TLA-45 Beckman Coulter, Krefeld 
FACSAria Becton Dickinson, Heidelberg 
FACSVantage Becton Dickinson, Heidelberg 
FACSCalibur Becton Dickinson, Heidelberg 
Gel Doc 2000 Bio-Rad, München 
Incubator Heraeus CO2-Auto-Zero Kendro, Langenselbold 
LKB Ultraspec III Amersham Biosciences, Freiburg 
Microscope Axiovert 40 C Zeiss, Göttingen 
Microscope LSM 510 Meta Confocal Zeiss, Göttingen 
Mini Trans-Blot Cell Bio-Rad, München 
Mini-PROTEAN 3 Electrophoresis System Bio-Rad, München 
Nanodrop ND-1000 Spectrophotometer Peqlab, Erlangen 
Odyssey Infrared Imaging System LI-COR Biosciences, Bad Homburg 
PCR Primus Advanced 25 and 96 Peqlab, Erlangen 
pH-Meter 766 Calimatic Knick, Egelsbach 
Power Pack 200 and 300 Bio-Rad, München 
Roto-Shake Genie Scientific Industries, Bohemia, USA 
SMART System Amersham Biosciences, Freiburg 
Sonifier Cell Disruptor B 30 Heinemann, Schwäbisch Gmünd 
Sonorex Super RK 103 h Bandelin, Berlin 
Super RX Medical X ray film Fujifilm, Düsseldorf 
Thermomixer compact and comfort Eppendorf, Hamburg 
Tricorn 5/150 Column Amersham Biosciences, Freiburg 
Wide Mini-Sub Cell GT Bio-Rad, München 
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2.1.3 Plasmids 
 
173.174.IgG2apBSII Ingrid Haas, MPI, Freiburg 
peGFP-1 Clontech, Mountain View, USA 
pET15b-FGF2 Matthias Wuttke, AG Nickel, BZH, Heidelberg 
pET24-FGF1 Matthias Wuttke, AG Nickel, BZH, Heidelberg 
pET24-FGF4-S Matthias Wuttke, AG Nickel, BZH, Heidelberg 
pFB-hrGFP Stratagene, La Jolla, USA 
pGEM-T Promega, Madison, USA 
pGEM-T-TAP-Tag Christoph Zehe, AG Nickel, BZH, Heidelberg 
pQE16 Qiagen, Hilden 
pRevTRE2 Clontech, Mountain View, USA 
pRevTRE2-FGF2-GFP Sabine Wegehingel, AG Nickel, BZH, Heidelberg 
pRTi Jörg Mölleken, AG Wieland, BZH, Heidelberg 
pVPack Eco Stratagene, La Jolla, USA 
pVPack GP Stratagene, La Jolla, USA 
pYES-mtGFP1 Benedikt Westermann, LMU, München 
 
2.1.4 Primers and Oligonucleotides 
 
Primers and oligonucleotides were purchased from Thermo Electron Company. All 
sequences are listed in 5’ to 3’ direction. Reverse primers and oligonucleotides 
labelled with ‘rev’ in the title were ordered as reverse complement sequences. 
 
PCR primers for DHFR constructs 
 
DHFR-Cystein-BsrGI-for: 44 bases, Tm: 66°C 
Overhang – BsrGI – 2 bases for in frame – sequence DHFR (mutation: ser to cys) 
gactgg-tgtaca-ag-atg gtt cga cca ttg aac tgc atc gtc gcc 
 
FGF2-GFP-DHFR-REV: 37 bases, Tm:60°C 
Sequence DHFR – ClaI – overhang 
ccagatctcatcaccatcaccatcactaa-atcgat-gg 
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mtpre HindIII for: 27 bases, Tm: 59°C 
HindIII – sequence MTS 
ccaagctt-atggcctccactcgtgtcc 
 
mtpre AgeI rev: 24 bases, Tm: 61°C 
sequence MTS (without stop codon) - AgeI 
cgcgcctactcttcc-gcaccggtc 
 
PCR primers for piggyback constructs 
 
L-FGF1-for: 39 bases, Tm: 54°C 
PmeI – Kozak sequence – sequence FGF1 
gtttaaac-cgccacc-atggctgaaggggaaatcaccacc 
 
L-FGF1-rev: 30 bases, Tm: 56°C 
sequence FGF1 (without stop codon) – HindIII 
ctccccctgccagtctcttctgat-aagctt 
 
L-FGF2-for: 35 bases, Tm: 53°C 
PmeI – Kozak sequence – sequence FGF2 
gtttaaac-cgccacc-atggcagccgggagcatcac 
 
L-FGF2-rev: 39 bases, Tm: 56°C 
sequence FGF2 (without stop codon) – HindIII 
gctatactttttcttccaatgtctgctaagagc-aagctt 
 
L-FGF4-for: 33 bases, Tm: 56°C 
PmeI – Kozak sequence – sequence FGF4-S 
gtttaaac-cgccacc-atgtcggggcccgggacg 
 
L-FGF4-rev: 26 bases, Tm: 55°C 
sequence FGF4-S (without stop codon) – HindIII 
cccacttcctccccaggctg-aagctt 
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L-GFP-for: 43 bases, Tm: 55°C 
BamHI – FseI – Kozak sequence - sequence eGFP 
ggatcc-ggccggcc-cgccacc-atggtgagcaagggcgaggagc 
 
L-GFP-rev: 30 bases, Tm: 56°C 
sequence eGFP – SalI 
ctcggcatggacgagctgtacaag-gtcgac 
 
L-IgG2a-for: 41 bases, Tm: 59°C 
HindIII – 2 base for in frame - Kozak sequence – artificial ATG – sequence IgG2α 
aagctt-gc-cgccacc-atg-gatcaggagcccagagggcccac 
 
L-IgG2a-rev: 31 bases, Tm: 54°C 
sequence IgG2a (without stop codon) – NotI 
gcttctcccggactccaggtaaa-gcggccgc 
 
L-ProtA-for: 28 bases, Tm: 53°C 
SalI – sequence ProtA 
gtcgac-aaaaccgcggctcttgcgcaac 
 
L-ProtA-rev: 29 bases, Tm: 56°C 
sequence ProtA (without stop codon) – HindIII 
cgaattccgcggggaagtcaacc-aagctt 
 
Oligonucleotides for piggyback constructs: 
 
L-LuxA-NES-for: 62 bases, Tm: 71°C 
NotI open – 1 base for in frame – SGG-Linker – NES sequence– PacI – ClaI open 
5’- ggccgc-t-agcggcggc-ctgcagaagaagctggaggagctggagctggactaa-ttaattaa-at -3’ 
 
L-LuxA-NES-rev: 60 bases, Tm: 71°C 
NotI open – 1 base for in frame – SGG-Linker – NES sequence– PacI – ClaI open 
3’- cg-a-tcgccgccg-gacgtcttcttcgacctcctcgacctcgacctgatt-aattaatt-tagc-5’ 
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L-LuxB-NES-for: 60 bases, Tm: 75°C 
HindIII open – SGG-Linker – NES sequence– SbfI – NotI open 
5’- agctt-agcggcggc-ctgcagaagaagctggaggagctggagctggactaa-cctgcagg-gc-3’ 
 
L-LuxB-NES-rev: 60 bases, Tm: 76°C 
HindIII open – SGG-Linker – NES sequence– SbfI – NotI open  
3’- a-tcgccgccg-gacgtcttcttcgacctcctcgacctcgacctgatt-ggacgtcc-cgccgg-5’ 
 
2.1.5 DNA Modifying Enzymes 
 
AmpliTaq Polymerase Perkin Elmer (Roche), Branchburg, USA 
BamHI New England Biolabs, Frankfurt 
BsrGI New England Biolabs, Frankfurt 
Calf Intestinal Phosphatase (CIP) New England Biolabs, Frankfurt 
ClaI New England Biolabs, Frankfurt 
FseI New England Biolabs, Frankfurt 
HindIII New England Biolabs, Frankfurt 
NotI New England Biolabs, Frankfurt 
PacI New England Biolabs, Frankfurt 
PmeI New England Biolabs, Frankfurt 
SalI New England Biolabs, Frankfurt 
SbfI New England Biolabs, Frankfurt 
 
2.1.6 Bacteria and Bacterial Media 
 
For transformation and plasmid amplification competent DH5α cells (Invitrogen) or 
XL1-Blue supercompetent cells (Stratagene) were used. They were grown in LB 
medium (Luria Bertani medium) or on LB agar plates supplied with ampicillin or 
kanamycin in a final concentration of 100 µg/ml to select for successfully transformed 
cells carrying plasmids with a resistance gene. 
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Bacteria: subcloning efficiency DH5α competent cells, 
Genotype: F- φ80dlacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 
hsdR17(rk-, mk+) phoA supE44 λ- thi-1 gyrA96 relA1 
 
  XL1-Blue supercompetent cells, 
Genotype: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ 
proAB lacIqZΔM15 Tn10 (Tetr)] 
 
LB medium:  0.5 - 1.0% NaCl (w/v) 
   1%  Tryptone (w/v) 
   0.5%  Yeast Extract (w/v) 
     ddH2O 
 
LB agar plates: 0.5 - 1.0% NaCl (w/v) 
   1%  Tryptone (w/v) 
   0.5%  Yeast Extract (w/v) 
   1.5%  Agar (w/v)   
ddH2O 
 
2.1.7 Eukaryotic Cell Lines 
 
HEK293T cells (Human Embryonic Kidney cells) were used as a host cell line for the 
production of retroviral particles carrying the various reporter constructs.  
CHO cells (Chinese Hamster Ovary cells) were used as target cells for retroviral 
transduction. They were stably transduced with cDNA constructs and subsequently 
used for the expression of reporter molecules to function as an eukaryotic in vivo 
system to investigate proteins in a living cell environment. All reporter cell lines used 
for later analyses were generated using CHO cells. 
 
Eukaryotic cell lines: CHO cells (ECACC; Ref. No. 85050302) 
    HEK293T cells (ATCC, Ref. No. CRL-11268) 
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2.1.8 Eukaryotic Cell Culture Media 
 
αModification of the Minimal Essential Medium (αMEM) 
 
The αModification of the Minimal Essential Medium (Biochrom AG) was used to 
cultivate CHO cells. Dry medium was dissolved in 5 l ddH2O, and 10 g of sodium 
hydrogencarbonate were added to adjust the pH to 7.4, which was checked 
continuously. The prepared medium was sterile filtered into autoclaved bottles and 
stored at 4°C. Before addition to cells the medium was supplemented with 10% (v/v) 
fetal calf serum (FCS) and 100 µg/ml Streptomycin / Penicillin. If the medium was 
stored longer than six weeks, 2 mM glutamine were added. 
 
Dulbecco’s Modified Eagle Medium (DMEM) 
 
Dulbecco’s Modified Eagle Medium (Biochrom AG) was used to cultivate HEK cells. 
Dry medium was dissolved in 5 l ddH2O and 10 g of sodium hydrogencarbonate were 
added to adjust the pH to 7.4, which was checked continuously. The prepared 
medium was sterile filtered into autoclaved bottles and stored at 4°C. If the medium 
was stored longer than six weeks, 2 mM glutamine were added. Before addition to 
cells the medium was supplemented with 10% (v/v) fetal calf serum and 100 µg/ml 
Streptomycin / Penicillin. 
 
2.1.9 Antibodies 
 
Primary antibodies: 
 
To detect GFP containing reporter constructs, affinity-purified anti-GFP antibodies 
(Pineda Antibodies, acidic elution) were used (Engling et al., 2002). They were 
applied in a 1:200 dilution for Western blot and FACS analysis and in a 1:50 dilution 
for confocal microscopy. When performing immunoprecipitation or co-
immunoprecipitation experiments 10 µl of affinity-purified anti-GFP antibodies 
(Pineda Antibodies, basic elution, (Engling et al., 2002) or affinity-purified anti FGF2 
antibodies (Pineda Antibodies, acidic elution) were used per reaction. To analyze 
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DHFR containing reporter constructs, monoclonal anti DHFR antibodies (Becton 
Dickinson) were applied in a 1:250 dilution for Western blot analysis. To probe for 
reporter proteins containing a His6-tag, Penta-His antibodies (Qiagen) were used. 
They were applied in a 1:200 dilution in Western blot, FACS and confocal microscopy 
analysis. To detect mouse IgG2α containing reporter constructs, goat anti mouse IgG 
Allophycocyanin-coupled antibodies (Molecular Probes) were used in a 1:500 dilution 
for FACS analysis. For Western blot analysis goat anti mouse IgG Alexa 680-coupled 
antibodies (Molecular Probes) were applied in a 1:1000 dilution. 
 
Secondary antibodies: 
 
Secondary antibodies for Western blot analysis were goat anti rabbit IgG HRP-
coupled antibodies (Bio-Rad), goat anti mouse IgG HRP-coupled antibodies (Bio-
Rad), monoclonal mouse anti rabbit IgG clone RG-16 HRP-coupled antibodies 
(Sigma-Aldrich), goat anti rabbit IgG Alexa 680-coupled antibodies (Molecular 
Probes) and goat anti mouse IgG Alexa 680-coupled antibodies (Molecular Probes). 
HRP-coupled antibodies, except RG-16, were applied in a 1:5000 dilution and Alexa 
680-coupled antibodies in a 1:10000 dilution. RG-16 HRP-coupled antibodies were 
diluted 1:3000. Secondary antibodies for FACS analysis were goat anti rabbit IgG 
and goat anti mouse IgG antibodies, both conjugated with Allophycocyanin 
(Molecular Probes). They were used in a 1:750 dilution. Secondary antibodies for 
confocal microscopy were goat anti rabbit or goat anti mouse IgG Alexa 546-coupled 
antibodies (Molecular Probes). They were applied in a 1:1000 dilution. 
 
2.2 Molecular Biological Methods 
 
2.2.1 Bacterial Transformation 
 
To transform DH5α cells, 1 µl of plasmid DNA (1-10 ng DNA) or 5 µl of a ligation 
reaction were added to 30 µl bacteria and incubated on ice for 30 min followed by a 
heat shock of 20 s at 37°C and an additional incubation period of 2 min on ice. After 
that 1 ml LB medium without antibiotics was added followed by incubation at 37°C for 
1 h under constant shaking (300 rpm).  
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To transform XL1-Blue cells, 1 µl of plasmid DNA (1-10 ng DNA) or 5 µl of a ligation 
reaction were added to 50 µl bacteria and incubated on ice for 30 min followed by a 
heat shock of 45 s at 42°C and an additional incubation period of 2 min on ice. After 
that 1 ml LB medium without antibiotics was added followed by incubation at 37°C for 
1 h under constant shaking (300 rpm).  
Bacteria were then spread on LB plates supplemented with 100 µg/ml ampicillin or 
kanamycin and incubated at 37 °C for 12 to 16 h or used to inoculate liquid cultures 
of LB medium supplemented with the respective antibiotic at 37°C for 12 to 16h 
under constant skaking (180 rpm). 
 
2.2.2 Selection and Amplification of Plasmids 
 
If bacteria were grown on agar plate in correct density, they form colonies each 
originating from a single bacterium. To obtain genetically identical plasmids, bacteria 
from one colony were transferred to 5-10 ml LB medium using a 20 µl pipet tip. The 
liquid cultures which contain the respective antibiotic to select for bacteria carrying 
the plasmid with the resistance gene were incubated at 37°C for 12 to 16h under 
constant shaking (180 rpm). 
 
2.2.3 Plasmid Preparation 
 
Plasmids were prepared from overnight LB medium cultures of transformed bacteria 
by the application of Qiagen or Macherey & Nagel Plasmid DNA purification kits. The 
kit used is dependent on the volume of the overnight culture. 
 
Culture Volume Qiagen Kit Macherey & Nagel Kit 
5 - 10 ml QIAprep Spin Miniprep Kit Nucleospin Plasmid 
20 - 50 ml QIAGEN Plasmid Midi Kit Nucleobond-PC 100 
More than 150 ml QIAGEN Plasmid Maxi Kit Nucleobond-PC 500 
 
Purification was performed following the manufacturer’s manual employing alkaline 
lysis and binding of DNA to silica membranes or anion-exchange resins, respectively. 
Elution of the DNA was performed using appropriate volumes of ddH2O. 
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2.2.4 Determination of DNA Concentration 
 
The concentration of a DNA solution was determined photometrically by measuring 
the absorption at 260 nm wavelength. The measurement was either performed in a 
photometer with a diluted DNA solution using a quarz cuvette with a thickness of 10 
mm or by directly measurement 1 µl of the DNA solution in a Nanodrop photometer. 
The concentration of double stranded DNA was calculated based on the fact that an 
optical density (OD) of 1 corresponds to a concentration of 50 µg/ml. 
To determine contamination the OD at 280 nm was measured additionally. The ratio 
OD260 / OD280 represents the grade of purity since pure DNA shows a value between 
1.8 and 2.0. Values above 2.0 show contamination with RNA, values below 1.8 
contamination with protein. 
 
2.2.5 Agarose Gel Electrophoresis 
 
To separate mixtures of DNA molecules by size, agarose gel electrophoresis was 
used. Separation was achieved by subjecting the negatively charged DNA molecules 
after loading on a gel matrix with a defined pore size to an electric field where they 
migrate to the anode. The migration speed depends on the size of the DNA 
molecules and is limited by the pore size of the gel which was controlled by the 
amount of agarose used. 
Agarose gels were prepared by heating 1% agarose (w/v) in TAE buffer. After the 
agarose was dissolved, ethidiumbromide in a final concentration of 0.5 µg/ml was 
added. The gel was poured into an agarose gel casting chamber and a plastic comb 
was inserted which forms the loading wells. After hardening the gel can be stored at 
4°C until use up to two weeks. 
To perform electrophoresis the gel was transferred into an agarose gel running 
chamber (Wide Mini-Sub Cell GT, Bio-Rad) and TAE was added until the gel is 
completely covered with liquid. Samples containing DNA sample buffer in a 1:5 
dilution were loaded on the gel and electrophoresis is performed at 100 V until 
sufficient separation was reached as visualized by the migration behaviour of the 
blue bromphenol marker front. Agarose gels were documented using the Gel Doc 
2000 imaging system (Bio-Rad). 
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TAE buffer (50x):  2 M  Tris 
  1 M  Glacial acidic acid 
  50 mM EDTA, pH 8 
    ddH2O 
 
DNA sample buffer (5x): 0.25%  Bromphenol blue (w/v)  
  0.25%  Xylencyanol FF (w/v) 
  30%  Glycerol (w/v) 
    ddH2O 
 
2.2.6 DNA Marker 
 
As a size standard two premixed DNA ladders were used, the 1 kB DNA ladder and 
the 100 bp DNA ladder (New England Biolabs). They contain DNA fragments of 
defined sizes ranging from 100 to 1500 bp (100 bp ladder) to analyze smaller DNA 
fragments or from 500 to 10.000 bp (1 kb ladder) to analyze large inserts and 
vectors. The markers were applied by loading 10 µl of a stock solution containing 
0.05 µg/µl DNA in DNA sample buffer. Since each band of the marker contains a 
defined amount of DNA, the marker can be used to approximate the mass of DNA of 
an unknown sample by comparing band intensities visually.  
 
2.2.7 Polymerase Chain Reaction 
 
To amplify a gene or DNA fragment the polymerase chain reaction (PCR) was used 
(Lawyer et al., 1989; Saiki et al., 1988). During PCR a DNA template defined by a 
forward and reverse primer is amplified and can be used for further cloning to 
generate desired reporter constructs. PCRs were performed with the enzyme 
AmpliTaq polymerase (Perkin Elmer) which generates adenosine overhangs at the 
3’-end. This is important when using the pGEM-T vector system for further cloning 
since the vector contains thymidine overhangs at its 3’-end for simplified ligation of 
PCR products. The following reaction mix was used for PCRs. 
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50 ng template DNA 
25 pmol forward primer 
25 pmol reverse primer 
2.5 units Taq polymerase 
10 mM dNTPs 
25 mM MgCl2 
1x PCR buffer II 
 ddH2O 
 
The reaction was performed employing a Primus Advance Thermocycler (PeqLab). 
The following program was used to amplify template DNA. 
 
Denaturation  2 min, 95°C    
Amplification  45 s, 94°C   Denaturation 
   1 min, T<Tm of primers Hybridization  30 cycles 
   1 min, 72°C   Elongation 
Elongation  10 min, 72°C    
Store   ∞, 4°C 
 
The annealing temperature was chosen depending on the melting temperatures (Tm) 
of the primers used. 5°C were subtracted from the lowest Tm of all primers used (T = 
Tm – 5°C). The melting temperature for each individual primer was calculated 
according to the following equation. 
 
 
[Na+] = 0.05 M; %GC = GC content of annealing sequence; N = number of annealing basepairs 
 
When problematic primers were used which result in very low yields or lead to no 
amplification at all, up to 10% DMSO (dimethyl sulfoxide) were added to the reaction 
mix. DMSO reduces secondary structures like loops or hairpins and the primers can 
anneal more easily at the template. A disadvantage of DMSO is, that mutations and 
mispairing of bases occur more frequently. When using DMSO, it is of great 
importance, to sequence obtained PCR products, to verify the correct sequence 
before using them for further cloning. 
[ ]
N
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+
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2.2.8 PCR Purification 
 
To purify PCR products and remove primers and reaction mix components, the 
samples were processed using a PCR purification kit (QiaQuick PCR purification kit, 
Qiagen). DNA is bound to a silica membrane under high salt conditions and eluted 
after washing with an appropriate volume of ddH2O. 
 
2.2.9 Gel Extraction of DNA Fragments 
 
To purify desired DNA fragments after restriction digests, the reaction mix was 
separated on a 1% agarose gel. The bands were transiently visualized with a UV 
lamp (366 nm) and cut out of the gel with a sharp blade. To purify the DNA from the 
agarose gel the samples were processed using a gel extraction kit (Qiagen). The 
agarose was melted in a specific buffer and DNA is bound to a silica membrane 
under high salt conditions. Following a washing step Elution was performed in an 
appropriate volume of ddH2O. 
 
2.2.10 Restriction Digests 
 
Restriction enzymes were purchased from New England Biolab. Restriction digests 
were performed according to the manufacturer’s manual. An optimized buffer system 
consisting of buffer 1 to 4 of which one is optimal for a specific enzyme was used. 
Additionally, unique buffers for certain enzymes are available. In the case of a double 
digest a buffer was chosen which provides the highest cleavage efficiency for both 
enzymes or the digest was performed sequentially with a DNA purification step in 
between. Depending on the enzyme and the quality of the DNA 1 to 5 units/µg DNA 
were used in the restriction digest incubated 2 to 4 h at 37°C. 
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2.2.11 DNA Dephosphorylation 
 
To dephosphorylate linearized vectors at the 5’-end after restriction digests in order 
to prevent self-ligation Calf Intestinal Phosphatase (CIP, New England Biolabs) was 
added to the reaction mix in a concentration of 1 u/µg DNA for 30 min at 37°C. The 
enzyme was heat inactivated by incubation at 70°C for 10 min. 
 
2.2.12 Ligation of DNA Fragments 
 
In order to ligate PCR products or other DNA fragments to each other or into 
linearized vectors a ligation kit was used (Ver. 2.1, Takara Bio Inc.). The ligation 
partners were digested with the same restriction enzymes to provide compatible 
ends. Following the manual, 50 ng of vector (or the longer DNA fragment) were used. 
The amount of insert (or the shorter DNA fragment) was calculated according to the 
following equation. 
 
 
The DNA solutions and 5 µl of Takara Solution 1 which contains the T4 DNA ligase 
and an optimized buffer in a 2 fold concentration were mixed and ddH2O was added 
to a total volume of 10 µl. The reaction was incubated for 2 h at room temperature or 
for at least 16 h at 4°C. After the incubation period the enzyme was heat inactivated 
by incubation at 70°C for 10 min. 
 
2.2.13 DNA Sequencing 
 
Cloned inserts or cDNA constructs in different plasmids were sequenced in order to 
rule out mutations and to verify the correct sequence. Therefore, plasmid samples 
and primers were sent to commercial sequencing companies (Seqlab, Göttingen or 
GATC, Konstanz). Obtained sequences were analyzed using the Lasergene software 
suite (Lasergene, DNAStar) or the ‘align 2 sequences’ function on the BLAST project 
in the world wide web (http://www.ncbi.nlm.nih.gov/blast/bl2seq/wblast2.cgi). 
[ ] [ ]
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2.2.14 Cloning Strategy: cDNA Constructs of the DHFR Approach 
 
To generate the cDNA constructs FGF2-GFP-DHFR and MTS-GFP-DHFR the 
plasmid pQE16 (Qiagen) was used as a template to clone the DHFR moiety. pQE16 
contains the open reading frame (ORF) of murine DHFR with a mutation of wildtype 
cysteine at position 7 to serine by exchange of two basepairs at the respective 
position. To reverse the mutation a forward primer was designed which contains the 
nucleotide sequence coding for a cysteine residue at position 7 (see section 2.1.4, 
primer: DHFR-Cystein-BsrGI-for). The construct MTS-GFP-DHFR was generated 
according to the cloning strategy depicted in Fig. 2.1. 
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Fig. 2.1 Schematic overview: cloning strategy DHFR constructs. 
MTS = mitochondrial targeting sequence from the S9 subunit of the F0-ATPase (Neurospora crassa), 
GFP = enhanced green fluorescent protein (Aequoria victoria), DHFR = dihydrofolate reductase (Mus 
musculus) 
 
As a first step a PCR was performed using the mitochondrial targeting sequence 
(MTS) of the S9 subunit of the mitochondrial F0 ATPase in the plasmid pYES-mtGFP-
1 as a template. The PCR product was purified and subcloned into the pGEM-T 
vector. After bacterial transformation and amplification of positive clones, the insert 
was sequenced and finally excised using the restriction enzymes HindIII and AgeI. 
The restriction sites for this digestion step were artificially introduced by the primers 
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used in the PCR (see section 2.1.4, primers: mtpre HindIII for, mtpre AgeI rev). In 
parallel the vector peGFP-1 (Clontech) which contains enhanced green fluorescent 
protein (GFP) was linearized using the same enzymes. After purification of the vector 
and the MTS insert a ligation was performed generating the construct MTS-GFP 
which is flanked 5’ by a HindIII and 3’ by a BsrGI restriction site. Sequencing was 
performed to verify correct ligation and to rule out frame shifts. Digestion with HindIII 
and BsrGI excised the insert MTS-GFP which was used for later cloning steps (Fig. 
2.1 A). The ORF of DHFR was amplified by PCR using the pQE16 vector (Qiagen) as 
a template. As described above, the serine at position 7 was mutated to a cysteine to 
restore wildtype conditions. The PCR product was subcloned into the pGEM-T vector 
and sequenced. Following amplification and purification of correct clones a digestion 
with the restriction enzymes BsrGI and ClaI was performed to generate the DHFR 
insert (Fig.2.1 B). The obtained inserts, MTS-GFP and DHFR, were ligated into the 
retroviral transduction vector pRevTRE2 in a triple ligation reaction. The vector was 
linearized with HindIII and ClaI to provide sticky ends which guarantee ligation of the 
inserts in the right sequence and orientation due to the used restriction sites. After 
amplification and purification, the insert was checked by digestion using HindIII and 
ClaI. The digestion reactions were analyzed by agarose gel electrophoresis followed 
by sequencing of positive clones to verify successful insertion (Fig. 2.1 C). 
To generate the construct FGF2-GFP-DHFR a similar cloning strategy was applied. 
Due to the availability in our laboratory it was not necessary to generate the insert 
FGF2-GFP. The plasmid pRevTRE2-FGF2-GFP was digested with NotI and BsrGI to 
obtain the insert FGF2-GFP. The vector pRevTRE2 was digested using NotI and 
ClaI. Then the inserts FGF2-GFP and DHFR, which was digested with BsrGI and 
ClaI as described above (Fig. 2.1 B), were ligated into pRevTRE2. After amplification 
and purification the construct was analyzed by digestion with NotI and ClaI. Digestion 
reactions were analyzed by agarose gel electrophoresis followed by sequencing of 
positive clones. 
Both constructs, MTS-GFP-DHFR and FGF2-GFP-DHFR in pRevTRE2, were used 
for retroviral transduction of CHOMCAT-TAM2 cells (see section 2.3.4) to generate cell 
lines expressing the reporter molecules. 
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2.2.15 Cloning Strategy: cDNA Constructs of the Piggyback Approach 
 
To generate the cDNA constructs used for the piggyback approach a three step 
cloning strategy was applied. Each construct consists of two ORFs enconding distinct 
proteins expressed from a bicistronic expression vector termed pRTi. pRTi is a 
derivative of the retroviral transduction vector pRevTRE2, which was modified by 
insertion of an internal ribosome entry site (IRES) into the existing multiple cloning 
site (MCS). The result is a bicistronic expression vector with two MCS separated by 
the IRES element. To be able to use the restriction enzymes required for the cloning 
strategy the MCS upstream of the IRES was further extended with additional 
restriction sites. 
The strategy to generate the cDNA constructs consists of three steps. In a first step 
the construct inserted upstream of the IRES element was generated. Second, the 
construct inserted downstream of the IRES element was produced. In the final step 
the two inserts were ligated sequentially into the pRTi vector. A schematic overview 
is presented in the following figure (Fig. 2.2). 
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Fig. 2.2 Schematic overview: cloning strategy piggyback constructs. 
IgG2α = Fc domain of immunoglobulin 2α (Mus musculus), Protein A = Protein A (Staphylococcus 
aureus), NES = nuclear export signal from mitogen activated protein kinase kinase 1 (Rattus 
norvegicus), FGF2 = fibroblast growth factor 2 (Homo sapiens), GFP = green fluorescent protein 
(Aequria victoria), IRES = internal ribosome entry site 
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To generate the construct inserted upstream of the IRES element, namely FGF2-
IgG2α-NES, a PCR was performed to amplify the ORF of the mouse immunoglobulin 
2α (IgG2α) from the plasmid 173.174.IgG2apBSII. Two artificial restriction sites, 
HindIII and NotI, were introduced by the primers used (see section 2.1.4, L-IgG2a-for 
and L-IgG2a-rev). The product was purified and ligated into the pGEM-T vector. After 
bacterial transformation, selection of clones, multiplication in bacteria and plasmid 
purification the insert was sequenced to verify correct amplification during PCR. Then 
a digestion was performed using the restriction enzymes HindIII and NotI and the 
excised insert was purified applying gel extraction. In parallel the synthetic 
oligonucleotides coding for a nuclear export signal (NES) were annealed (see section 
2.1.4, L-LuxA-NES-for, L-LuxA-NES-rev). They were designed to have a NotI 
restriction site at the 5’-end, as well as a PacI followed by a ClaI restriction site at the 
3’-end. After annealing the overhangs form sticky ends which allow direct ligation 
without digestion. The IgG2α insert and the NES oligonucleotide were ligated into the 
pRevTRE2 vector which was digested using HindIII and ClaI. After bacterial 
transformation, selection of clones, amplification in bacteria and plasmid purification 
the insert was sequenced to verify correct ligation and exclude frame shifts. In a next 
step a PCR was performed amplifying the ORF of human FGF2 from the plasmid 
pET15b-FGF2 and introducing artificial PmeI and HindIII restriction sites (for primers 
see section 2.1.4, L-FGF2-for and L-FGF2-rev). The PCR product was purified by gel 
extraction and ligated into pGEM-T. After transformation of bacteria clones were 
selected and propagated. The plasmids were purified and sequenced to check for 
correctly amplified inserts. In the next step the FGF2 insert was excised using PmeI 
and HindIII and ligated into pRevTRE2-IgG2α-NES. The plasmid was digested using 
the same enzymes due to the existence of a PmeI site upstream of the HindIII site in 
the MCS which was used before to insert IgG2α-NES. Therefore, it was then 
possible to link the two inserts into one continuous ORF. Following ligation, bacteria 
were transformed, clones were selected and propagated, plasmids were purified and 
the insert was sequenced. The correct insert was excised using PmeI and PacI and 
used for the next cloning step. A detailed overview of the procedure is depicted in 
Fig. 2.2 A. 
To generate the construct GFP-Protein A-NES which was inserted downstream of the 
IRES element the same cloning strategy was applied. In a first step, the ORF of 
protein A from the plasmid pGEM-T-TAP-Tag was amplified via PCR and artificial 
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SalI and HindIII restriction sites were introduced (for primers see section 2.1.4, L-
ProtA-for and L-ProtA-rev). The PCR product was subcloned into pGEM-T, 
sequenced and excised using SalI and HindIII. The Protein A insert was ligated into 
pRevTRE2 digested with SalI and NotI. Thereby, it was linked in a triple ligation with 
NES oligonucleotides which were designed with a HindIII restriction site at the 5’-end 
and a SbfI followed by a NotI restriction site at the 3’-end (for oligonucleotides ee 
section 2.1.4, L-LuxB-for and L-LuxB-rev). After ligation a correctly ligated clone was 
chosen and verified by sequencing. To insert the GFP moiety, a PCR was performed 
using the plasmid peGFP-1 as a template to generate the GFP insert which was 
subcloned into pGEM-T and sequenced. The primers used were designed to 
introduce a BamHI followed by a FseI restriction site at the 5’-end and a SalI 
restriction site at the 3’-end of the ORF (for primers see section 2.1.4, L-GFP-for and 
L-GFP-rev). After digesting the previously generated Plasmid pRevTRE2-Protein A-
NES with BamHI and SalI the GFP insert was ligated into the linearized vector to 
form the construct GFP-Protein A-NES. It was subsequently excised using FseI and 
SbfI and used for following cloning steps (Fig. 2.2 B). 
In the final step the pRTi vector was digested with PmeI and PacI which are located 
in the MCS upstream of the IRES element and the insert FGF2-IgG2α-NES which 
was excised using the same enzymes was ligated into the linerarized vector. The 
ligation products were used to transform bacteria and clones were selected. After 
verifying successfully ligated clones, was propagated and a digestion was performed 
using FseI and SbfI. These enzymes cut in the MCS downstream of the IRES 
element and were also used to excise the insert GFP-Protein A-NES. Subsequently, 
the insert was ligated into the vector and bacteria were transformed again and clones 
were chosen. After verification of correct ligation one final clone was chosen which 
contains FGF2-Ig2α-NES upstream and GFP-Protein A-NES downstream of the 
IRES element (Fig. 2.2 C). 
To generate the cDNA constructs consisting of FGF1 or FGF4 with a signal 
sequence (FGF4-S) the same cloning strategy was applied using FGF1 in the 
plasmid pET24-FGF1 or FGF4-S in the plasmid pET24-FGF4-S as templates for the 
PCR instead of FGF2 (Fig. 2.2 A). To produce the construct IgG2α without FGF 
moiety the insert IgG2α-NES was excised directly from pRevTRE2 using PmeI and 
PacI. The PmeI restriction site is present in the MCS upstream of the insert and the 
PacI restriction site at the 3’-end of the insert introduced via PCR (see Fig. 2.2 A). All 
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constructs were used for retroviral transduction of CHOMCAT-TAM2 cells (see section 
2.3.4) to generate cell lines expressing the reporter molecules. 
 
2.3 Eukaryotic Cell Culture Techniques 
 
2.3.1 Maintaining Cell Lines 
 
Adherent cell lines were grown on culture dishes in their respective culture medium 
at 37°C with 5% CO2. The cells were splitted dependent on confluency every 3 to 5 
days by washing with PBS and addition of 0.125% trypsin/EDTA in PBS (v/v). After 1 
min incubation the trypsin solution was removed and the cells were resuspended in 
the appropriate volume of medium used for the culture dish. Cells were then seeded 
in the desired dilution on new culture dishes prepared with fresh medium. 
 
PBS (Phosphate buffer saline):  140 mM  NaCl 
      2.7 mM KCl 
      10 mM  Na2HPO4 
      1.8 mM  KH2PO4 
        ddH2O 
 
Trypsin / EDTA:    0.125% Trypsin (w/v) 
0.5 mM EDTA 
PBS 
 
2.3.2 Freezing of Eukaryotic Cells 
 
To prepare frozen stocks for long term storage cells grown to about 100% confluency 
were washed once with PBS and trypsinized. Then the cells were resuspended in 
normal growth medium, transferred to a 15 ml tube and collected by centrifugation 
(200 g, 5 min, 4°C). The pellet was carefully resuspended in 2 ml freeze medium and 
transferred to 2 ml cryo-vials (Greiner). An alternative procedure is to resuspend the 
cells directly in freeze medium after trypsinization. The cryo-vials were frozen at  
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-80°C in special cryo boxes which ensure a temperature decrease of 1°C per minute. 
For long term storage the deep frozen cryo-vials were transferred to liquid nitrogen 
cell storage tanks. 
 
Freeze Medium: 20%  FCS (v/v) 
   10%   DMSO (v/v) 
   100 µg/ml Streptomycin / Penicillin 
     αMEM or DMEM 
 
2.3.3 Thawing of Eukaryotic Cells 
 
To defreeze cells cryo-vials were removed from liquid nitrogen and immediately 
thawed in a water bath at 37°C. The content was transferred to 20 ml fresh, 
prewarmed culture medium in a 50 ml tube and cells were sedimented by 
centrifugation (200 g, 5 min, 4°C). To remove DMSO the medium was discarded and 
the cell pellet was resupended in fresh culture medium. The cells were then seeded 
on culture dishes of the same size they were taken from to prepare the frozen stocks 
and incubated at 37°C with 5% CO2. 
 
2.3.4 Retroviral Transduction 
 
To stably integrate reporter genes into the genome of target cells a MBS Mammalian 
Transfection Kit (Stratagene) was used following the instructions of the 
manufacturer’s manual. The procedure takes 5 days and consists of preparation of 
plasmids coding for virus components and the reporter gene, production of retroviral 
particles using HEK293T host cells, harvesting of retroviral particles and infection of 
target cells. The target cell line CHOMCAT-TAM2 (Engling et al., 2002) expresses the 
murine cationic amino acid transporter MCAT-1 (Albritton et al., 1989; Davey et al., 
1997) on the cell surface which is recognized by the virus and mediates docking and 
uptake. Additionally, the doxicycline-sensitive transactivator rtTA2-M2 (Urlinger et al., 
2000) is constitutively expressed and allows protein expression in a doxicycline-
dependent manner. The cDNA reporter constructs were cloned into the retroviral 
transduction vector pRevTRE2 or its derivative the vector pRTi which allows the 
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simultaneous expression of two proteins from a single, bicistronic mRNA. Both 
vectors contain a doxicycline-responsive element (TRE) which mediates doxicycline-
dependent protein expression. As a transduction control hrGFP in the vector pFB 
was used which is constitutively expressed after successful infection. The plasmid 
containing the reporter construct was mixed with two other plasmids, pVPack GP and 
pVPack eco, encoding the viral gag-pol elements (GP) and the viral envelope protein 
(Eco). 
On Day 1 DNA was precipitated using ethanol and stored at 4°C. Virus producing 
HEK293T cells were seeded on freshly prepared culture dishes to be used for 
transfection the next day. On day 2 HEK293T cells were transfected with the three 
plasmids prepared the day before following the manual of the MBS mammalian 
transfection kit (Stratagene) and incubated for 72 h at 37°C to produce retroviral 
particles. On day 3 CHOMCAT-TAM2 cells were seeded on culture dishes in the desired 
dilution to be used for transduction 48 h later. On day 5 virus particle-containing 
medium was harvested from transfected HEK293T cells and passed through a sterile 
45 µm filter. Subsequently, this medium was transferred to target cells and 
transduction occurs by virus mediated gene transfer leading to stable integration of 
the cDNA reporter constructs into the target cell genome. Normal growth medium 
was added and cells were incubated for two days with retroviral particles. Cells were 
further analyzed using flow cytometry and transduction efficiency was measured by 
counting GFP positive cells transduced with pFB-hrGFP. 
 
Vectors: pVPack GP  Stratagene 
pVPack Eco   Stratagene 
pFB-hrGFP Clontech, derived from Moloney Murine Leukemia 
Virus (MMLV) 
pRevTRE2 Clontech, derived from MMLV, contains tet-
response element (TRE) 
pRTi modified pRevTRE2 vector kindly provided by Jörg 
Mölleken and further modified during this study 
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2.3.5 Addition of Doxicycline 
 
Doxicycline (Clontech) was added to the culture medium of different reporter cell 
lines to induce protein expression by the tetracycline/doxicycline-responsive element. 
A stock solution of 1 mg/ml in PBS was diluted 1:1000 in culture medium to achieve a 
final concentration of 1 µg/ml. The incubation period varied dependent on the 
experimental conditions from 16 to 24 h. 
 
2.3.6 Addition of Aminopterin 
 
Aminopterin (Sigma-Aldrich Chemie GmbH), a substrate analogon of DHFR, was 
used in experiments analyzing different DHFR fusion constructs. It was added in a 
concentration of 50 µM to the culture medium by dilution of a 50 mM stock solution 
1:1000. Addition was performed simultaneously with doxicycline incubation because 
the aminopterin-responsive reporter constructs are expressed in a doxicycline-
dependent manner. The time period of aminopterin incubation varied from 16 to 24 h. 
 
2.4 Biochemical Methods 
 
2.4.1 Preparation of Cell Lysates 
 
Cells grown on culture dishes were detached using PBS/EDTA and sedimented by 
centrifugation (200 g, 4°C, 5 min). The pellet was washed once by careful 
resuspension in PBS followed by centrifugation. After that cells were resuspended in 
an appropriate volume of SDS sample buffer and processed for SDS-PAGE analysis. 
If defined amounts of protein were needed the pellet was subjected to detergent-
based lysis followed by determination of total protein concentration. Therefore, lysis 
was performed by resuspension of the pellet in PBS supplemented with 1% Triton X-
100 (w/v) followed by sonication in a water bath for 3 min. To solubilize membrane 
proteins samples were incubated at room temperature for 15 min combined with 
vortex-mixing every 3 min. Insoluble material was sedimented by centrifugation 
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(16.000g, 4°C, 10 min). The supernatant was used to determine total protein 
concentration and for SDS-PAGE analysis. 
 
PBS/EDTA:  0.5 mM EDTA 
     PBS 
 
2.4.2 Preparation of Cell Free Supernatants 
 
To prepare cell free supernatants without detergent cells were grown to a confluency 
of about 80%. The cell monolayer was washed three times with PBS followed by 
detachment of cells using PBS/EDTA. Detached cells were carefully resuspended 
and collected by centrifugation (200 g, 4°C, 5 min). The pellet was resuspended in 
PBS containing protease inhibitors (Protease Inhibitor Cocktail Tablets, Complete 
Mini, Roche, 1 tablet / 10 ml) and subjected to two freeze-thaw-cycles in liquid 
nitrogen. The cells were further disrupted by sonication using a sonication tip for 
initially 15 s and then 10 s (Pulse 50%) in an ice water bath. Membranes were 
removed by a two step centrifugation procedure first sedimenting insoluble cell 
fragments (200 g, 4°C, 10 min) and second performing an ultracentrifugation 
(100.000 g, 4°C, 1h). The supernatant was used for further analysis. 
 
2.4.3 Determination of Protein Concentration 
 
The concentration of a protein solution was determined employing the BCA Protein 
Assay Kit (Pierce). It uses a combination of the biuret reaction (reduction of Cu2+-
cations to Cu1+-cations by proteins in an alkaline medium) and the colorimetric 
detection of the Cu1+-cations by a bicinchoninic acid-containing color reagent. 
10 µl of protein sample were added to 490 µl ddH2O (dilution 1:50). In parallel a 
dilution series of a 0.5 µg/µl BSA stock solution in ddH2O was prepared to be used as 
a standard in later evaluation. Applied amounts were 0, 1.25, 2.5, 3.75, 5, 7.5 and 10 
µg BSA in 500 µl ddH2O. 500 µl of a mixture of kit reagent A and B (ratio 50:1) were 
added to each sample followed by an incubation at 60°C for 30 min. After another 
incubation at room temperature for 10 min 150 µl of each reaction were transferred 
into a 96 well plate. The read out was performed using an Anthos 2001 Microplate 
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Photometer. Protein concentrations of the unknown samples were calculated by 
multiplication of the obtained values with a factor of 50 since the samples were 
diluted 1:50 at the beginning of the procedure. 
 
2.4.4 Sample Preparation for SDS Polyacrylamide Gel Electrophoresis 
 
SDS sample buffer (4x) was added to samples in a ratio of 1:4 followed by an 
incubation at 95°C for 5 min. Before loading the samples onto the gel a centrifugation 
step was performed (16,000 g, 4°C, 1 min) to collect all liquid at the bottom of the 
reaction tube. In the case of cell lysates directly prepared in SDS sample buffer, 
insoluble DNA aggregates were sedimented (16.000g, 4°C, 10 min) and the 
supernatant was applied to the gel. 
 
SDS sample buffer (4x): 200 mM Tris-HCl, pH 6.8 
  25%  Glycerol (w/v) 
  2%  SDS (w/v) 
  0.2%  Bromphenol blue (w/v) 
  0.7 M  β-Mercaptoethanol 
      ddH2O 
 
2.4.5 SDS Polyacrylamide Gel Electrophoresis 
 
To separate proteins which were denatured by sodium dodecyl sulfate (SDS) 
according to their molecular mass SDS polyacrylamide gel electrophoresis (SDS-
PAGE) was performed as described (Laemmli, 1970) using the Mini PROTEAN III 
Electrophoresis System (Bio-Rad). 
Gels with dimensions of 80 x 73 mm and a thickness of 0.75 mm were casted 
between to glass plates by pouring freshly prepared separating gel solution 
containing 10% or 13% acrylamide into the gel cassette fixed in a casting frame. 
Unpolymerized separating gel solution was overlayed with isopropanol to achieve an 
even surface. After polymerization isopropanol was poured off and remains were 
removed using filter paper (Whatman 3MM, Whatman AG). Then unpolymerized 
stacking gel solution was poured into the gel cassette and a plastic comb was 
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inserted from the top which forms the loading wells in the stacking gel. After 
polymerization gels can be stored at 4°C wrapped in wet paper towels up to 3 weeks. 
To perform electrophoresis the gel was placed into the electrode assembly device 
inside a clamping frame in the tank of the Mini PROTEAN III system. Electrophoresis 
running buffer was added to the inner and outer chamber of the tank and the plastic 
comb was carefully removed. Samples were loaded into the wells of the stacking gel 
using extralong loading pipet tips. Electrophoretic separation was performed at 200 V 
until the bromphenol blue front of the SDS sample buffer reached the end of the 
separating gel. 
 
Separating Gel Solution: 10% Gel 13% Gel 
    2 ml  1.68 ml ddH2O 
    1.25 ml 1.25 ml 1.5 M Tris-HCl, pH 8.8 
    50 µl  50 µl  10% SDS (w/v) 
    1.66 ml 2 ml  Acrylamide/Bis 30%(w/v) 
    25 µl  25 µl  10% APS (w/v) 
    2.5 µl  2.5 µl  Temed 
 
Stacking Gel Solution: 4.8% Gel 
1,53 ml ddH2O 
  0,625 ml 0.5 M Tris-HCl, pH 6.8 
  25 µl  10% SDS (w/v) 
  335 µl  Acrylamide/Bis 30% (w/v) 
  12.5 µl 10 % APS (w/v) 
  2.5 µl  Temed 
 
Electrophoresis running buffer: 25 mM Tris-HCl, pH 8.3 
   192 mM Glycine 
   0.1%  SDS (w/v) 
     ddH2O 
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2.4.6 SDS-PAGE Protein Molecular Weight Standards 
 
As protein molecular weight standards either peqGOLD Protein-Marker I (Peqlab) or 
Odyssey Protein Molecular Weight Marker (LICOR) were used. peqGold marker, 
ranging from 14 to 116 kDa, as used when analyzing gels by Western blot using the 
ECL detection system. Odyssey marker, ranging from 10 to 250 kDa, was applied 
when performing the analysis using an Odyssey infrared imaging system since the 
marker proteins are prestained with Coomassie which is visualized by this system. 
Markers were applied by loading 1 to 5 µl of the premixed solutions. 
 
2.4.7 Western Blot Transfer 
 
To transfer proteins separated by SDS-PAGE to a polyvinylidene fluoride (PVDF) 
membrane for further analysis (Towbin et al., 1979) a wet blot transfer device was 
used (Mini Trans-Blot Cell, Bio-Rad). A PVDF membrane and two pieces of filter 
paper (Whatman 3MM, Whatman AG) were cut to the size of the separating gel. The 
PVDF membrane was activated by incubation in 100% methanol for 1 min followed 
by rinsing with ddH2O. Filter paper, two sponges and a sandwich blotting cassette 
were equilibrated in blotting buffer. All parts were assembled as depicted in Fig. 2.3. 
 
anode (+) 
 
Sponge 
Filter paper 
PVDF membrane 
SDS-Gel 
Filter paper 
Sponge 
 
cathode (-) 
 
Fig. 2.3 Schematic overview: Assembly of a Western blot wet blot sandwich cassette. 
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The assembled blotting cassette was inserted into the transfer tank, an ice block for 
cooling was added and the tank was filled with blotting buffer. Protein transfer was 
performed at 100 V for 1 h with constant stirring. 
 
Blotting buffer:  192 mM  Glycine 
    25 mM  Tris, pH 8.4 
    20%  MetOH (v/v) 
      ddH2O 
 
2.4.7.1 Reversible Ponceau Staining of Proteins 
 
To verify successful protein transfer PVDF membranes were reversibly stained with 
Ponceau S (Serva Electrophoresis GmbH). The PVDF membrane was incubated in 
Ponceau solution for 1 min. Subsequently, excessive Ponceau solution was washed 
away using ddH2O until the proteins bands became clearly visible. Marker bands 
were labelled using a ball pen and the membrane was completely destained by 
incubating in PBS-T on a shaker. Ponceau staining was not performed if the LICOR 
detection system was used because this would increase background signals. 
 
PBS-T:   0.05%  Tween 20 (w/v) 
PBS 
 
Ponceau Solution:  0.25%  Ponceau S (w/v) 
    3%  Trichloroacetic acid (v/v) 
      ddH2O 
 
2.4.7.2 Immunochemical Protein Detection Using the ECL System 
 
Western blotting was performed as described above using Immobilon-P PVDF 
membrane (Millipore Corporation). The membrane was incubated in blocking buffer 
for 1 h at room temperature or at 4°C overnight on a shaker. Following blocking, the 
membrane was rinsed with PBS-T and incubated with the primary antibody in the 
desired dilution for 1 h at room temperature on a shaker. Three 5 min washing steps 
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with PBS-T were performed and the membrane was incubated with secondary goat 
anti rabbit IgG or goat anti mouse IgG antibodies coupled to HRP in a 1:5000 
dilution. If samples derived from an immunoprecipitation experiment (IP) were 
analyzed monoclonal anti-rabbit Immunoglobulin clone RG-16 HRP-coupled 
antibodies in a 1:5000 dilution were used to detect only native antibodies excluding 
those derived from the IP procedure. After three times 5 min washing with PBS-T min 
on a shaker, visualization was performed using the enhanced chemiluminescence-
system (ECL, Amersham Pharmacia). The membrane was incubated with the ECL 
solution for 1 min at room temperature and chemiluminescence was detected using 
medical x-ray films (Super RX Medical X ray film, Fuji). 
 
Blocking buffer:   5%  Milk powder (w/v) 
       PBS-T 
 
Primary antibody buffer:  3%  BSA (w/v) 
     0.02%  Sodium azide (w/v) 
       PBS-T 
 
Secondary antibody buffer: 3%  Milk powder (w/v) 
   PBS-T 
  
2.4.7.3 Immunochemical Protein Detection Using the LICOR System 
 
Western blotting was performed as described using Immobilon-FL PVDF membrane 
(Millipore Corporation) optimized for fluorescence detection. The membrane was 
incubated in blocking buffer for 1 h at room temperature on a shaker. Following 
blocking, the membrane was rinsed two times 5 min with PBS-T and incubated with 
the primary antibody in the desired dilution for 1 h at room temperature on a shaker. 
Four times 5 min washing with PBS-T was performed followed by incubation with 
secondary goat anti rabbit IgG or goat anti mouse IgG antibodies coupled to the 
fluorophor Alexa 680 diluted 1:10000 for 30 min at room temperature under constant 
shaking in the dark. Finally the membrane was washed four times for 5 min with 
PBS-T on a shaker and once with PBS without Tween 20. Visualization was 
performed using the Odyssey infrared imaging system. 
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Blocking buffer:   5%  Milk powder (w/v) 
       PBS 
 
Primary antibody buffer:  3%  BSA (w/v) 
     0.02%  Sodium azide (w/v) 
0.1%  Tween 20 (w/v) 
  PBS 
Secondary antibody buffer: 3%  Milk powder (w/v) 
 0.01%  SDS (w/v) 
 0.1%  Tween 20 (w/v) 
PBS 
 
2.4.8 Protease Protection Assay 
 
To analyze the stability of the DHFR domain present in the reporter constructs FGF2-
GFP-DHFR and MTS-GFP-DHFR a protease protection assay was performed. Cells 
expressing the reporter constructs were lysed by addition of a detergent-containing 
lysis buffer and scraped off the culture dishes using a rubber policeman. In order to 
complete lysis the cell suspension was incubated at 4°C for 30 min combined with 
mixing by pipetting every 5 min. Finally, insoluble material was removed by 
centrifugation (16.000g, 4°C, 10 min). 
The supernatants were incubated for 15 min at room temperature in the absence or 
presence of 50 µM aminopterin added from a stock solution (2.5 mM aminopterin in 
lysis buffer) by diluting 1:50. Subsequently, trypsin in a final concentration of 200 
µg/ml was added by direct dilution of a stock solution (10 mg/ml) in a ratio of 1:50 
followed by an incubation for 30 min at 4°C. After the trypsin treatment protease 
inhibitors (Complete Mini, Roche) were added to stop the reaction and samples were 
mixed with SDS sample buffer in a 3:1 ratio for analysis by SDS-PAGE and Western 
blot. 
 
Lysis buffer:   100 mM Hepes-KOH, pH 7.4 
    2 mM  CaCl2 
    0.2%  Triton X-100 (w/v) 
      ddH2O 
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Trypsin stock solution: 10 mg/ml  trypsin (w/v) 
      Lysis buffer 
 
2.4.9 Immunoprecipitation of Proteins 
 
To immunoprecipitate GFP containing reporter molecules a mixture of Protein A-
Sepahrose beads, CL-4B beads (Amersham Pharmacia) and 20% ethanol (1:1:2) 
was prepared and 40 µl slurry, corresponding to 20 µl pure beads, was used per 
sample. The beads were washed three times with IP-Buffer 1. Sedimentation was 
performed at 3000 g, 1 min, 4°C. To couple affinity-purified GFP antibodies to the 
beads they were incubated with 10 µl anti-GFP antibodies (basic elution) in 190 µl IP-
Buffer 1 per 20 µl packed beads overnight at 4°C using end-over-end rotation. 
Following the coupling procedure, unspecific binding sites were quenched by two 
times washing with IP-Buffer 2 containing 1% BSA and a final washing step using IP-
Buffer 1. After sedimentation and removal of the buffer the sample consisting of 1 ml 
culture medium obtained from the respective reporter cell line grown on 6 well-plates 
and 500 µl PBS Ca2+/Mg2+ obtained from a washing step (see 2.5.12 Biotinylation) 
were added to the beads followed by an 2 to 4 h incubation at room temperature 
using end-over-end rotation. After this incubation the beads were washed three times 
with IP-Buffer 0. Bound material was eluted by addition of SDS sample buffer and 
incubation at 95°C for 5 min. Subsequently, samples were subjected to SDS-PAGE 
and Western blot analysis 
 
IP-Buffer 0: 25 mM  Tris-HCl, pH 7.4 
150 mM NaCl 
1 mM   EDTA 
    ddH2O 
 
IP-Buffer 1: 25 mM  Tris-HCl, pH 7.4 
150 mM NaCl 
1 mM   EDTA 
0.5%  NP-40 (w/v) 
    ddH2O 
 
Material and Methods  69 
 
 
IP-Buffer 2: 25 mM  Tris-HCl, pH 7.4 
150 mM NaCl 
1 mM   EDTA 
0.5%  NP-40 (w/v) 
1%  BSA 
    ddH2O 
 
2.4.10 Co-Immunoprecipitation of Proteins 
 
To co-precipitate proteins bound to GFP containing reporter molecules cell free 
supernatants were prepared as described in section 2.5.2. The samples were 
subjected to immunoprecipitation as described in section 2.5.9. Additionally, anti-
FGF2 antibodies were coupled to Protein A-sepharose beads and NP-40-free buffers 
were used to perform washing steps following antibody coupling to the beads prior to 
incubation with the samples. In general, use of detergent was avoided when handling 
the samples in order not to disrupt protein-protein interactions. 
 
2.4.11 Gel Filtration Analysis 
 
To perform a gel filtration analysis cell free supernatants were prepared as described 
(see section 2.5.2). A column of 150 mm length and a diameter of 5 mm with a bed 
volume of 3 ml (Tricorn 5/150, Amersham) was packed with Superdex 200 size 
exclusion beads (Amersham) using a peristaltic pump thereby avoiding air bubbles. 
Superdex 200 beads retain proteins from 10 to 600 kDa on the column. The packed 
column was mounted in a SMART FPLC system (Amersham) and washed with 10 ml 
filtered and degased ddH2O and subsequently with 10 ml IP-Buffer 0 (see section 
2.5.9). 50 µl of each sample were injected into the tube system of the SMART and 
proteins were retained according to their size on the column when moving at a flow 
rate of 100 µl/min. The absorption at 260 nm wavelength which corresponding to 
protein molecules was measured simultaneously and plotted against the eluted 
volume. Fractions of 50 µl were collected starting from 0.9 ml to 3 ml after sample 
injection resulting in 42 fractions. 50 µl of SDS sample buffer was added and every 
second fraction from 10 to 28 was analyzed by SDS-PAGE and Western blot. 
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2.4.12 Biotinylation of Cell Surface Proteins 
 
To analyze exported, cell surface bound material a biotinylation assay was performed 
as described (Seelenmeyer et al., 2005). A membrane impermeable biotinylation 
reagent was added to cells and covalently binds to all free ε-amino groups of lysine 
residues present in surface proteins. Following lysis, biotinylated proteins were 
purified by incubation with streptavidin beads and the amounts of biotinylated and 
non-biotinylated proteins were compared to determine the ratio of exported to non-
exported reporter molecules. 
Cells were grown on 6 well-plates in the presence of doxicycline to a confluency of 
about 80%. Following two times washing with 500 µl cold PBS Ca2+/Mg2+ they were 
incubated with 0.5 mg/ml biotinylation reagent (EZ-link Sulfo-NHS-SS-biotin, Pierce) 
in incubation buffer for 30 min at 4°C. To quench unbound biotinylation reagent cells 
were washed once with quenching buffer followed by an incubation with 500 µl 
quenching buffer for 20 min at 4°C. Two additional washing steps using PBS were 
preformed and 200 µl lysis buffer was added. Cells were incubated 10 min at 37°C 
with lysis buffer and subsequently scraped off the 6 well-plates using a rubber 
policeman. The cell solution was homogenized by pipetting and transferred to an 
eppendorf tube on ice. To complete lysis the samples were subjected to sonication in 
a water bath and incubated for 15 min at room temperature mixed by vortexing every 
5 min. To remove insoluble material a sedimentation was performed (16,000 g, 10 
min, 4°C) and 10 µl of the supernatant was saved to be used as input sample for 
later analysis. The rest was added to 40 µl packed streptavidin beads equilibrated 
with lysis buffer and incubated for 1 h at room temperature under constant end-over-
end rotation to allow binding of biotinylated proteins to streptavidin moiety. After the 
incubation period, the beads were washed two times with washing buffer 1 and 
another two times with washing buffer 2. Sedimentation in between the washing 
steps was performed by centrifugation (3.000 g, 4°C, 1 min). After the last washing 
step the supernatant was carefully discarded and bound material was eluted by 
incubation in SDS sample buffer for 5 min at 95°C. Subsequently, samples were 
analyzed by SDS-PAGE and Western blot. 
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PBS Ca2+/Mg2+:  1 mM  MgCl2 
    0.1 mM CaCl2 
      PBS 
 
Incubation buffer:  150 mM  MgCl2 
    10 mM Triethanolamine, pH 9 
    2 mM  CaCl2 
      ddH2O 
 
Quenching buffer :  100 mM Glycine 
      PBS Ca2+/Mg2+ 
 
Lysis buffer:   62.5 mM EDTA 
    50 mM Tris-HCl, pH 7.5 
    0.4%  Deoxycholate (w/v) 
      Protease Inhibitor tablet (1 per 10 ml) 
      ddH2O 
 
Washing buffer 1:  62.5 mM EDTA 
    50 mM Tris-HCl, pH 7.5 
    0.4%  Deoxycholate (w/v) 
    1%  NP-40 
    0.5 M  NaCl 
      ddH2O 
 
Washing buffer 2:  62.5 mM EDTA 
    50 mM Tris-HCl, pH 7.5 
    0.4%  Deoxycholate (w/v) 
    0.1%  NP-40 
    0.5 M  NaCl 
      ddH2O 
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2.5 Flow Cytometry 
 
2.5.1 Sample Preparation for FACS Analysis Detaching Cells From 
Culture Dishes 
 
To analyze GFP fluorescence and exported reporter molecules by specific antibody 
cell surface staining cells were processed according to the following protocol and 
analyzed using flow cytometry. 
Cells were grown on 6 well-plates to a confluency of about 70% in the absence or 
presence of doxicycline. After removal of the growth medium they were washed with 
500 µl PBS and 500 µl Cell Dissociation Buffer (CDB, Invitrogen) or PBS/EDTA were 
added. Cells were incubated for 10 min at 37°C and detached by resuspension using 
a pipet. After transfer to an eppendorf tube on ice, a centrifugation step was applied 
(200 g, 4°C, 5 min) and the supernatant was discarded. The pellet was carefully 
resuspended in 300 µl αMEM supplemented with primary antibodies in the desired 
dilution. After an incubation period of 1 h at 4°C under constant end-over-end 
rotation, cells were sedimented and the pellet was washed once with αMEM without 
antibodies. Then, secondary antibodies coupled to the fluorophor allophycocyanin 
were added in a 1:750 dilution in αMEM and cells were incubated for 30 min as 
described above. To remove secondary antibodies cells were washed once with 
αMEM without antibodies and the pellet was resuspended in 500 µl sorting medium 
containing propidium iodide in a concentration of 1 µg/ml to stain dead cells. Samples 
were subsequently analyzed using a FACSCalibur flow cytometer (Becton 
Dickinson). 
 
Primary antibodies:   αMEM 
Affinity-purified rabbit anti-GFP anibodies (acidic 
elution) 1:200 
monoclonal mouse anti-His-tag antibodies 1:200 
 
Secondary antibodies:  αMEM 
goat anti rabbit IgG APC-coupled antibodies 1:750 
goat anti mouse IgG APC-coupled antibodies 1:750 
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Sorting Medium: 5%  CDB (v/v) 
   0.2%  FCS (v/v) 
     αMEM without FCS 
 
2.5.2 Plate Labelling Technique 
 
To prepare samples for FACS analysis using the plate labelling technique cells were 
grown on 12 well-plates to a confluency of about 70% in the absence or presence of 
doxicycline. Following washing with 500 µl PBS the primary antibody in the desired 
dilution in 300 µl αMEM was added and the plates were incubated for 1 h at 4°C 
under constant shaking. Subsequently, cells were washed three times with 500 µl 
PBS and secondary antibodies were added in the desired dilution in 300 µl αMEM. 
Samples were incubated for 30 min at 4°C under constant shaking in the dark 
followed by three times washing with 500 µl PBS. Cells were detached by addition of 
200 µl PBS/EDTA followed by an incubation period of 10 min at 37°C. Using a pipet 
samples were resuspended and transferred to an eppendorf tube which was 
prepared with 500 µl αMEM without FCS additionally containing propidium iodide in a 
concentration of 1 µg/ml. Samples were analyzed using a FACSCalibur flow 
cytometer (Becton Dickinson). 
 
Primary antibodies:  αMEM 
Affinity-purified rabbit anti-GFP anibodies (acidic elution) 
1:200 
Goat anti mouse IgG Allophycocyanin-coupled antibodies 
1:500 (no secondary antibodies needed) 
Secondary antibodies: αMEM 
Goat anti rabbit IgG Allophycocyanin-coupled antibodies 
1:750 
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2.5.3 FACS Sort 
 
FACS-based sorting was performed in collaboration with Dr. Blanche Schwappach 
from the Center of Molecular Biology Heidelberg (ZMBH). Cells induced by addition 
of doxicycline for 12 h or grown after a sort in the absence of doxicycline for 7 days 
were detached from culture dishes after washing with PBS using sterile CDB 
(Invitrogen). After sedimentation at 200 g, 4°C, 5 min CDB was removed and the 
pellet was carefully resuspended in sorting medium. The cells were filtered using cell 
strainer caps (Becton Dickinson) into 5 ml round bottom FACS tubes (Becton 
Dickinson) and propidium iodide in a final concentration of 1 µg/ml was added. 
Subsequently, cells were sorted using a FACSVantage or FACSAria sorting device 
(Becton Dickinson) as pools of 50.000 or 100.000 cells in 6 well-plates or as single 
cells to generate clonal cell lines in 96 well-plates. 
 
2.6 Confocal Microscopy 
 
2.6.1 Sample Preparation for Confocal Microscopy 
 
Cells were grown on coverslips placed in 24 well-plates. Following two times washing 
with PBS on ice 200 µl 3% PFA in PBS per well was added and the cells were fixed 
without permeabilization for 20 min. After removal of PFA cells were washed four 
times with PBS. Coverslips were mounted on microscopic slides using Fluoromount 
G (Southern Biotechnology Associates). After hardening at room temperature 
overnight in the dark the specimens were sealed at the edge of the coverslip 
employing clear nail polish (Wet’n Wild USA) and analyzed using a LSM 510 Meta 
confocal microscope (Zeiss). 
 
 
PFA in PBS:  3% PFA (w/v) 
    PBS 
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2.6.2 Immunostaining of Cell Surface Proteins for Confocal Microscopy 
 
Samples were prepared as described in section 2.7.1. Following fixation with PFA 
and two times washing with PBS, the samples were quenched by incubation with 250 
µl quenching buffer for 10 min at room temperature. Unspecific antibody binding sites 
were blocked by incubation in blocking buffer for 10 min at room temperature. 
Primary antibodies were added in the desired dilution in 250 µl blocking buffer for 1 h 
at room temperature. Following three times washing with PBS, unspecific binding 
sites were blocked again by incubation in 250 µl blocking buffer for 10 min at room 
temperature. Secondary antibodies were added in 250 µl blocking buffer and the 
specimens were incubated for 30 min at room temperature. After four times washing 
the samples were mounted as described in 2.7.1 and analyzed using a LSM 510 
Meta confocal microscope (Zeiss). 
 
Quenching buffer:  50 mM  NH4Cl 
PBS 
 
Blocking buffer:  1%  BSA (w/v) 
PBS 
 
Primary antibodies: Affinity-purified rabbit anti-GFP antibodies (acidic elution) 
1:50 
    Monoclonal mouse anti-His-tag antibodies 1:200 
    Blocking buffer 
 
Secondary antibodies: Goat anti rabbit or goat anti mouse IgG antibodies Alexa 
546-coupled 1:1000 
 Blocking buffer 
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3 Results 
 
Fibroblast Growth Factor 2 (FGF2) belongs to the protein family of heparin binding 
growth factors (Powers et al., 2000). It is a strong mediator of angiogenesis 
(Moscatelli et al., 1986) and neovascularization (Wilting et al., 1991) and is often 
associated with tumor growth (Zetter, 1998) and developmental processes (Bikfalvi et 
al., 1997). FGF2 is unconventionally secreted by an unknown machinery that 
functions independently of the classical ER/Golgi pathway (Florkiewicz et al., 1995; 
Nickel, 2005). 
The purpose of the current study was to analyze the folding state FGF2 during 
unconventional secretion. To investigate the conformation of FGF2 during membrane 
translocation two independent experimental systems were applied. First a 
dihydrofolate reductase fusion protein system and second a molecular piggyback 
export analysis system. 
 
3.1 Dihydrofolate Reductase Fusion Protein System to Study 
Protein Folding During Membrane Translocation Events 
 
The dihydrofolate reductase fusion protein system is based on the fact that a 
substrate analogon, aminopterin, can bind to the enzyme dihydrofolate reductase 
(DHFR) in a very tight manner (Salvador et al., 2000). DHFR can be inhibited via 
binding of aminopterin to its active center. Of great importance in this concern is, that 
upon binding of aminopterin the conformation of the enzyme is highly stabilized so 
that it can not be unfolded during membrane translocation processes or by 
chaperone activity. Thus, if a fusion protein consisting of a molecule which is 
translocated across a membrane and DHFR needs to be unfolded, the process can 
be blocked by the addition of aminopterin. This system was widely used in analyzing 
mitochondrial protein import, glycosomal protein import in trypanosomes or protein 
import into peroxisomes (Eilers and Schatz, 1986; Wienhues et al., 1991). 
For the current study a fusion protein consisting of FGF2, enhanced green 
fluorescent protein (GFP) and DHFR was generated and the export of the construct 
was analyzed in an in vivo system based on CHO cells with regard to aminopterin-
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influence on membrane translocation applying different experimental approaches. Of 
great importance for export analysis is that, following secretion, FGF2 binds to 
heparan sulfates of proteoglycans in the ECM on the cell surface (Moscatelli, 1987). 
This allows the detection of exported material by externally added antibodies.  
The detection of cell surface-bound material is the basis for the analysis by flow 
cytometry. In a FACS-based assay reporter molecules on the cell surface are 
immunolabelled with antibodies that, in turn, are detected by secondary antibodies 
coupled to a fluorescent dye. The FACS system detects the fluorescence of the dye 
and simultaneously the intrinsic fluorescence of the GFP moiety on a single cell 
basis. This allows a quantitative analysis of expression levels (GFP fluorescence) 
and exported reporter protein (cell surface staining). Another analysis technique used 
to investigate FGF2 export is confocal microscopy. It uses the same basic principle of 
antibody labelling of exported, surface bound material and intrinsic GFP 
fluorescence. It allows a qualitative and spatial analysis of the reporter construct with 
regard to intracellular localization and cell surface distribution. Furthermore, 
biochemical analysis methods were applied. Cell lysates prepared from cells which 
express the reporter construct were analyzed for doxicycline-dependent protein 
expression by SDS-PAGE and Western blot using specific antibodies. Moreover, a 
protease protection assay was performed to analyze binding of aminopterin to the 
reporter construct and the influence of aminopterin on its stability. 
 
3.1.1 Generation of Cell Lines 
 
To generate reporter cell lines which express the reporter proteins the respective 
cDNA constructs were cloned into the pRevTRE2 vector (Clontech, see Material & 
Methods, section 2.2.14). The vector allows stable integration of the constructs into 
the genome of target cells and reporter protein expression in a doxicycline-
dependent manner due to the doxicycline/transactivator-responsive element. As a 
prerequisite the cells have to express the doxicycline-sensitive transactivator rtTA2-
M2 (Urlinger et al., 2000) to make use of the doxicycline-dependent protein 
expression system. 
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Fig. 3.1 Schematic overview: cDNA constructs. 
FGF2 = fibroblast growth factor 2, GFP = green fluorescent protein, DHFR = dihydrofolate reductase, 
His6 = hexa-histidin-tag, orientation = left to right corresponds to 5’ to 3’ 
 
The construct FGF2-GFP was already existent and a clonal cell line was available in 
our laboratory (Engling et al., 2002). The calculated molecular mass of this construct 
is 44 kDa. FGF2-GFP-DHFR corresponds to a construct in which FGF2 is fused to 
GFP and a DHFR domain (Eilers and Schatz, 1986) with a C-terminal His6-tag. The 
calculated molecular mass is 67 kDa. MTS-GFP-DHFR entitles a construct where the 
mitochondrial targeting sequence (MTS) of the S9 subunit of the F0 ATPase 
(Salvador et al., 2000) is fused to GFP and a DHFR domain with a C-terminal His6-
tag. The calculated molecular mass of this construct is 57 kDa. 
The reporter cell lines were generated using CHOMCAT-TAM2 cells (Engling et al., 2002) 
which constitutively express the murine cationic transporter MCAT-1 (Albritton et al., 
1989; Davey et al., 1997) and the doxicycline-sensitive transactivator rtTA2-M2 
(Urlinger et al., 2000). Retroviral particles carrying the reporter constructs were 
produced and used for gene transfer (see Material & Methods, section 2.3.4). After 
viral transduction reporter molecule expression can be induced by addition of 
doxicycline to the culture medium. 
 
 
Fig. 3.2 Schematic overview: Retroviral transduction procedure to generate reporter cell lines. 
CHO = Chinese Hamster ovary (cells), FGF2 = Fibroblast Growth Factor 2, GFP = green fluorescent 
protein, DHFR = dihydrofolate reductase, His6 = Hexa-Histidine-tag, DOX = Doxicycline. 
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The virally transduced cells were subjected to a FACS-based sorting procedure to 
generate clonal cell lines (see Material & Methods, section 2.5.3). Three days after 
retroviral transduction, 1 µg/ml doxicycline was added to the culture medium for 12 h. 
Subsequently, cells were detached from culture dishes using a protease free buffer 
system and processed for FACS analysis. Dead cells were excluded by staining with 
propidium iodide, which intercalates into the DNA after membrane damage. 50,000 
cells from each cell line were isolated by FACS sorting based on GFP fluorescence 
using a FACSVantage sorting device (Becton Dickinson). The obtained pools of cells 
were incubated for 7 days in the absence of doxicycline followed by the isolation of 
50,000 cells from each population that did not display any GFP fluorescence at this 
point. Each population was now cultured for another 7 days including 12 h in the 
presence of 1 µg/ml doxicycline at the end of this period. Single cells were obtained 
by FACS sorting based on GFP fluorescence. Exemplarily the results of the sorting 
procedure are displayed for the cell line CHO FGF2-GFP-DHFR in Fig. 3.3. 
 
Fig. 3.3 FACS sorting based on GFP fluorescence to generate the cell line FGF2-GFP-DHFR. 
Cells were detached from culture dishes using a protease free buffer system and processed for FACS 
analysis to measure GFP fluorescence. Sort 1 displays cells 3 days after viral transduction incubated 
in the presence of 1 µg/ml doxicycline for 12 h (panel A). 50,000 cells were sorted within the sorting 
gate (red population). Sort 2 shows cells grown for 7 days in the absence of doxicycline after sort 1 
(panel B). Again 50,000 cells were sorted within the sorting gate. Sort 3 shows cells 7 days after sort 2 
incubated in the presence of 1 µg/ml doxicycline for 12 h. Single clones were sorted within the sorting 
gate and propagated to generate clonal cell lines. Panel D and E show the clonal cell line FGF2-GFP-
DHFR obtained from sort 3 grown in the absence or presence of 1 µg/ml doxicycline for 18 h. Panel F 
displays a histogram overlay of the obtained data from D and E verifying the shift in GFP fluorescence 
dependent on the addition of doxicycline (grey curve: - doxicycline, green curve: + doxicycline). 
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The obtained single clones were tested and propagated to generate clonal cell lines. 
The cell lines were termed CHOFGF2-GFP-DHFR and CHOMTS-GFP-DHFR in order to reflect 
the reporter molecules expressed. 
To detect reporter molecules on the cell surface in forthcoming experiments 
appropriate antibodies can be used (Fig. 3.2, see scheme cell plus doxicycline). All 
three constructs can be detected applying affinity-purified polyclonal anti-GFP 
antibodies (Seelenmeyer et al., 2003) due to the presence of the GFP moiety in the 
fusion proteins (Engling et al., 2002). The two constructs designed with the DHFR 
domain can furthermore be analyzed employing commercially available monoclonal 
anti-DHFR antibodies (Becton Dickinson). Furthermore the His6-tag at the C-terminus 
of the DHFR domain allows the use of commercially available anti-His6-tag antibodies 
(Qiagen) to detect specifically the DHFR fusion constructs and within them the 
extreme C-terminus which is of great importance for later localization studies (see 
sections 3.1.8 to 3.1.10). 
 
3.1.2 Biochemical Analysis of Doxicycline Dependent Protein 
Expression 
 
To analyze the doxicycline-dependent protein expression, cells transduced with the 
different reporter constructs, were grown in the absence or presence of 1 µg/ml 
doxicycline for 18 h. Cell lysates obtained from these cultures were analyzed by 
SDS-PAGE and Western blot applying primary affinity-purified anti-GFP antibodies 
and secondary HRP-coupled antibodies. Visualization was performed using the 
chemiluminescence-based ECL system and x-ray film detection. 
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Fig. 3.4 Western Blot analysis of doxicycline-dependent protein expression. 
Reporter cell lines were grown in the absence or presence of 1 µg/ml doxicycline for 18 h. Cell lysates 
were separated on 10% SDS gels followed by Western blot transfer. Detection was performed 
applying affinity-purified anti-GFP antibodies. When analyzing FGF2-GFP material derived from 
10,000 cells was loaded. In the case of FGF2-GFP-DHFR and MTS-GFP-DHFR, material derived from 
20,000 cells was analyzed. Visualization was performed using the ECL system and x-ray film 
detection. Three species of MTS-GFP-DHFR are detectable: a precursor (), an intermediate form () 
and the fully processed form (). 
 
All reporter cell lines show doxicycline-dependent protein expression when compared 
to non-induced cells (Fig. 3.4, compare lanes 1, 3 and 5 to lanes 2, 4 and 6). The 
fusion proteins show a migration behaviour corresponding to their calculated 
molecular masses when compared to a protein standard. FGF2-GFP migrates at 
about 45 kDa (Fig 3.4, lane 2), FGF2-GFP-DHFR at about 67 kDa (Fig 3.2,lane 4) 
and MTS-GFP-DHFR around 60 kDa (Fig. 3.4, lane 6). 
Expression of MTS-GFP-DHFR results in production of three isoforms. The slow 
migrating precursor form () displaying a size of 57 kDa, the intermediate form () 
and the fully processed form (), which are both smaller in size (Fig. 3.4, lane 6). 
They correspond to the mitochondrial import steps and are the result of two 
membrane translocation events into the mitochondrial matrix during which the MTS is 
cleaved twice. This result is a first hint that the MTS construct is imported into 
mitochondria. 
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3.1.3 Characterization of the Reporter Cell Lines by Confocal 
Microscopy 
 
Cells were grown on cover slips in the absence or presence of 1 µg/ml doxicycline for 
18 h and processed without permeabilization for confocal microscopy. 
Immunostaining was performed applying primary affinity-purified anti-GFP antibodies 
and Alexa 546-coupled secondary antibodies. All samples were analyzed using a 
Zeiss LSM 510 confocal microscope. 
 
 
Fig. 3.5 Characterization of generated cell lines by confocal microscopy. 
Generated cells were cultivated on cover slips in the absence or presence of 1µg/ml doxicycline for 
18h. Samples were prepared without permeabilization and immunostained applying affinity-purified 
anti-GFP antibodies. The microscopic analysis was performed using a Zeiss LSM 510 confocal 
microscope. Panels A, B, D, E, G and H show total GFP fluorescence, panels C, F and I cell surface 
staining. 
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All cell lines exhibit doxicycline-dependent protein expression analyzed by total GFP 
fluorescence (Fig. 3.5 A and B, D and E, G and H). Moreover, the reporter constructs 
FGF2-GFP and FGF2-GFP-DHFR show cytosolic and nuclear localization upon 
expression (Fig. 3.5 panels B and E). MTS-GFP-DHFR localizes to dot-like structures 
throughout the cytoplasm and is excluded from the nucleus and the plasma 
membrane. This staining pattern is consistent with mitochondrial localization (Fig. 3.5 
panel H). Combined with the biochemical analysis performed previously, it is safe to 
conclude that the MTS construct is indeed imported into mitochondria (see section 
3.1.2 and 3.1.6). 
FGF2-GFP and FGF2-GFP-DHFR can be detected on the cell surface applying 
externally added anti-GFP antibodies (Fig. 3.5 panel C and F), which demonstrates 
that both are translocated across the plasma membrane. MTS-GFP-DHFR is not 
detectable on the cell surface using anti-GFP antibodies (Fig. 3.5 panel I). 
 
3.1.4 Analysis of Doxicycline Dependent Protein Expression and 
Secretion by Flow Cytometry 
 
Cells transduced with the reporter constructs were grown in 6-well culture dishes in 
the absence or presence of doxicycline, respectively 1 µg/ml for 18h. After detaching 
the cells from the culture dishes using a protease-free buffer system, immunostaining 
was performed using either anti-GFP or monoclonal anti-His6-tag primary antibodies 
and allophycocyanin-coupled secondary antibodies. Additionally, propidium iodide 
staining was performed to exclude dead cells from the subsequent evaluation. 
Samples were analyzed using a FACSCalibur flow cytometer (Becton Dickinson). 
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Fig. 3.6 Quantitative analysis of doxicycline-dependent protein expression and secretion based 
on flow cytometry. 
FGF2-GFP cells (A, B), FGF2-GFP-DHFR cells (C, D) and MTS-GFP-DHFR cells (E, F) were grown in 
the absence (grey curves) and presence (green curves) of 1 µg/ml doxicycline for 18 h. Cells were 
detached from culture plates employing a protease-free buffer and immunostained using either affinity-
purified anti-GFP (A, C, E) or monoclonal anti-His6-tag antibodies (B, D, F). Living cells were analyzed 
simultaneously for GFP fluorescence and cell surface staining using a FACSCalibur flow cytometer 
(Becton Dickinson). 
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All cell lines show expression of the reporter constructs dependent on the addition of 
doxicycline as shown by the diagrams representing GFP fluorescence (Fig. 3.6, 
panels A to F, GFP fluorescence). The grey curves represent cells grown in the 
absence of doxicycline, the green curves show cells grown in the presence of 
doxicycline. A clear shift in the presence of doxicycline can be observed. 
The proteins FGF2-GFP and FGF2-GFP-DHFR are detectable on the cell surface 
using GFP antibodies when protein expression is induced (Fig. 3.6, panels A and C, 
cell surface staining, green curves). FGF2-GFP-DHFR is also detectable on the cell 
surface employing anti-His6-tag antibodies (Fig. 3.6, panel D, cell surface staining, 
green curve). As expected FGF2-GFP, which lacks the C-terminal His6-Tag can not 
be detected on the cell surface using anti His6-tag antibodies (Fig. 3.6, panel B, cell 
surface staining). Importantly, MTS-GFP-DHFR is not detectable on the cell surface 
neither with anti-GFP nor with anti-His6-tag antibodies (Fig. 3.6, panels E and F, cell 
surface staining) 
 
In summary, employing different methods, it could be shown that all cell lines express 
the reporter constructs exclusively in the presence of doxicycline. The reporter 
proteins FGF2-GFP and FGF2-GFP-DHFR are translocated across the plasma 
membrane and can be detected on the cell surface employing anti-GFP or anti-His6-
tag antibodies. MTS-GFP-DHFR is shown to be imported into mitochondria confirmed 
by confocal microscopy and Western blot analysis. 
 
3.1.5 Influence of Aminopterin on the Mitochondrial Import of the 
Reporter Construct MTS-GFP-DHFR  
 
To test if the import of the MTS construct into mitochondria is influenced by 
aminopterin cells were grown on coverslips in the presence of 1 µg/ml doxicycline for 
18 h. Aminopterin was added as indicated, respectively 50 µM for 18 h. Samples 
were fixed using paraformaldehyde and analyzed by confocal microscopy. 
Visualization was performed using a Zeiss LSM 510 confocal microscope. 
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Fig. 3.7 Influence of aminopterin on the mitochondrial import of MTS-GFP-DHFR. 
MTS-GFP-DHFR cells were grown on coverslips for 18 h in the presence of 1 µg/ml doxicycline and 
50 µM aminopterin as indicated. Samples were prepared for microscopic analysis and GFP 
fluorescence was analyzed using a Zeiss LSM 510 confocal microscope. 
 
Without aminopterin the reporter construct is not found in the cytoplasm, at the 
plasma membrane or in the nucleus. It localizes to mitochondria confirmed by the 
staining pattern, which was shown to represent mitochondrial localization (see 
section 3.1.3)  
Upon addition of aminopterin the localization pattern changes dramatically. The 
protein exhibits cytosolic and nuclear localization. No distinct mitochondrial staining is 
detectable anymore. Aminopterin blocks the mitochondrial import of the fusion 
construct and, therefore, the expressed protein is distributed throughout the 
cytoplasm. It can also be found in the nucleus due to the GFP moiety since GFP is 
known for its nuclear localization to a certain extent by diffusion along the 
concentration gradient in order to establish an equilibrium. 
 
3.1.6 Biochemical Analysis of the Influence of Aminopterin on MTS-
GFP-DHFR Import Into Mitochondria 
 
MTS-DHFR-GFP cells were cultivated in media supplied either with 1 µg/ml 
doxicycline or 1 µg/ml doxicycline and 50 µM aminopterin for 18 h. Cell lysates were 
prepared and analyzed by SDS-PAGE and Western blot using anti-GFP antibodies 
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and HRP-coupled secondary antibodies. Visualization was performed using the 
chemiluminescence-based ECL system and x-ray film detection. 
 
 
Fig. 3.8 Biochemical Analysis of MTS-GFP-DHFR import into mitochondria in the absence or 
presence of aminopterin. 
MTS-GFP-DHFR cells were grown in the absence or presence of 1 µg/ml doxicycline for 18h. Where 
indicated 50 µM aminopterin was added during the protein induction period. Obtained cell lysates were 
analyzed by SDS-PAGE and Western blotting employing affinity-purified anti-GFP antibodies. Material 
of about 20,000 cells was loaded in each lane. Visualization was performed using the ECL system and 
x-ray film detection. The previously described isoforms of MTS-GFP-DHFR are detectable; the 
precursor (), the intermediate form () and the fully processed form (). 
 
The protein MTS-GFP-DHFR is expressed in a doxicycline-dependent manner (Fig. 
3.8, lane 2). The three isoforms observed previously are detectable (see section 
3.1.2), the slow migrating precursor form (), the intermediate form () and the fully 
processed form () which migrates fastest (Fig. 3.8, lane 3). The visible band 
migrating slower than the precursor form corresponds to a cross reaction signal since 
it is detected even in the absence of doxicycline. In the absence of aminopterin an 
accumulation of the processed form can be observed. 
Upon addition of aminopterin the distribution and detectable amounts of the isoforms 
change dramatically (Fig. 3.8, compare lanes 2 and 3). The amount of the processed 
form is strongly reduced. Regarding the intermediate form the signal remains the 
same and when analyzing the precursor form one can also see a strong reduction. 
Taken together the whole amount of protein found in the cells is largely reduced. 
The observed reduction of the overall protein amount occurs because fusion proteins 
binding to the mitochondrial import complexes and blocking these, since they can not 
be translocated when bound by aminopterin, are probably actively degraded by the 
cell. This is done to clear the import complexes in order to keep them in a functional 
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state. Therefore, the amount of the precursor form bound to the cytosolic face of the 
mitochondria is strongly reduced and also the amount of imported protein detectable 
as fully processed form is diminished since the import is blocked. The transient 
intermediate form is not reduced since the small fraction of protein passing through 
the intermembrane region even in the presence of aminopterin is rapidly translocated 
to the mitochondrial matrix. 
 
3.1.7 Protease Protection Assay to Analyze the Stability of the DHFR 
Domain in the Absence or presence of Aminopterin 
 
To test if aminopterin binds to the DHFR domain and if it is able to stabilize the 
conformation of the molecule a protease protection assay was performed. FGF2-
GFP and FGF2-GFP-DHFR cells expressing their reporter molecules were lysed in a 
detergent-containing buffer followed by centrifugation to remove insoluble material. 
The Lysates were subjected to trypsin protease treatment (200 mg trypsin/ml) in the 
absence or presence of 50 µM aminopterin for 30 min at 4°C. Samples were 
analyzed employing SDS-PAGE and Western blot. Fusion proteins were detected 
using primary monoclonal anti-DHFR antibodies (Becton Dickinson) and HRP-
coupled secondary antibodies. Signals were visualized using the 
chemiluminescence-based ECL system and x-ray film detection. 
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Fig. 3.9 Protease protection assay analyzing the stabilizing effect of aminopterin on the DHFR 
domain. 
MTS-GFP-DHFR and FGF2-GFP-DHFR cells expressing the reporter constructs were lysed in a 
detergent-containing buffer. The lysates were cleared by centrifugation and subjected to protease 
treatment (200 µg trypsin/ml) in the presence or absence of aminopterin (50 µM) for 30 min at 4°C. 
The samples were subjected to SDS-PAGE and Western blot transfer. Detection was performed 
applying monoclonal anti-DHFR antibodies. Lanes 1-3: MTS-GFP-DHFR; Lanes 4-6: FGF-2-GFP-
DHFR. As can be seen in lanes 1 (MTS-GFP-DHFR) and 4 (FGF-2-GFP-DHFR), post lysis 
degradation results in the appearance of the DHFR fragment without adding exogenous protease. 
 
In the absence of trypsin and aminopterin the fusion proteins are detectable and 
show the expected migration behaviour (Fig. 3.9 lanes 1 and 4). Also a fragment with 
a size of 20 kDa corresponding to the DHFR domain alone is detectable, which 
results from degradation occurring during sample preparation. Addition of trypsin in 
the absence of aminopterin results in complete proteolysis of the reporter molecules 
(Fig. 3.9 lanes 2 and 5). By contrast, trypsin treatment in the presence of aminopterin 
shows stabilization of both the complete fusion proteins and the DHFR fragments 
(Fig. 3.9 lanes 4 and 6). The stabilization of the fusion proteins and protection against 
proteolysis demonstrates tight binding of aminopterin to DHFR. Only in the presence 
of the drug protection is achieved giving a proof for binding and stabilization of the 
conformation by the substrate analogon. 
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3.1.8 Rationale For the Analysis of the Aminopterin Effect on FGF2-
GFP-DHFR Export 
 
As depicted in Fig. 3.10 the use of affinity-purified anti-GFP antibodies to analyze the 
effect of aminopterin on protein secretion in the in vivo assays is not sufficient to 
obtain correct results. 
 
 
Fig. 3.10 Schematic overview: Rationale for the analysis of FGF2-GFP-DHFR in the presence of 
aminopterin. 
 
Anti-GFP antibodies can also detect fusion proteins, which might be stuck in a 
putative membrane pore or protein conducting channel upon aminopterin binding to 
the DHFR domain (Fig. 3.10, 1.). A part of the GFP molecule could reach out into the 
extracellular space and function as an antibody epitope since the used antibodies are 
polyclonal and detect multiple epitopes in the sequence of the GFP moiety. 
Misleading observations would be made when investigating the possible inhibition of 
protein export mediated by aminopterin binding by employing polyclonal anti-GFP 
antibodies only. 
In contrast, the use of anti-His6-tag antibodies allows the detection of completely 
secreted molecules since the translocation signal is located in the N-terminal FGF2 
moiety of the fusion construct and the C-terminal His6-tag is only available as an 
antibody epitope when secretion of the molecule is complete (Fig 3.10, 2.). It is 
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therefore necessary to have the possibility to detect the extreme C-terminus of the 
reporter constructs what can be achieved by the use of anti-His6-tag antibodies. 
 
3.1.9 Effect of Aminopterin on FGF2-GFP-DHFR Export As Analyzed by 
Confocal Microscopy 
 
Cells expressing the reporter construct FGF2-GFP-DHFR were cultured on cover 
slips in the absence or presence of 50 µM aminopterin for 18 h. The specimens were 
fixed without permeabilization and cell surface localization was probed using primary 
anti-GFP or anti-His6-tag antibodies and secondary Alexa 546-coupled antibodies. 
Samples were analyzed using a Zeiss LSM 510 confocal microscope. 
 
Fig. 3.11 Microscopic analysis of FGF2-GFP-DHFR export in the absence or presence of 
aminopterin. 
FGF-2-GFP-DHFR cells were grown on cover slips in the presence of 1 µg/ml doxicycline for 18 h and 
in the absence (panel A and D) or presence of 50 µM aminopterin (panels B, C, E and F). Cells were 
fixed without permeabilization using paraformaldehyde followed by immunostaining applying either 
affinity-purified anti-GFP antibodies (panels D and E) or monoclonal anti-His6-tag antibodies (panel F). 
Total GFP fluorescence (panels A to C) as well as cell surface staining (panels D to F) were analyzed 
using a Zeiss LSM 510 confocal microscope. 
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Analysis of the GFP fluorescence shows that protein expression is functional in the 
absence or presence of aminopterin (Fig. 3.11, panels A, B and C). 
In the absence of aminopterin the expressed reporter molecules are translocated 
across the plasma membrane and can be detected on the cell surface using anti-
GFP antibodies (Fig. 3.11, panel D). In the presence of the drug the protein is also 
exported and recognized on the cell surface by both anti-GFP and anti-His6-tag 
antibodies (Fig. 3.11, panels E and F). The addition of aminopterin does not influence 
FGF2-GFP-DHFR export or inhibit its secretion as shown by the detection of the GFP 
moiety and also the extreme C-terminus of the fusion protein outside of the cells. 
 
3.1.10 Effect of Aminopterin on FGF2-GFP-DHFR Export As Analyzed by 
Flow Cytometry 
 
FGF2-GFP-DHFR cells were grown in the absence or presence of 1 µg/ml 
doxicycline and 50 µM aminopterin for 18 h. After preparation for FACS analysis by 
washing and detaching the cells using a protease-free buffer system, exported 
reporter proteins on the cell surface were immunolabelled employing anti-GFP or 
anti- His6-tag antibodies. Primary antibodies were detected using allophycocyanin-
coupled secondary antibodies. Dead cells were identified by propidium iodide 
staining and are thereby excluded from later evaluation. Samples were analyzed 
using a FACSCalibur flow cytometer (Becton Dickinson). 
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Fig. 3.12 Analysis of FGF2-GFP-DHFR export in the absence or presence of aminopterin 
employing FACS. 
Non-induced (grey curves) and doxicycline-induced (green curves) FGF2-GFP-DHFR cells were 
grown in the absence (panels A, B, E and F) or presence of 50 mM aminopterin (panels C, D, G and 
H). Following detachment cells were processed for FACS analysis using either affinity-purified anti-
GFP antibodies (panels A, C, E and G) or monoclonal anti-His6-tag antibodies (panels B, D, F and H). 
Total GFP fluorescence (panels A to D) as well as cell surface staining (panels E to H) were measured 
simultaneously using a FACSCalibur flow cytometer (Becton Dickinson). 
 
Grey curves represent cells grown in the absence of doxicycline and green curves 
cells grown in the presence of doxicycline. Regarding the GFP fluorescence a clear 
shift is visible (Fig. 3.12, panels A, B, C and D). Addition of aminopterin causes an 
increase in protein expression even in not induced cells compared to non-
aminopterin conditions (Fig. 3.12, grey curves panels A and B compared to panels C 
and D). 
The export analysis of the reporter construct reveals that in the absence of 
aminopterin the protein is detectable on the cell surface using externally added anti-
GFP or anti- His6-tag antibodies (Fig. 3.12, panels E and F, green curves). Upon 
addition of aminopterin the protein remains detectable on the cell surface in a 
comparable extent to non-aminopterin conditions employing both antibodies (Fig. 
3.12, panels G and H, green curves). Therefore, being consistent with the data 
obtained by confocal microscopy, secretion of the reporter construct is not affected 
by aminopterin (see section 3.1.9). 
 
Because of the elevated expression levels in the presence of aminopterin, the 
amount of doxicycline added to the cells to induce protein expression was titrated to 
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adjust the expression level to that of cells grown in the absence of aminopterin 
(analysis of the GFP fluorescence by FACS, data not shown). After adjusting the 
protein expression in the presence of aminopterin, the FACS analysis was repeated 
three times. The obtained values for cell surface staining were averaged and signals 
in the absence of aminopterin were set to 100% to compare export levels in the 
absence or presence of aminopterin. 
 
 
Fig. 3.13 Statistical analysis of FGF2-GFP-DHFR export in the absence or presence of 
aminopterin-based on expression corrected cell surface staining. 
Since aminopterin causes a significant increase of FGF2-GFP-DHFR expression, the amount of 
doxicycline added to aminopterin treated cells was titrated until an expression level was reached 
similar to cells grown in the absence of aminopterin. Under these conditions, FGF2-GFP-DHFR export 
was determined based on cell surface staining. Cell surface staining measured in the absence of 
aminopterin was set to 100% and compared to cell surface staining in the presence of aminopterin 
(n=3). 
 
When using anti-GFP antibodies the signal in the presence of aminopterin is not 
elevated or reduced demonstrating that FGF2-GFP-DHFR export is not influenced by 
aminopterin (Fig. 3.13, anti-GFP). Results obtained with the monoclonal anti-His6-tag 
antibody show an about two-fold higher signal in cell surface staining in the presence 
of aminopterin (Fig. 3.13, anti-His6). This might be due to an increased accessibility 
of the C-terminal His6-tag fused to the DHFR domain when aminopterin binds and 
alters the conformation of the DHFR domain. 
Taken together the analyses by confocal microscopy and the data obtained by flow 
cytometry revealed that the addition of aminopterin does not influence the export of 
the reporter constructs. FGF2-GFP-DHFR is efficiently exported in the presence of 
aminopterin. 
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3.1.11 Limitations of the DHFR Approach 
 
The purpose of the DHFR system was to analyze if export of FGF2 requires protein 
unfolding. Fusion of FGF2 to a DHFR domain results in a reporter molecule, which 
can not be unfolded in the presence of aminopterin, a substrate analogon of DHFR 
that binds tightly to the active center. 
The export of FGF2-GFP-DHFR was not inhibited in the presence of aminopterin. 
When analyzing the fusion construct by employing anti-GFP and anti-His6-tag 
antibodies it could furthermore be shown that the reporter molecule is exported 
completely as analyzed by both flow cytometry and confocal microscopy (see 
sections 3.1.9 and 3.1.10). In contrast, the analysis of the control construct consisting 
of a mitochondrial targeting sequence (MTS) fused to DHFR revealed that the import 
into the mitochondrial matrix is blocked upon addition of aminopterin as revealed by 
both confocal microscopy and a biochemical analysis based on MTS processing (see 
sections 3.1.6 and 3.1.9). The mitochondrial import process consists of two 
membrane translocations steps and is dependent on the unfolding of the cargo 
proteins. By proving that the applied DHFR system is functional in the mitochondrial 
import translocation process, the results obtained for the FGF2 fusion construct show 
that FGF2 can be exported in a folded conformation since its export is not blocked by 
the addition of the drug. But it has to be taken into consideration that there are 
certain limitations applying to this system. 
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Fig. 3.14 Schematic overview: Limitations of the DHFR system. 
 
The first and expected case would be that the fusion construct is exported in a fully 
folded state with aminopterin bound to the DHFR domain (Fig. 3.14 A). However, a 
second possibility could be that specific cytosolic chaperones function in the 
unconventional export pathway of FGF2 capable of unfolding the reporter molecule 
even in the presence of aminopterin. Unfolded material would be exported (Fig. 3.14 
B). A third possibility could be that reporter molecules get exported before folding 
occurs. In this scenario only a fraction of total protein is exported consisting of 
nascent polypeptide chains, which directly function as substrates for the export 
machinery in a co-translational manner. These proteins are not folded when they are 
exported, so that aminopterin could not bind to the active since the DHFR domain 
does not reach its functional conformation and the active center of the enzyme is not 
formed. Proteins in the cytosol being folded on the other hand would not leave the 
cell. In that case unfolded material would be exported in the presence of aminopterin 
(Fig. 3.14 C). 
Thus, to rule out these possibilities show that only folded molecules are exported a 
new approach is necessary. An experimental approach to overcome the limitations of 
the DHFR system is a molecular piggyback export analysis system, which is 
presented in the next part of the study. 
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3.2 Molecular Piggyback Export Analysis System 
 
The rationale of the piggyback export analysis system is to investigate whether two 
proteins are exported attached to each other. Moreover, it addresses the question if a 
protein has to be folded correctly and maintain its conformation to be exported by the 
non-classical export pathway. 
One protein is a cargo molecule destined for export, the other an interaction partner 
that is not exported on its own. The two molecules associate prior to export by non-
covalent interactions. In case the conformation of the two molecules is maintained 
during membrane translocation they can be exported as a complex. Based on this 
rationale, the strategy monitors the folding state during membrane translocation by 
the fact that protein-protein interactions are lost upon unfolding or any other 
conformational change. The system is termed piggyback export analysis system 
since a non-exported protein is co-translocated ‘on the back’ of an exported one as 
observed in nuclear or peroxisomal import (Weil et al., 1999; Wu et al., 2000). 
Moreover, it shows parallels to bacterial protein export mediated by the twin-arginine 
(Tat) transporter. It was observed that this translocation system mediates export of 
oligomeric complexes, even if they contain additional co-factors (DeLisa et al., 2003). 
 
 
Fig. 3.15 Schematic overview: Piggyback export system (simplified). 
 
The system overcomes the limitations of the DHFR approach since correct folding is 
a prerequisite and must be maintained during the whole export process in order to 
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transport the non-exported interaction partner out of the cell. To apply this system to 
the unconventional secretion of FGF2 one of two interacting protein domains, which 
are not exported on their own were either fused to FGF2 or to GFP. When both 
reporter molecules are expressed in the same cell it is possible to analyze if export of 
the complex formed by the interacting domains occurs.  
 
3.2.1 Generation of Piggyback Reporter Cell Lines 
 
To generate cell lines, which express the reporter proteins cDNA constructs, 
molecular cloning techniques were employed (see Material & Methods, section 
2.2.15). To express both reporter proteins in one cell a bicistronic expression vector, 
termed pRTi, was used. The pRTi vector is based on the pRevTRE2 viral 
transduction vector (Clontech) which was modified in a way that an internal ribosome 
entry site (IRES) is inserted into the multiple cloning site. The MCS itself was 
extended with more restriction sites to be more flexible in the use of restriction 
enzymes. These modifications resulted in a vector with two multiple cloning site 
separated by the IRES element. After integration into the genome of target cells 
transcription leads to a bicistronic mRNA from which two proteins are translated. One 
derived from the first MCS upstream, and the other from the second MCS 
downstream of the IRES element. Following generation of the reporter constructs, 
CHOMCAT-TAM2 cells were transduced using viral particles which carry the respective 
cDNAs (Engling et al., 2002) similar to the generation of cell lines used in the DHFR 
approach (see section 3.1.1, Fig. 3.2 and 3.3 as well as text and Material & Methods, 
sections 2.3.4 and 2.5.3). The sorting step to obtain clonal cell lines was performed 
using a FACSAria system (Becton Dickinson). 
The interacting proteins used to establish the piggyback export analysis system are 
the Fc domain of the mouse immunoglobulin 2α (IgG2α) and the IgG binding domains 
of Protein A from staphylococcus aureus. They form a stable, non-covalently linked 
complex and are used in standard research techniques and purification procedures. 
A well known example is the twin affinity purification (TAP) method which is used to 
purifiy proteins present at low cellular level under native conditions which, in turn, 
allows purification of associated proteins or oligomeric complexes. It consists of 
fusion of the TAP-tag to the target protein and the introduction of the construct into 
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cells for expression. The TAP-tag consists of the IgG binding domains of Protein A 
and the calmodulin binding peptide (CBP). These two tags are fused in tandem 
separated by a TEV (tobacco virus etch) protease cleavage site (Carrington and 
Dougherty, 1988). The fusion protein and associated components are recovered from 
cell lysates by affinity purification using an IgG-matrix. After washing, TEV protease 
is added to release the bound material and removed in a final purification step (Puig 
et al., 2001; Rigaut et al., 1999). The IgG2α domain and Protein A were used to 
generate the following piggyback interaction constructs. 
 
 
Fig. 3.16 Schematic overview of piggyback cDNA constructs. 
FGF1 = fibroblast growth factor 1, FGF2 = fibroblast growth factor 2, FGF4-S = fibroblast growth factor 
4 containing a classical signal sequence, IgG2α = Fc domain of the mouse immunoglobulin 2α, GFP = 
green fluorescent protein, Prot.A = Protein A from staphylococcus aureus, NES = nuclear export 
signal derived from subunit 9 of the F0 ATPase from neurospora crassa, IRES = internal ribosome 
entry site, orientation = left to right corresponds to 5’ to 3’ 
 
The first reporter construct, termed F1-IG / G-PA, consists of FGF1 fused to the 
IgG2α domain with a C-terminal nuclear export signal (NES). FGF1 is an 
unconventionally secreted protein that belongs to the family of heparin binding 
fibroblast growth factors. The calculated molecular mass for this construct is 46 kDa. 
The second fusion protein, termed F2-IG / G-PA, is comprised of FGF2 fused to the 
IgG2α domain with the NES sequence at the C-terminus. It is also a member of the 
heparin binding growth factor family and closely related to FGF2. FGF2 is the main 
focus of the current study investigating its folding state during unconventional 
secretion. The calculated molecular mass is 46 kDa. The next construct, termed F4-
IG / G-PA, consists of FGF4 with a classical signal sequence (FGF4-S) fused to GFP 
C-terminally extended with the NES sequence. FGF4 also belongs to the FGF 
protein family but is secreted via the classical secretory pathway mediated by the ER 
and the Golgi system. It was employed in the piggyback export analysis approach to 
function as a control since no co-export of the piggyback interaction partner is 
expected. FGF4-S is inserted co-translationally into the ER and transported to the 
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cell exterior by membrane-bound vesicles passing the Golgi apparatus. The non-
secreted interaction partner GFP-Protein A is synthesized on free ribosomes in the 
cytosol so that the two molecules are intracellularly separated and can not associate 
to form the complex. The calculated molecular mass for FGF4-S-IgG2α-NES is 51 
kDa. The fourth reporter construct is termed IG / G-PA and was designed without a 
FGF moiety to function as an additional control which should not be secreted since 
no targeting motif for the classical secretory pathway or an unconventionally secreted 
protein moiety is present. Unlike the FGF4-S-containing construct the complex of the 
two interacting molecules can form since both proteins are synthesized in the cytosol 
and none is sequestered into a membrane-bound organelle. The calculated 
molecular mass is 29 kDa. 
The non-exported interaction partner used to generate the different reporter 
constructs consists of GFP fused to Protein A C-terminally extended by a NES 
sequence. It was cloned into the MCS downstream of the IRES element which 
results in expression of a discrete protein from the bicistronic mRNA. It has a 
calculated molecular mass of 44 kDa. GFP was used to generate the non-exported 
interaction partner because it can easily be monitored due to its fluorescence activity. 
Moreover, it can be detected by affinity-purified polyclonal anti-GFP antibodies as 
described by engling et al. (Engling et al., 2002) which are available in our laboratory 
(see section 3.1.1.1 and Material & Methods section 2.1.9). The reason for the 
addition of the NES (nuclear export signal) sequence (Fukuda et al., 1996) to all 
reporter molecules is to minimize the nuclear localization observed in the analysis of 
the DHFR fusion constructs. The addition of the NES sequence results in an increase 
of the pool of cytosolic reporter molecules being available for export and complex 
formation. 
As a standard control a cell line which expresses FGF2-GFP (Engling et al., 2002) in 
a doxicycline-dependent manner was used. The reporter construct was also 
extended with a C-terminal NES sequence to reduce nuclear localization. The 
corresponding cell line was generated by modifying the construct in the vector 
pRevTRE2 by adding the C-terminal NES using molecular cloning techniques. 
Following viral transduction of CHOMCAT-TAM2 cells (Engling et al., 2002) FACS-based 
sorting was performed to obtain single clones as described in section 3.1.1 (see also 
Material & Methods, sections 2.3.4 and 2.5.3). The generated clonal cell line was 
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termed CHO FGF2-GFP-NES and the reporter protein has a calculated molecular 
mass of 46 kDa. 
 
3.2.2 Biochemical Analysis of Doxicycline Dependent Protein 
Expression 
 
To test for doxicycline-dependent protein expression cells being transduced with the 
reporter constructs were grown in the absence or presence of 1 µg/ml doxicycline for 
18 h. Cell lysates prepared in SDS sample buffer were analyzed by SDS-PAGE and 
Western blot. Fusion constructs containing the IgG2α domain were detected using 
Alexa 680-coupled goat anti-mouse IgG antibodies normally used as secondary 
antibodies. To detect the piggyback interaction partner containing the GFP moiety 
affinity-purified anti-GFP antibodies in combination with secondary Alexa 680-
coupled antibodies were used. Alexa 680-labelled proteins were visualized using an 
Odyssey infrared imaging system. 
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Fig. 3.17 Western Blot analysis of doxicycline-dependent protein expression. 
Reporter cell lines were grown in the absence or presence of 1 µg/ml doxicycline for 18h. Cell lysates 
were separated on 13% SDS gels followed by Western blot transfer. Detection was performed 
applying either anti-mouse IgG antibodies (panel A) or affinity-purified anti-GFP antibodies (panel B). 
For the analysis of each cell line material derived from 10,000 cells was loaded. 
 
The analysis revealed that the expression of the two discrete reporter proteins from 
one mRNA is functional. Detection of reporter proteins employing anti-mouse IgG 
antibodies showed doxicycline-dependent protein expression of the IgG2α-containing 
reporter molecules (Fig 3.17, panel A, lanes 2, 4, 6 and 8). Additionally, if the 
samples are analyzed using anti-GFP antibodies doxicycline-dependent protein 
expression of GFP-containing reporter proteins is observed (Fig 3.17, panel B, lanes 
2, 4, 6 and 8). All GFP-containing fusion proteins migrate corresponding to their 
calculated molecular mass of 44 kDa as compared to the protein standard (Fig. 3.17, 
panel B, lanes 2, 4, 6 and 8) although being expressed in the different piggyback cell 
lines. Some samples contain post lysis degradation products visible as faint bands 
migrating faster than the reporter construct. 
The IgG2α-containing fusion proteins also migrate corresponding to their calculated 
molecular masses as compared to the protein standard. The only exception is the 
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FGF1 construct, which was expected to migrate alike the FGF2 fusion protein 
because the polypeptide chains are of the same length (Fig. 3.17, panel A, lanes 2 
and 4). The observation made might be due to the different amino acid composition 
of the two molecules, which can result in a different migration behaviour in the 
electric field during SDS-PAGE. The analysis of the FGF4-containing fusion 
constructs revealed additional bands migrating faster than the one with the highest 
intensity (Fig. 3.17, panel A, lane 6). These might correspond to differently 
glycosylated forms of the molecule which result from ER- and Golgi-associated 
posttranslational modifications providing first evidence that the FGF4 construct 
indeed enters the classical secretory pathway. 
 
3.2.3 Analysis of Doxicycline Dependent Protein Expression Based on 
Flow Cytometry 
 
Cells grown in the absence or presence of 1 µg/ml doxicycline were prepared for 
FACS analysis using the plate labelling technique (see Materials & Methods, section 
2.5.2). To detect the IgG2α fusion proteins on the cell surface, cells were labelled 
using anti-mouse IgG allophycocyanin-coupled antibodies. Dead cells were stained 
using propidium iodide to exclude them from the subsequent data evaluation. 
Samples were analyzed in a FACSCalibur flow cytometer (Becton Dickinson). 
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Fig. 3.18 Quantitative analysis of doxicycline-dependent protein expression and secretion 
based on FACS. 
F1-IG / G-PA cells (A, B), F2-IG / G-PA cells (C, D), F4-IG / G-PA cells (E, F) and IG / G-PA (G, H) 
were grown in the absence (grey curves) and presence (green curves) of 1 µg/ml doxicycline for 18h. 
Cells were processed employing plate labelling using anti-mouse IgG allophycocyanin-coupled 
antibodies (B, D, F and H). Living cells were analyzed for GFP fluorescence and cell surface staining 
simultaneously in a FACSCalibur flow cytometer (Becton Dickinson). 
 
All cell lines show doxicycline-dependent protein expression detectable by an 
increase of the GFP fluorescence upon addition of doxicycline. Grey curves 
correspond to cells grown in the absence of doxicycline, green curves to cells grown 
in the presence of doxicycline (Fig. 3.18, panels, A, C, E and G) 
The analysis of cell surface staining revealed that FGF1, FGF2 and FGF4 fusion 
constructs are exported. There is a significant increase in the allophycocyanin-
derived fluorescence detectable when comparing grey to green curves. This 
demonstrates that protein export occurs since extracellular, cell surface bound 
material is detectable (Fig 3.18, panels B, D, and F). As expected the cell line 
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expressing the IG / G-PA fusion proteins exhibits no cell surface staining since the 
reporter protein IgG2α-NES is not exported due to the absence of a FGF moiety (Fig. 
3.18, panel H). 
The F4-IG / G-PA construct shows an elevated export efficiency compared to the 
FGF1- and FGF2-containing reporter construct. Moreover, the cell surface staining 
signal is already increased compared to the other cell lines in the absence of 
doxicycline. The reason for this increase under doxicycline-free conditions might be 
that the cells express the reporter construct on a very low basic level even without 
being induced. Since the export via the ER/Golgi pathway occurs efficiently a part of 
this basic level population might already be exported. Upon addition of doxicycline 
the obtained signal shifts to the upper limit of the FACS detection range so that the 
green curve starts at the end of the x-axis and is out of range and thus can not be 
depicted. 
 
The analysis of the generated cell lines employing Western blot and flow cytometry 
revealed that the reporter constructs are expressed in a doxicycline-dependent 
manner. Furthermore, both piggyback interaction proteins are expressed 
simultaneously from one mRNA in all cell lines. A FACS-based analysis revealed that 
all FGF-containing reporter constructs are exported and localize to the cell surface. 
 
3.2.4 Rationale of the Piggyback System 
 
The basis for the piggyback export system is the formation of a complex consisting of 
the exported fusion protein FGF2-IgG2α and the interaction partner GFP-Protein A. 
The complex is formed based on the correct three-dimensional structure of the 
reporter molecules which leads to a non-covalent interaction of the IgG2α domain 
with the IgG binding domains of Protein A. This association has to occur prior to 
export inside the cell. 
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Fig. 3.19 Schematic overview: Rationale of the piggyback export system. 
FGF2 = fibroblast growth factor 2, IgG2α = Fc domain of the mouse immunoglobulin 2α, GFP = green 
fluorescent protein, Protein A = Protein A from staphylococcus aureus. 
 
When the reporter molecules associate the unidentified targeting motif of FGF2 
directs the complex to the unconventional export machinery which mediates 
membrane translocation. In scenario 1 export occurs without conformational changes 
of the reporter molecules. The interaction between IgG2α and Protein A is not 
disrupted and GFP-Protein A is detectable outside of the cell (Fig. 3.19, Scenario 1). 
As depicted in scenario 2 the conformation of the FGF2-containing fusion protein is 
changed. The complex is disrupted and reporter construct FGF2-IgG2α is exported 
alone. GFP-Protein A can not be detected in th extrcellular space.  
To be able to analyze the co-export of the interacting molecules the formation of the 
complex inside the cell has to be verified. If the two reporter proteins do not interact 
prior to export no clear conclusions can be drawn regarding the folding state of FGF2 
during membrane translocation. To analyze complex formation two independent 
experimental strategies were employed. First, a co-immunoprecipitation analysis was 
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performed and in second approach the reporter proteins were subjected to gel 
filtration employing FPLC analysis techniques. 
 
3.2.5 Co-Immunoprecipitation Analysis of Piggyback Complex 
Formation 
 
In a co-immunoprecipitation experiment one component of the piggyback complex is 
selectively bound by specific antibodies immobilized on sepharose-beads whereas 
the second component is not recognized and can not bind to the beads on its own. 
This assay analyzes complex formation because only if an interaction between the 
two complex building molecules takes place both are co-precipitated by this 
approach. Cell lysates of the piggyback cell lines grown in the presence of 1 µg/ml 
doxicycline for 18 h were prepared. A detergent-free buffer and mechanical lysis 
employing sonication and sample clearance by centrifugation were used in order not 
to disrupt the complexes. The samples were incubated with Protein A coupled to 
sepharose beads to which the IgG2α reporter molecules can bind. To precipitate F1- 
and F2-IG / G-PA from samples additionally anti-FGF2 antibodies immobilized on 
sepharose beads were employed. These antibodies recognize both, FGF2 and 
FGF1, with high specificity (see Materials & Methods, sections 2.1.9, 2.4.10 and 
2.4.11). 
After extensive washing steps the bound material was eluted from the beads using 
SDS sample buffer and analyzed by SDS-PAGE and Western blot. IgG2α-containing 
reporter constructs were detected using anti-mouse IgG Alexa 680-coupled 
antibodies which were visualized using the Odyssey infrared imaging system. The 
detection of GFP-containing constructs was performed employing primary anti-GFP 
and secondary RG16-HRP-coupled antibodies, which only detect native antibody 
molecules. The use of the RG16 secondary antibodies excludes the detection of 
antibodies derived from immunoprecipitation procedure so that only precipitated 
reporter proteins are visualized on the Western blot using the chemiluminescence-
based ECL system and x-ray film detection. Additionally, input samples consisting of 
cell lysates not incubated with beads were analyzed in order to probe for expression 
of the interacting reporter molecules and to have an intrinsic marker for each reporter 
construct to compare precipitated material. 
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Fig. 3.20 Co-immunoprecipitation analysis of piggyback interactions. 
Reporter cell lines were grown in the presence of 1 µg/ml doxicycline for 18 h. Cell free supernatants 
were prepared employing detergent-free buffer combined with mechanical lysis and cleared by 
centrifugation. Samples were incubated with Protein A-sepharose-beads or in the case of F1- and F2-
IG / G-PA with Protein A-sepharose beads decorated with affinity-purified anti-FGF2 antibodies for 3 h 
at 4°C. Bound material was eluted using SDS sample buffer and analyzed by SDS-PAGE (13% gels) 
and Western blotting. Reporter molecules were detected applying anti-mouse IgG HRP-coupled 
antibodies (panel A) or primary affinity-purified anti-GFP and secondary RG16-HRP-coupled 
antibodies (panel B). Input samples, not incubated with beads, were loaded additionally. I = input 
samples (1% of total protein), EP = eluates from Protein A beads (10% of total protein), EF = eluates 
from sepharose beads decorated with anti-FGF2 antibodies immobilized (10% of total protein). 
 
The analysis employing anti-mouse IgG antibodies revealed that all piggyback 
constructs containing the IgG2α domain bind to Protein A-sepharose beads (Fig. 
3.20, panel A, lanes 2, 5, 8 and 10) or to beads decorated with anti-FGF2 antibodies 
in the case of F1- and F2-IG / G-PA (Fig. 3.20, panel A, lanes 3 and 6) when 
compared to the untreated input samples (Fig. 3.20, panel A, lanes 1, 4, 7 and 9). 
This demonstrates that it is possible to specifically precipitate the IgG2α-containing 
reporter molecules. 
For the construct F1-IG / G-PA it could be shown that the interacting reporter 
constructs form a complex because the interaction partner GFP-Protein A-NES can 
be co-precipitated using Protein A-sepharose beads or sepharose beads decorated 
with anti-FGF2 antibodies (Fig. 3.20, panels A and B, lanes 2 and 3). 
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The analysis of the F2-IG / G-PA reporter construct also confirms an interaction 
between the two molecules demonstrated by co-precipitation of the GFP-containing 
reporter protein using Protein A-sepharose beads or beads decorated with anti-FGF2 
antibodies (Fig. 3.20, panels A and B, lanes 5 and 6). 
The formation of the complex consisting of FGF4-S-IgG2α and GFP-Protein A could 
also be verified since the GFP-containing piggyback interaction protein is co-
precipitated using protein A-sepharose beads (Fig. 3.20, panels A and B, lane 8). 
When analyzing the IG / G-PA reporter construct, binding of the IgG2α domain to the 
Protein A-sepharose beads was detectable (Fig. 3.20, panel A, lane 10). However, 
co-precipitation of GFP-Protein A-NES could not be observed. Thus, it is not possible 
to analyze the formation of the complex IgG2α and GFP-Protein A in this experiment. 
On the other hand this demonstrates specificity of the employed method with regard 
to the results obtained for the other reporter constructs. The detected co-precipitation 
must be due to complex formation and can not be an experimental artefact or the 
result of unspecific binding. 
 
3.2.6 Probing Complex Formation Employing Gel Filtration  
 
In order to analyze complex formation using an independent method, cell lysates of 
the reporter cell lines were subjected to gel filtration using a size exclusion column 
and an analytical fast performance liquid chromatography (FPLC) system (SMART, 
Amersham Biosciences, see Material & Methods, section 2.4.11). 
The cell lines expressing the piggyback interaction reporter proteins and, as a 
control, cells expressing FGF2-GFP-NES were grown in the presence of 1 µg/ml 
doxicycline for 18h. Cell free supernatants were prepared avoiding the use of 
detergent to keep the proteins under native conditions. A mechanical lysis procedure 
was employed consisting of a sonication step using a low pulse-intensity and freeze-
thaw-cycles (see Material & Methods, section 2.4.2). 50 µl of each protein sample 
were separated according to the molecular mass of the proteins by the use of 
superdex 200 beads in a Tricorn 5/150 column (Amersham Pharmacia, length: 150 
mm, diameter: 5 mm, bed volume: 3 ml). Superdex 200 beads retain proteins from 10 
to 600 kDa on the column. 
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To allocate proteins of different molecular masses to respective fractions a premixed 
marker protein solution (Gel Filtration Chromatography Standard, Bio-Rad) was 
subjected to separation by gel filtration using the freshly prepared column. 
 
 
Fig. 3.21 Elution profile of marker proteins separated on a Superdex 200 column. 
10 µl of a premixed marker proteins solution with defined sizes (Gel Filtration Chromatography 
Standard, BioRad) were fractionated by gel filtration in an analytical FPLC system (SMART, 
Amersham Pharmacia). Superdex 200 beads were used as matrix material to separate proteins by 
molecular mass in a range of 10 to 600 kDa. A column of 150 mm length and a diameter of 5 mm with 
a bed volume of 3 ml (Tricorn 5/150, Amersham Pharmacia) was employed. The absorbance at 280 
nm is plotted against the eluted fractions. 
 
The separation of the marker protein mixture showed that the proteins are retained 
differently on the gel filtration column according to their molecular masses and 
therefore elute in different fractions: 
 
Protein Size [kDa] Fraction 
Thyroglobulin 670 12 
IgG 158 19 
Ovalbumin 44 26 
Myoglobin 17 33 
Cyanocobalamin 1,3 41 
 
Fig. 3.22 Table: Molecular masses of marker proteins (Gel Filtration Chromatography Standard, 
BioRad) and retention by Superdex 200 beads (Amersham Pharmacia) using a Tricorn 5/150 
column (Amersham Pharmacia) in an FPLC system. 
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The obtained data were used as a standard in order to estimate molecular masses of 
proteins of the unknown samples when these elute from the column in their 
respective fractions. 
The correlation of protein size and retention behaviour depending on the molecular 
mass (Fig.3.22) is shown graphically in the following diagram displayed as an 
exponential function corresponding to the curve fitting equation: y = 8482,2e -0,2041x. 
 
Fig. 3.23 Diagram: Relation of molecular masses of marker proteins to retention behaviour 
employing Superdex 200 beads. 
Molecular masses of marker proteins in correlation to retention on a Superdex 200 matrix and elution 
in respective fractions is displayed as an exponential function (curve fitting equation:  
y = 8482,2e -0,2041x). The calculation is based on the data obtained from the analysis of a marker 
protein mixture (Gel Filtration Chromatography Standard, BioRad) as described. 
 
After determination of the standard 50 µl of the different cell free supernatants were 
run separately over the column and 42 fractions of each run were collected. Every 
second fraction starting from fraction 10 through fraction 28 was analyzed employing 
SDS-PAGE and Western blot analysis. To detect the IgG2α-containing reporter 
proteins anti-mouse IgG antibodies coupled to the fluorophore Alexa 680 were used. 
The GFP fusion constructs were detected by the use of primary anti-GFP and Alexa 
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680-coupled secondary antibodies. Visualization was performed using an Odyssey 
infrared imaging system. 
 
 
Fig. 3.24 Biochemical analysis of cell lysates fractionated by gel filtration. 
Cell free supernatants of induced reporter cell lines were prepared using a detergent-free buffer, 
sonication and clearance by centrifugation (100,000 g, 45 min, 4°C). 50 µl of the samples were 
fractionated according to molecular mass using superdex 200 beads by FPLC (SMART system, 
Amersham). Every second fraction from 10 to 28 was analyzed on 13% SDS gels and Western blot. 
Per fraction 15% of eluted material was loaded. Detection of the reporter molecules was performed 
applying anti-mouse IgG Alexa 680-coupled antibodies (panels B, D, F, H) or affinity-purified anti-GFP 
and secondary Alexa 680-coupled antibodies (panels A, C, E, G, I). Visualization was performed using 
an Odyssey infrared imaging system. 
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To be able to interpret the data obtained from the gel filtration analysis it is important 
to known what are the calculated molecular masses of the reporter proteins and the 
putative complexes. If the reporter proteins associate into complexes they are 
retained on the column according to the molecular mass of the complex. Therefore, 
they elute in fractions which correspond to the molecular mass of the complex not in 
fractions which correspond to the molecular mass of the monomeric reporter protein. 
The putative complexes could be on the one hand heterodimers consisting of the 
IgG2α-containing reporters and the interaction partner GFP-Protein A-NES or on the 
other hand heterotetramers consisting of two heterodimers since the GFP moiety has 
the tendency to dimerize what would result in a tetramer formation. FGF2-GFP is 
expected to be either monomeric (46 kDa) or to form homodimers (92 kDa). The 
possible combinations and calculated molecular masses for the piggyback pairs are 
summarized in the following table. 
 
Sizes [kDa] monomer heterodimer heterotetramer 
FGF1-IgG2α-NES 46 90 180 
FGF2-IgG2α-NES 46 90 180 
FGF4-S-IgG2α-NES 51 95 190 
IgG2α-NES 29 73 146 
GFP-Protein A-NES 44 - - 
 
Fig. 3.25 Table: Calculated molecular masses of reporter molecules and putative complexes. 
Based on the amino acid sequence the molecular masses of the reporter molecules were calculated 
(Editseq software, DNA Star). Molecular masses of the putative heterodimers were calculated by 
addition of the molecular mass of an IgG2α-containing reporter molecule and GFP-Protein A-NES. 
Molecular masses of putative heterotetramers were determined by multiplying the values of the 
heterodimers by a factor of two. 
 
The fractionation according to molecular mass of the construct FGF2-GFP, when 
detected with anti-GFP antibodies, showed the highest amount of protein in fraction 
22. There is a clear elution-peak detectable compared to the other fractions (Fig. 
3.24, panel A). This corresponds to a molecular mass of 80 to 90 kDa when 
compared to the retention behaviour of the marker proteins suggesting that most of 
the protein is found in a homodimeric state with a calculated molecular mass of 92 
kDa. 
When analyzing the fractions obtained from the sample F1-IG / G-PA employing anti-
mouse IgG antibodies most of the protein elutes in fraction 18 (Fig. 3.24, panel B). 
This demonstrates a shift of the elution-peak compared to FGF2-GFP from fraction 
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22 to fraction 18 implying an increase in molecular mass. Fraction 18 corresponds to 
a molecular mass of 180 to 200 kDa which would match the calculated mass of a 
heterotetramer complex of 180 kDa. Also F2-IG / G-PA and F4-S-IG / G-PA exhibit 
an elution peak in fraction 18 when analyzed by anti-mouse IgG antibodies (Fig. 
3.24, panels D and F). This shows that most of the proteins also seem to form 
heterotetramers because these have a calculated molecular mass of 180 or 190 kDa 
what would fit to the observed retention behaviour on the column. For the cell line F4-
IG / G-PA the appearance of the elution peak in this mass range is an unexpected 
result. The construct FGF4-S-IgG2α-NES is expected to be co-translationally 
inserted into the ER due to the presence of a classical hydrophobic signal sequence. 
The interaction partner GFP-Protein A-NES is translated on free ribosomes in the 
cytosol and a complex is not expected to form because the molecules are spatially 
separated. However, a shift of the elution peak, which corresponds to the molecular 
mass of the complex, is observed and can only be explained by post lysis complex 
formation. If upon cell lysis the ER/Golgi system and the plasma membrane are 
disrupted the two proteins can associate since they are no longer sequestered in 
membrane-bound compartments. The construct IgG2α-NES without FGF moiety 
exhibits the elution-peak in fraction 23 corresponding to a molecular mass of 60 to 80 
kDa (Fig. 3.24, panel H). This result implies that IgG2α-NES forms a heterodimer 
with the piggyback interaction partner which is expected to have a molecular mass of 
73 kDa. 
The analysis of the piggyback interaction partner GFP-Protein A-NES using anti-GFP 
antibodies showed an unexpected result. A large amount of protein is detectable in 
high molecular weight fractions. Especially F1-, F2- and F4-S-IG / G-PA show intense 
signals in fractions 10 and 12 which corresponds to a size of 670 kDa or even more 
(Fig. 3.24, panels C, E and G). This might be due to the formation of high molecular 
weight aggregates as a result of the lysis procedure that are not retained on the 
column. They are found in the exclusion volume, which is defined by the range of 
molecular masses that are retained. Proteins larger than 600 kDa and smaller than 
10 kDa are not retained on the Superdex 200 matrix and pass through the column 
without associating to the beads. Therefore, they elute in the very first fractions. High 
amounts of protein are also found in the low molecular weight fractions 24 and 26 
corresponding to a size of 60 to 40 kDa (Fig. 3.24, panels C, E and G). These 
fractions represent GFP-containing proteins not attached to other molecules but 
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rather being monomeric. Another quite unexpected finding is that the elution peaks 
for the IgG2α-containing reporter constructs and GFP-Protein A-NES are not present 
in the same fractions. This would have been expected if they were attached to each 
other in complexes. It might be possible that only a small portion of the overall GFP 
reporter molecules is actually present in the piggyback complexes and that the rest 
are free monomers or form high molecular weight aggregates as detected by the 
Western blot analysis visualized using GFP antibodies. 
 
The analysis of the complex formation by a co-immunoprecipitation method and gel 
filtration shows that the piggyback complexes are formed to a significant extent. It 
was possible to co-precipitate GFP-Protein A-NES with Protein A-sepharose beads 
or with sepharose beads decorated with anti-FGF2 antibodies. The gel filtration 
analysis shows a shift of the elution peak to higher molecular weight fractions 
compared to FGF2-GFP-NES representing an increase in molecular mass as a result 
of complex formation. The elution peaks of the IgG2α-containing reporter constructs 
match with the expected molecular masses of the putative complexes demonstrating 
a stable interaction between the piggyback reporter proteins. 
 
3.2.7 Export of Reporter Molecules as Analyzed by Flow Cytometry 
 
Cells were cultivated in the absence or presence of 1 µg/ml doxicycline for 18 h and 
prepared for FACS analysis using the plate labelling technique (see Materials & 
Methods, section 2.5.2). Doublets of each sample were processed in order to 
simultaneously analyse the export of the IgG2α-containing reporter constructs and a 
possible co-export of the piggyback interaction partner GFP-Protein A-NES. The 
detection of the IgG2α-containing reporter constructs was performed using anti-
mouse IgG allophycocyanin-coupled antibodies. The interaction partner GFP-Protein 
A-NES was detected employing primary anti-GFP antibodies and secondary 
allophycocyanin-coupled antibodies. Dead cells were stained using propidium iodide 
and thus could be excluded from the following evaluation. Immuno-labelled cells 
were analyzed using a FACSCalibur flow cytometer (Becton Dickinson). 
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Fig. 3.26 Export of piggyback complexes analyzed by Flow Cytometry. 
Cells grown in the absence (grey curves) and presence (green curves) of 1 µg/ml doxicycline for 18 h 
were prepared for FACS analysis applying plate labelling technique. Exported reporter molecules on 
the cell surface were detected by anti-mouse IgG allophycocyanin-coupled antibodies or primary anti-
GFP and secondary allophycocyanin-coupled antibodies. Samples were analyzed in a FACSCalibur 
flow cytometer (Becton Dickinson). 
 
All cell lines express their respective reporter constructs in the presence of 
doxicycline as shown by GFP fluorescence. Grey curves represent non-induced cells 
whereas green curves represent cells grown in the presence of doxicycline (Fig. 
3.26, panel A, D, G, J and M). 
Probing for cell surface staining using anti-mouse IgG antibodies showed no 
significant signal for the control cell line FGF2-GFP since no IgG2α domain is 
present in the reporter construct (Fig. 3.26, panel B, grey versus green curve). The 
cell lines F1-, F2- and F4-IG / G-PA instead show significant cell surface staining 
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signals in the presence of doxicycline (Fig. 3.26, panel E, H and K, green curves,) 
demonstrating an efficient export of their respective IgG2α-containing reporter 
constructs. The cell line F4-IG / G-PA shows export with a higher efficiency 
compared to F1- and F2-IG / G-PA as observed previously (see section 3.2.3, Fig. 
3.18). The obtained values are at the upper limit of the FACS detection range higher 
than 10,000 arbitrary fluorescence units. The green curve is therefore not visible in 
the diagram as it begins at the end of the x-axis. The cell line IG / G-PA shows no 
cell surface staining signal when employing anti-mouse IgG antibodies. This findings 
suggest that the construct IgG2α-NES is not exported as expected because it does 
not contain a protein moiety with a targeting signal (Fig. 3.26, panel N). 
When employing anti-GFP antibodies the FGF2-GFP control cell line shows a 
significant cell surface staining signal representing efficient export of the reporter 
construct (Fig. 3.26, panel C). F1-IG / G-PA exhibits a low cell surface staining signal 
of the piggyback reporter GFP-Protein A compared to FGF2-GFP although a shift of 
the peak in the presence of doxicycline is detectable (Fig. 3.26, panel F). Here one 
has to take into consideration that the piggyback reporter is expressed at a much 
lower level in comparison to FGF2-GFP-NES. This is a known phenomenon of the 
pRTi vector, since proteins translated from the MCS upstream of the IRES element 
are expressed with reduced efficiency compared to proteins being expressed from 
the MCS downstream of the IRES element for an unknown reason. The difference is 
also visible in the diagrams representing the GFP fluorescence. When comparing 
signals of the FGF2-GFP cell line (Fig. 3.26, panel A, green curve) to any of the 
piggyback cell lines (Fig. 3.26, panels D, G, J or M, green curves) one can see an 
enormous difference in fluorescence intensity of nearly two decades. This shows that 
the overall protein amount of GFP-containing reporter molecules is much lower. 
Therefore, it is problematic to directly compare the obtained cell surface staining 
signals, however those of the piggyback interaction partners are probably significant 
with regard to the low expression level. The analysis of the cell line F2-IG / G-PA 
shows nearly the same result. The observed signal using the anti-GFP antibody is 
even lower compared to F1-IG / G-PA (Fig. 3.26, panel I). It is slightly above 
background fluorescence in the absence of doxicycline but displays a shift of the 
green curve. Also the F4-IG / G-PA cell line shows a low signal of exported GFP-
containing interaction partner comparable to F2-IG / G-PA (Fig. 3.26, panel L). This is 
an unexpected finding because FGF4-S-IgG2α-NES is exported via the classical 
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secretory pathway. The complex should not be formed because the IgG2α-containing 
reporter molecule is cotranslationally inserted into the ER and the GFP-containing 
interaction partner is translated in the cytosol. The control cell line IG / G-PA shows 
no cell surface staining at all employing anti-GFP antibodies. The green and grey 
curve match for induced and not induced cells and no difference can be observed 
(Fig. 3.26, panel O). This finding demonstrates specificity of the assay. The signals 
obtained when analyzing the other cell lines must be a result of co-exported material 
on the cell surface. 
To statistically analyze export of the different reporter molecules the FACS 
experiment was repeated three times. The obtained values for cell surface staining 
analyzed with either anti-mouse IgG or anti-GFP antibody were averaged. The 
background fluorescence of untransfected CHOMCAT-TAM2 cells was subtracted from 
all values to obtain data representing the fluorescence derived from the expression of 
the reporter constructs. In the case of negative values after subtraction of the 
background fluorescence the values were set to zero. This shows that absolutely no 
export occurred. 
 
Fig. 3.27 Statistical analysis of secreted IgG2α-containing reporter molecules. 
The FACS analysis was performed three times. Export of the reporter molecules was determined by 
measuring cell surface staining using anti-mouse IgG allophycocyanin-coupled antibodies. The 
background fluorescence of untransfected CHOMCAT-TAM2 was subtracted and the values were 
averaged. Negative values after subtraction were set to zero. Standard deviation was calculated and 
is displayed as error bars (n=3). 
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The diagram in Fig. 3.27 displays cell surface staining of the different reporter cell 
lines detected with the anti-mouse IgG antibody. By the use of this antibody the 
secretion of the actively exported piggyback partner is measured. 
FGF2-GFP cells exhibit no fluorescence since the fusion protein does not contain the 
mouse IgG2α domain. This also demonstrates specificity of the antibody used since 
no background signal is observed and functions as a negative control. F1-IG / G-PA 
cells show a significant cell surface staining signal of about 3100 arbitrary 
fluorescence units demonstrating efficient export of the FGF1 construct. F2-IG / G-PA 
cells also show a significant surface staining signal of about 470 arbitrary 
fluorescence units. This construct is also actively exported by the cells. The cell line 
F4-IG / G-PA exhibits the highest cell surface staining signal of the IgG2α-containing 
reporter constructs. The obtained values of all three experiments are at the limit of 
the FACS detection range of about 10,000 arbitrary fluorescence units. Since the 
FACS does not display signals higher than 10,000 arbitrary fluorescence units the 
values obtained in the three independent experiments were displayed as 9910,46 
arbitrary fluorescence units. The FACS system calculates the median values for each 
sample which take into account the signal of each cell measured and the number of 
cells showing the signal. Therefore, the signal is not shown as the maximum of 
10,000 arbitrary fluorescence units. After background subtraction the values are 
exactly 9902,3 arbitrary fluorescence units and, therefore, calculation of the standard 
deviation is not possible. The construct consisting only of the IgG domain (IG / G-PA) 
is not detectable on the cell surface resembling the fact that it is not secreted since it 
lacks a FGF fusion domain to mediate export or binding. 
The analysis employing anti-mouse IgG antibodies demonstrates that all constructs 
consisting of a growth factor moiety fused to the IgG2α domain are actively exported 
by the cells and can be detected on the cell surface. 
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Fig. 3.28 Statistical analysis of secreted GFP-containing reporter molecules. 
The FACS analysis was performed three times. Export of the reporter molecules was determined by 
measuring cell surface staining using anti-GFP antibodies and allophycocyanin-coupled secondary 
antibodies. The background fluorescence of untransfected CHOMCAT-TAM2 cells was subtracted and the 
values were averaged. Negative values after subtraction were set to zero. Standard deviation was 
calculated and is displayed as error bars (n=3). 
 
The analysis of the cell lines employing anti-GFP antibodies revealed that the 
reporter construct FGF2-GFP is exported efficiently and can be detected on the cell 
surface (Fig. 3.28). 
Analysis of the piggyback cell lines shows that only a small portion of the GFP-
containing piggyback interaction partner is present on the cell surface. The cell lines 
which are expected to export the complex, F1-IG and F2-IG / G-PA, and the cell line 
F4-IG / G-PA which should not show co-export display low signals of cell surface 
bound GFP-Protein A-NES. The control cell line IG / G-PA shows no export of the 
GFP-containing interaction partner (Fig. 3.28). Against the background of the strongly 
different expression levels discussed before this findings suggest that the piggyback 
interaction partner GFP-Prot A-NES is co-exported to a certain extent. 
 
3.2.8 Biochemical Analysis of Piggyback Export 
 
To further probe for cell surface localization of the reporter molecules employing a 
biochemical method, cells expressing the various reporters were analyzed in a 
biotinylation assay. For this purpose cells expressing the reporter proteins were 
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incubated with a membrane impermeable biotinylation reagent (EZ-link Sulfo-NHS-
SS-biotin, Pierce) after washing and removal of the growth medium. The biotinylation 
reagent binds covalently to all surface proteins via the ε-amino group of all accessible 
lysine residues. After preparing cell lysates using a detergent-containing buffer, 
biotinylated proteins can be purified applying streptavidin beads. It is then possible to 
compare the biotinylated and non-biotinylated fraction of the protein employing SDS-
PAGE and Western blot analysis. Biotinylated proteins, which can be recovered from 
streptavidin beads, represent exported material which was associated with the cell 
surface. The non-biotinylated proteins separated from the biotin-reagent inside the 
cell correspond to non-secreted material. For this purpose samples taken before 
(input) and after streptavidin purification (eluate) were analyzed. To detect the 
reporter constructs either anti-mouse IgG Alexa 680-coupled antibodies or primary 
anti-GFP and secondary Alexa 680-coupled antibodies were used. All Western blots 
were analyzed in an Odyssey infrared imaging system. 
 
Fig. 3.29 Biochemical analysis of piggyback export applying biotinylation. 
Cells expressing the reporter constructs were incubated with a membrane impermeable biotinylation 
reagent (30 min, 4°C). Lysates were prepared using a detergent-containing buffer, sonication and 
cleared by centrifugation. An input sample was saved and the total protein concentration was 
determined. Samples were incubated with streptavidin beads (1 hour, room temperature, constant 
shaking), followed by extensive washing steps. Bound material was eluted using SDS sample buffer. 
Input (1% of total protein) and eluate (10% of total protein) were analyzed on 13% SDS gels followed 
by Western blot transfer. Detection was performed using anti-mouse IgG Alexa 680-coupled 
antibodies (panel A) or primary anti-GFP and secondary Alexa 680-coupled antibodies (panel B). 
Visualization was performed in an Odyssey infrared imaging system. 
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The control cell line FGF2-GFP exhibits export of the reporter construct shown by a 
significant signal of biotinylated protein in the eluate fraction when using anti-GFP 
antibodies (Fig. 3.29, panel B, lane 2). The band of biotinylated protein displays half 
the intensity compared to the band of the non-biotinylated fraction observed when 
analyzing the input sample. This corresponds to an amount of 0.5% of total cellular 
protein because when analyzing the input sample 1% of total cellular protein was 
loaded as quantified by protein concentration determination (Fig. 3.29, panel B, lane 
1). The analysis employing anti-mouse IgG antibodies displays no signal since no 
IgG domain is present in the reporter construct (Fig. 3.29, panel A, lanes 1 and 2). 
This shows a high specificity of the anti-mouse IgG antibody since no cross-reactivity 
can be observed. 
When analyzing the F1-IG / G-PA reporter construct one can see a low signal of the 
reporter protein on the cell surface when using anti-mouse IgG antibodies compared 
to the overall protein in the input sample (Fig. 3.29, panel A, lane 3 and 4). A small 
population of the reporter construct seems to be exported compared to the input 
sample. The analysis using anti-GFP antibodies revealed that probably also a small 
fraction of the piggyback reporter GFP-Protein A-NES is co-exported visible as a faint 
band in the eluate fraction (Fig. 3.29, panel B, lane 4). 
The reporter construct F2-IG / G-PA shows signals of the same intensity in the input 
and eluate fraction detectable by anti-mouse IgG antibodies (Fig. 3.29, panel A, 
lanes 5 and 6). This demonstrates that a high amount of the reporter construct is 
exported. The same observation is made when analyzing the piggyback interaction 
partner (Fig. 3.29, panel B, lanes 5 and 6). The interaction partner seems to be co-
exported to a high extent. 
The reporter molecule FGF4-IgG2α-NES shows signals of low intensity in the input 
and eluate fractions. The bands are not distinct and represent differently glycosylated 
forms of the molecule (Fig. 3.29, panel A, lanes 7 and 8) as observed previously (see 
section 3.2.2, Fig. 3.17). The amount of expressed protein seems to be reduced 
when compared to the other reporter molecules. Also the GFP interaction partner is 
partially exported visible as a faint band (Fig. 3.29, panel B, lane 8). 
The construct IG / G-PA displays no export when comparing the input and eluate 
fraction. Neither the IgG2α construct nor the GFP construct is detectable on the cell 
surface (Fig. 3.29, gels anti-mouse IgG and anti-GFP, lanes 9 and 10). This is an 
expected results since no FGF moiety is present. 
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Compared on a qualitative basis the biotinylation assay and the FACS analysis show 
co-export of the GFP-containing piggyback interaction partner to a certain extent (see 
section 3.2.7). However, when compared on a quantitative basis the data obtained in 
the two experimental approaches differ. In the biotinylation analysis the FGF2-
containing construct shows the highest signal of exported, cell surface attached 
material (Fig. 3.29, panel A, lane 6) which is not observed in FACS analysis. When 
using flow cytometry the cell line F4-IG / G-PA exhibits the highest cell surface 
staining signal (see section 3.2.7, Fig 3.26, panel K). Also the analysis of the co-
export of the GFP-containing interaction partner displays differences. F2-IG / G-PA 
cells seem to co-export a high amount of the piggyback interaction partner in 
comparison to the other cell lines as analyzed by biotinylation. The FACS analysis 
revealed only a minor portion of GFP-Protein A-NES being co-exported for all cell 
lines which express FGF-containing reporter constructs (see section 3.2.7, Fig. 3.28). 
To be sure that the results of the biotinylation are representative and to rule out 
experimental artifacts the analysis was repeated three times. Within the independent 
experiments the obtained results were not consistent concerning the amounts of 
exported IgG2α constructs and potentially co-exported GFP-Protein A-NES (data not 
shown). This might be due to the long and complicated experimental procedure 
consisting of biotinylation, cell lysate preparation, binding to streptavidin beads, 
elution, SDS-PAGE analysis and numerous washing steps in between. Taken 
together the FACS analysis is the more accurate, precise and stable analysis method 
and should be preferred when investigating export processes and piggyback effects.  
 
3.2.9 Analysis of GFP-Protein A-NES Release into Culture Medium 
 
In order to analyze whether GFP-Protein A-NES is released from the cells into the 
culture medium and could thus falsify the results obtained when analyzing export of 
the piggyback complexes an immunoprecipitation assay was performed. Culture 
medium from cells expressing the reporter molecules was incubated with Protein A-
sepharose beads decorated with anti-GFP antibodies. As a control for the 
immunoprecipitation procedure recombinant GFP was titrated into medium taken 
from CHOMCAT-TAM2, which were not transfected. Bound material was analyzed by 
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SDS-PAGE and Western blot applying primary anti-GFP antibodies and secondary 
RG16 HRP-coupled antibodies as described in 3.2.5. 
 
Fig. 3.30 Immunoprecipitation of GFP-containing reporter molecules unspecifically released 
from the reporter cells. 
Medium from induced reporter cells was incubated with Protein A-sepharose beads decorated with 
anti-GFP antibodies. As a control recombinant GFP was titrated into medium obtained from 
untransfected CHOMCAT-TAM2 cells and incubated with anti-GFP antibodies coupled to Protein A-
sepharose beads. After washing bound material was eluted in SDS sample buffer. Samples were 
analyzed by SDS-PAGE (13% gels) and Western blot transfer. Precipitated material was detected 
using anti-GFP antibodies and RG16 HRP-coupled secondary antibodies. 50% of eluted material was 
loaded in each lane. Visualization was performed using the ECL system and x-ray film detection. 
 
The analysis revealed that no GFP fusion protein can be found in the medium of the 
cell lines expressing the various reporter constructs (Fig. 3.30, lanes 1-5). The 
control were recombinant GFP was added to the medium of untransfected cells 
shows that GFP with a minimal concentration of 6,25 ng/ml medium is detectable by 
immunoprecipitation (Fig. 3.30, lane 7). Neither the control cell line FGF2-GFP nor 
the four piggyback cell lines show release of GFP-containing reporter constructs into 
the medium. This result implies that any signal of GFP-containing fusion proteins 
obtained in previous experiments which analyze cell surface staining must be due to 
an actively occurring export process. 
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3.2.10 Summary of the Piggyback Export Approach 
 
The goal of the piggyback export analysis system was to monitor the folding state of 
FGF2 during unconventional secretion. The reporter system is based on a non-
covalent interaction between the Fc domain of the mouse IgG2α and Protein A. 
Actively exported FGF2 was fused to the IgG2α domain and GFP which can not 
leave the cell on its own to Protein A. The two reporter constructs are expressed from 
one mRNA in cells stably transfected with the bicistronic expression vector pRTi. 
Additionally, three other cell lines were successfully generated in which FGF2 was 
substituted by FGF1, FGF4 with a classical signal sequence (FGF4-S) or no FGF 
moiety. It could be shown that all cell lines express both reporter molecules 
simultaneously in a doxicycline-dependent manner. 
Upon expression of the reporter constructs a complex between the IgG2α domain 
fused to the respective FGF moiety and Protein A fused to GFP is expected to form. 
Complex formation was analyzed by co-immunoprecipitation and gel filtration in 
which proteins are retained on a column according to their molecular mass in a FPLC 
system. The analyses revealed that the piggyback complexes are formed in all 
reporter cell lines to a significant extent. 
The analysis of the co-export of the reporter protein GFP-Protein A-NES proved to be 
problematic. A FACS-based analysis revealed that the FGF-containing reporter 
constructs are exported but only a small amount of the GFP-containing interaction 
partner seems to be co-exported. By contrast, the biochemical biotinylation assay 
showed a different result compared on a quantitative basis. However, when 
compared qualitatively both analysis techniques revealed that co-export occurs to a 
certain extent. A possible explanation might be that it can not be excluded that the 
export machinery mediating non-classical protein export is not capable of 
translocating the piggyback partners associated in a complex but can only export the 
FGF fusion constructs alone. 
Taken together the obtained data do not allow a clear interpretation. Because of the 
inconsistency of the independent experimental systems it is not possible to draw an 
unambiguous conclusion. The system needs to be further optimized in order to finally 
answer the question if FGF2 is exported in a folded conformation. 
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4 Discussion 
 
More than 15 years ago the phenomenon of unconventional protein secretion was 
discovered and an alternative protein export pathway that mediates secretion by an 
ER/Golgi-independent mechanisms was proposed (Muesch et al., 1990; Rubartelli et 
al., 1990). Although it was initially supposed that release occurs unspecifically in 
association with cell damage (McNeil et al., 1989) more and more evidence was 
provided that non-classical export is a controlled release mechanism actively 
regulated by the cell (Cleves, 1997; Engling et al., 2002; Florkiewicz et al., 1995; 
Hughes, 1999; Nickel, 2005; Rubartelli et al., 1990). 
The classical secretory pathway is the main export route of secretory proteins and 
characterized in great detail at the molecular level. Nascent secretory proteins are 
directed to the translocon by their N-terminal, hydrophobic signal sequence and are 
co-translationally inserted into the ER (Walter et al., 1984). They are modified and 
incorporated into membrane-bound vesicles which mediate transport to the Golgi 
apparatus where the protein maturation continues (Halban and Irminger, 1994; 
Rothman and Wieland, 1996). Additionally, the classical secretory pathway provides 
a high level of quality control to guarantee the production and release of functional 
proteins (Arvan et al., 2002; Hammond and Helenius, 1995). Transport to the plasma 
membrane is mediated by membrane-bound vesicles which travel along the 
cytoskeleton (Goodson et al., 1997). Upon fusion with the plasma membrane they 
release their content to the extracellular space (Pelham, 1996). 
By contrast, unconventional protein secretion starts with the synthesis of proteins on 
free ribosomes in the cytosol. All known examples are soluble protein, which do not 
contain a hydrophobic signal sequence and are, therefore, not directed to the 
ER/Golgi pathway (Muesch et al., 1990). Nevertheless, they are found in the 
extracellular space but plasma membrane translocation is not dependent on 
ER/Golgi transport since it is not affected by inhibitors of the classical secretory 
pathway (Rubartelli et al., 1990; Sato et al., 1993). Moreover, non-classically 
secreted proteins are not modified by, e.g. ER/Golgi-dependent glycosylation, 
despite bearing corresponding consensus sites (Hughes, 1999). The group of 
unconventionally secreted proteins is heterogeneous in terms of function, however, it 
is comprised of proteins which are in part structurally related. Among these are 
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growth factors like the proangiogenic mediator FGF2, lectins of the ECM such as 
galectin-1, inflammatory cytokines like IL-1β and MIF, viral proteins such as HIV-tat 
and stage-regulated parasitic proteins like HASPB of Leishmania. They do not share 
one unconventional secretion pathway but their release occurs by mechanistically 
distinct, vesicular and non-vesicular processes independent of the ER/Golgi-system 
(Nickel, 2005). Unconventionally secreted proteins are of high biomedical relevance 
and elucidating the molecular basis of their release mechanism is of great interest 
with regard to drug development and new therapeutical methods (Nickel, 2003; 
Nickel, 2005). 
In particular, FGF2 which acts as a direct stimulator of angiogenesis is of great 
interest since it is involved in tumor-associated neovascularization which contributes 
to elevated supply with nutrients and to spreading of metastases throughout the body 
(Nugent and Iozzo, 2000; Smith et al., 2001). The soluble, cytosolic 18 kDa isoform 
of FGF2 is released by non-classical means (Florkiewicz et al., 1995; Nickel, 2003) 
but the involved machinery remains elusive at the molecular level. Recent findings 
point to a direct translocation across the plasma membrane (Nickel, 2005; Schäfer et 
al., 2004). FGF2 contains spatially separated binding sites for association with high 
affinity tyrosine kinase receptors (FGFRs) and heparan sulfate side chains of HSPGs 
(Raman et al., 2003; Schlessinger et al., 2000) which, following secretion, allow 
binding of FGF2 to the cell surface (Engling et al., 2002). 
 
To further elucidate the mechanism of unconventional secretion of FGF2 two 
experimental in vivo systems were established using CHO cells. These cells are 
particularly suitable for the analysis of FGF2 export since they do not express FGF 
receptors so that FGF2 induced signalling and induction of differentiation processes 
does not occur. However, the cells possess HSPGs on their surface which allow 
binding of secreted FGF2 and, thus, direct analysis of exported material. By using 
CHOMCAT-TAM2 (Engling et al., 2002) proteins of interest can be introduced into the 
genome by retroviral transduction due to the constitutive expression of the murine 
cationic amino acid transporter MCAT-1 (Albritton et al., 1989; Davey et al., 1997) on 
the cell surface. Additionally, expression of the reporter constructs can be controlled 
by the addition of doxicycline because the doxicycline-sensitive transactivator rtTA2-
M2 (Urlinger et al., 2000) is also constitutively expressed in this cell line. The different 
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model cell lines expressing the reporter constructs were analyzed for non-classical 
export using independent read-out systems. 
 
1) Confocal microscopy. To qualitatively analyze export of reporter molecules non-
permeabilized cells were processed employing externally added antibodies and 
analyzed by confocal microscopy. This method allows the analysis of the 
subcellular localization of GFP-containing reporter proteins due to fluorescence. 
Simultaneously, export of FGF-containing reporter proteins can be analyzed by 
labelling of surface bound material using appropriate antibodies. 
 
2) Flow cytometry. To quantitatively analyse export of the various reporter proteins 
employing FACS exported material bound to the cell surface was labelled using 
antibodies directed against different epitopes of the various reporter constructs. 
Additionally, expression levels can be measured simultaneously by fluorescence 
of the GFP moiety present in various reporter constructs. This can be used to 
normalize the overall expression of reporter constructs with regard to different 
experimental conditions. 
 
3) Cell surface biotinylation. To analyze export of reporter proteins by an 
independent biochemical method a membrane-impermeable biotin reagent was 
used to label cell surface exposed proteins. Following detergent-based lysis the 
biotinylated population was recovered employing immobilized streptavidin. 
Biotinylated proteins corresponding to exported material and non-biotinylated 
proteins which represent the intracellular population were compared using 
Western blot and, thus, export of reporter molecules was analyzed. 
 
Additionally, experimental analyses were performed which did not directly analyze 
export processes but which were important to establish the systems, like protease 
protection assays, gel filtration using FPLC and co-immunoprecipitation. They are 
discussed in more detail in the respective sections. 
 
As already mentioned, two independent analysis systems were established during 
this study to analyze the folding state of FGF2 during membrane translocation. In the 
first approach FGF2 export was reconstituted by expression of a fusion construct, 
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which is comprised of FGF2, GFP and a C-terminal DHFR domain (Backhaus et al., 
2004). The DHFR domain allows aminopterin-dependent stabilization of the molecule 
to analyze a potential need for unfolding (Eilers and Schatz, 1986). The second 
experimental approach is based on the association of an FGF2 fusion construct with 
an interaction partner dependent on the three-dimensional structure of both 
molecules. It monitors co-export which can only occur if the conformation of both 
proteins is maintained during membrane translocation to answer the question 
whether FGF2 is exported in a folded state. Both systems were exploited using the 
described analytical techniques in various modifications. 
 
4.1 Analysis of the Need for Unfolding Employing a DHFR Fusion 
Protein System 
 
To establish the DHFR fusion protein system, two cDNA constructs, FGF2-GFP-
DHFR and MTS-GFP-DHFR respectively, were generated by molecular cloning and 
verified by sequencing (see sections 3.1.1 and 2.2.14). The reporter construct MTS-
GFP-DHFR contains an N-terminal mitochondrial targeting sequence and serves as 
a positive control for the experimental system. Mitochondrial import is known to be 
dependent on protein unfolding and import of DHFR fusion proteins can be blocked 
by addition of aminopterin (Eilers and Schatz, 1986). Additionally, the DHFR domain 
contains a C-terminal His6-tag which facilitates antibody-specific detection of both 
reporter proteins. To generate model cell lines virally transduced cells were subjected 
to a FACS-based sorting procedure. Three rounds of sorting were performed in the 
presence, absence and presence of doxicycline to obtain cells which express the 
reporter constructs in a doxicycline-dependent manner (see section 3.1.1, Fig. 3.3 as 
well as text). After generation of the model cell lines they were characterized by 
Western blot analysis, confocal microscopy and flow cytometry to verify doxicycline-
dependent protein expression and export of the FGF2-containing reporter constructs. 
Additionally, a cell line expressing the fusion protein FGF2-GFP without the DHFR 
domain was analyzed as a control. 
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4.1.1 Characterization of Model Cell Lines Expressing DHFR Fusion 
Proteins  
 
To characterize generated model cell lines biochemically, a Western blot analysis 
was employed using affinity-purified anti-GFP antibodies. It revealed that all cell lines 
express the reporter constructs in a doxicycline-dependent manner. Moreover, the 
reporter molecules migrate according to their calculated molecular masses in the 
SDS-PAGE when compared to a protein standard (see section 3.1.2, Fig. 3.4). An 
interesting observation was made when analyzing the reporter construct MTS-GFP-
DHFR which was designed to contain a mitochondrial targeting sequence. Three 
forms of the protein were detectable. The slow migrating precursor form, the 
intermediate form and the fully processed form which correspond to the mitochondrial 
membrane translocation steps upon transport to the mitochondrial matrix during 
which the MTS is cleaved twice (Cavadini et al., 2002; Daum et al., 1982; Eilers et 
al., 1988; Schmidt et al., 1984) (see section 3.1.2, Fig. 3.4, lane 6). The detection of 
the three different forms of the fusion protein provided first evidence that the MTS-
containing construct is imported into mitochondria because this specific cleavage of 
the MTS only occurs during mitochondrial import (see section 3.1.2, Fig. 3.4, lane 6). 
 
To verify the results obtained in the Western blot analysis, the cell lines were 
analyzed by confocal microscopy. It was confirmed that protein expression is induced 
upon addition of doxicycline as analyzed by total GFP fluorescence (see section 
3.1.3, Fig. 3.5, panels A, B, D, E, G and H). Regarding the subcellular localization of 
the FGF2-containing reporter constructs cytosolic and nuclear staining distribution 
was observed. The latter may results from the presence of the GFP moiety which is 
known to equilibrate between the nucleus and the cytoplasm upon expression in 
CHO cells. When expressed as a fusion protein with FGF2 the two proteins might 
also form a bipartite nuclear localization signal (NLS). Analysis of corneal endothelial 
cells revealed that the fusion protein FGF2-GFP is targeted to the nucleus in this cell 
line (Choi et al., 2000). Moreover, FGF2 is known to translocate to the nucleus upon 
receptor binding followed by internalization, however, this is rather unlikely in CHO 
cells since they do not possess FGFRs. Recent findings point to a role of HSPG 
binding to nuclear localization of externalized FGF2 (Hsia et al., 2003). These studies 
also made use of CHO cells so that the observations are directly comparable to the 
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in vivo system used in this experimental approach. The reporter protein MTS-GFP-
DHFR is excluded from the nucleus and localizes to dot-like structures throughout 
the cytoplasm which corresponds to a mitochondrial localization pattern (see section 
3.1.3, Fig. 3.5, panel H). Furthermore, it is not found in association with the plasma 
membrane. 
When analyzing exported material by staining with externally added anti-GFP 
antibodies only the FGF2-containing reporter proteins are detectable on the cell 
surface. This observation shows that FGF2-GFP and FGF2-GFP-DHFR are 
translocated across the plasma membrane and can rebind to the cell surface since 
non-permeabilized cells were used for the analysis so that only exported material is 
detected. The MTS-containing reporter is not detectable on the cell surface showing 
that it is not exported. 
 
To complete characterization of the model cell lines, a FACS analysis was performed 
employing affinity-purified anti-GFP and anti-His6-tag antibodies. By the use of these 
antibodies the GFP moiety in the central region of the reporter constructs or in case 
of the DHFR-containing fusion proteins the extreme C-termini can be detected which 
is of great importance for later localization studies. The analysis by flow cytometry 
verified the doxicycline-dependent protein expression since cells grown in the 
presence of doxicycline show a shift of GFP-derived fluorescence upon addition of 
doxicycline (see section 3.1.4, Fig. 3.6). The analysis of the cell surface staining by 
externally added antibodies revealed that FGF2-GFP and FGF2-GFP-DHFR are 
exported and rebind to the cell surface (see section 3.1.4, Fig. 3.6, panels C, G and 
H). The use of the anti-His6-tag antibodies demonstrates specificity of the observed 
signal when comparing cells expressing FGF2-GFP and cells expressing FGF2-GFP-
DHFR since detection of the reporter protein is only possible when the DHFR domain 
with the C-terminal His6-tag is present (see section 3.1.4, Fig. 3.6 panels D and H). 
Moreover, the DHFR domain does not influence export efficiency as both FGF2-
containing reporter construct show similar cell surface staining signals when using 
anti-GFP antibodies (see section 3.1.4, Fig. 3.6 panels C and G). The construct MTS-
GFP-DHFR does not exhibit cell surface staining neither employing anti-GFP nor 
anti-His6-tag antibodies (see section 3.1.4, Fig. 3.6 panels K and L). This shows that 
it is not exported and again demonstrates specificity of the analysis method when 
compared to the other constructs. Additionally, one can conclude that export is 
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directly related to the FGF2 moiety since only FGF2-containing reporter proteins are 
exported. 
 
Taken together, the observations made when analyzing the model cell lines by 
biochemical methods, confocal microscopy and FACS showed that protein 
expression is dependent on the addition of doxicycline. FGF2-GFP and FGF2-GFP-
DHFR are translocated across the plasma membrane and bind to the cell surface. 
Exported material is specifically detectable employing anti-GFP or anti-His6-tag 
antibodies. The reporter construct MTS-GFP-DHFR is not exported from CHO cells 
but mitochondrial import could be demonstrated by Western blot analysis and 
confocal microscopy. 
 
4.1.2 Analysis of Aminopterin Binding to DHFR Fusion Constructs 
 
In order to apply the DHFR system to mitochondrial import and to the unconventional 
secretion of FGF2, it was of great importance to show that aminopterin actually binds 
to the DHFR domain in the reporter constructs. Therefore, a protease protection 
assay was performed and analyzed employing monoclonal DHFR antibodies. Cell 
lysates obtained from model cell lines expressing FGF2-GFP-DHFR or MTS-GFP-
DHFR were incubated with trypsin in the absence or presence of aminopterin (see 
section 3.1.7, Fig. 3.9). In the absence of trypsin and aminopterin the reporter 
constructs are detectable as full length proteins migrating corresponding to their 
calculated molecular masses as compared to a protein standard. Additionally, the 
DHFR moiety is detectable as a fragment migrating at 20 kDa which results from post 
lysis degradation (see section 3.1.7, Fig. 3.9, lanes 1 and 4). In the presence of 
trypsin, but in the absence of aminopterin, all reporter molecules are completely 
degraded (see section 3.1.7, Fig. 3.9, lanes 2 and 5). In the presence of trypsin and 
aminopterin the full length reporter molecules and the DHFR fragment are detectable 
to a significant extent. This shows that aminopterin binds to the DHFR moiety and 
thereby mediates protection against proteolysis. Even the full length reporter proteins 
MTS-GFP-DHFR and FGF2-GFP-DHFR are protected as a result of aminopterin-
induced stabilization (see section 3.1.7, Fig. 3.9, lanes 4 and 6). These observations 
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are consistent with other reports showing that ligand binding to DHFR stabilizes 
proteins and protects them against proteolysis (Salvador et al., 2000). 
 
In summary, it was shown by protease protection analysis that aminopterin actually 
binds to the DHFR domain of both fusion proteins and mediates stabilization against 
proteolysis. 
 
4.1.3 Influence of Aminopterin on the Mitochondrial Import of MTS-GFP-
DHFR 
 
To show that protein translocation across a membrane can be blocked in living cells 
under conditions preventing protein unfolding (Eilers and Schatz, 1986; Rassow et 
al., 1989), cells expressing the construct MTS-GFP-DHFR were grown in the 
absence or presence of aminopterin and analyzed by confocal microscopy. In the 
absence of aminopterin the reporter protein localizes to mitochondria shown by the 
mitochondrial staining pattern observed previously (see section 3.1.5, Fig. 3.7). Upon 
addition of aminopterin the subcellular localization changed drastically and 
cytoplasmic and nuclear staining was observed. The mitochondrial localization 
pattern is not detectable anymore. This demonstrates that aminopterin blocks import 
of the reporter construct into mitochondria so that the molecule is distributed 
throughout the cytoplasm and additionally localizes to the nucleus due to the GFP 
moiety as discussed above. 
 
To analyze the influence of aminopterin on mitochondrial membrane translocation 
using an independent method, a biochemical analysis of cell lysates was performed 
following incubation of cells in the absence or presence of aminopterin. The 
previously observed forms of the reporter proteins corresponding to the mitochondrial 
import steps are detectable in the absence of aminopterin on an SDS gel as the slow 
migrating precursor form, the intermediate form resulting from the first membrane 
translocation into the intermembrane space of the mitochondria and the prevailing, 
fully processed form. The predominance of the latter demonstrates efficient import 
into the mitochondrial matrix (see section 3.1.6, Fig. 3.8, lane 2). Upon addition of 
aminopterin the amount of the fully processed from and the precursor form is largely 
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reduced demonstrating inhibition of mitochondrial import. The intermediate form 
remains unchanged (see section 3.1.6, Fig. 3.9, lane 3). These observations suggest 
degradation of the membrane-arrested precursor form in the presence of aminopterin 
to keep the mitochondrial import complexes in a functional state. However, a small 
portion of the reporter protein seems to pass to the intermembrane space even in the 
presence of aminopterin and is rapidly translocated to the mitochondrial matrix. 
These observations are consistent with earlier reports showing that mitochondrial 
import is dependent on unfolding prior to membrane translocation (Eilers and Schatz, 
1986; Wienhues et al., 1991). 
 
In summary, the analysis of the influence of aminopterin on mitochondrial import as a 
control for the DHFR system in vitro demonstrates that import of the fusion construct 
MTS-GFP-DHFR into mitochondria can be blocked efficiently. Thus, the system is 
functional and can be used in the background of the FGF2 reporter construct to 
analyze the need of unfolding for FGF2 plasma membrane translocation. 
 
4.1.4 Analysis of FGF2-GFP-DHFR Membrane Translocation in the 
Presence of Aminopterin 
 
To analyze the effect of aminopterin on FGF2-GFP-DHFR export, it was necessary to 
monitor whether plasma membrane translocation of the reporter protein occurs 
completely. Therefore, it was important to detect various domains of the reporter 
molecule independent of the GFP moiety located in the N-terminal region like, e.g., 
the extreme C-terminus using anti-His6-tag antibodies. Since the FGF2 moiety which 
mediates non-classical export is located at the N-terminus of the reporter construct 
potential detection of the extreme C-terminus in the extracellular space would confirm 
complete translocation of the molecule. This is because in case the reporter protein 
would be stuck in a putative plasma membrane-resident transporter detection of the 
N-terminal segment only could result in misinterpretation as it does not clearly 
demonstrate complete translocation of the reporter molecule. 
 
To qualitatively analyze the influence of aminopterin on the export of FGF2-GFP-
DHFR, reporter protein-expressing cells grown in the absence or presence of 
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aminopterin were analyzed by confocal microscopy. Cells were processed without 
permeabilization employing anti-GFP and anti-His6-tag antibodies for the reason 
given above. Detection employing both antibodies showed that export of the reporter 
protein is not affected by aminopterin as both the GFP moiety and the extreme C-
terminus were detectable on the cell surface. This shows that FGF2-GFP-DHFR is 
exported in the presence of aminopterin and suggests that unfolding is not required 
for FGF2 membrane translocation. 
 
To verify the results obtained using a quantitative system, a FACS assay was 
performed under the same experimental conditions. Again, both antibodies were 
used to analyze complete membrane translocation of the reporter molecule. When 
analyzing expression levels a threefold increase in the presence of aminopterin was 
detectable (see section 3.1.10, Fig. 3.12, green curves in panels A, B compared to C, 
D). This effect might be due to aminopterin-dependent stabilization of the reporter 
molecule which might lead to a prolonged half-life of the protein so that the pool of 
molecules available for export increases. This, in turn, leads to elevated cell surface 
staining levels since more protein is present in the same time period compared to 
non-aminopterin conditions. Remarkably, the cell surface staining signal is only 
increased about twofold suggesting a saturation of the export machinery with 
substrate (see section 3.1.10, Fig. 3.12, green curves in panels E, F compared to G, 
H). Nevertheless, export of the reporter protein is not inhibited in the presence of 
aminopterin. To directly compare cell surface staining signals derived from exported 
material the amount of doxicycline used to induce protein expression in the presence 
of aminopterin was titrated down to establish conditions where expression levels are 
comparable. The experiment was repeated three times with comparable expression 
levels in the absence and presence of aminopterin and the data were analyzed 
statistically. The analysis revealed that FGF2-GFP-DHFR export is not affected by 
aminopterin as analyzed by anti-GFP antibodies. When employing anti His6-tag 
antibodies the cell surface staining signal was found to be increased by a factor of 
two (see section 3.1.10, Fig. 3.13). This effect is probably the result of an enhanced 
accessibility of the C-terminal His6-tag due to the stabilization of the DHFR domain in 
the presence of aminopterin (Backhaus et al., 2004). 
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The results obtained from the analysis of the DHFR fusion protein system show that 
membrane translocation of FGF2 is likely to occur in a folded state. The export of the 
reporter construct is not blocked in the presence of aminopterin and secretion occurs 
as efficiently as under non-aminopterin conditions or as observed for the construct 
FGF2-GFP. Importantly, by employing antibodies directed against the N-terminal part 
of the fusion protein (anti-GFP) and against the extreme C-terminus (anti-His6-tag) 
complete translocation of the reporter molecule could be verified. The analysis of the 
control construct MTS-GFP-DHFR in the same cellular background and expression 
system showed that import into mitochondria is almost completely inhibited in the 
presence of the drug. The precursor form and, therefore, all subsequent isoforms are 
largely reduced in the presence of aminopterin due to degradation of the membrane-
arrested precursor to keep the mitochondrial import complexes in a functional state. 
By the protease protection assay it was shown that aminopterin stabilizes the DHFR 
moiety of the reporter constructs demonstrating that it not only binds to DHFR but 
also prevents unfolding. Taken together, these observations show that the DHFR 
system is functional and unfolding can be prevented in vivo. Therefore, it can be 
concluded that FGF2 export does not require protein unfolding (Backhaus et al., 
2004). 
 
However, there are certain limitations of the system that have to be taken into 
consideration. The system does not rule out that specific chaperones potentially 
involved in unconventional secretion are able to unfold the reporter molecule even in 
the presence of aminopterin. Another possibility would be that secreted reporter 
proteins are directly translocated as nascent polypeptide chains comparable to 
cotranslational insertion into the ER (Pfeffer and Rothman, 1987; Rapoport, 1992b; 
Rothman and Orci, 1992). In this case, aminopterin could not bind to this population 
of reporter molecules since the DHFR domain is not folded when export occurs. In 
both scenarios FGF2-GFP-DHFR would be exported in an unfolded state even 
though aminopterin does not block membrane translocation. To overcome these 
limitations a new experimental system was established which directly monitors the 
folding state of FGF2 during non-classical membrane translocation. 
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4.2 Piggyback Export Analysis System 
 
To further analyse the folding state of FGF2 during export, a piggyback export 
analysis system (see section 3.2 introducing text and 3.2.4) was established which 
monitors whether the conformation of FGF2 is maintained during membrane 
translocation. It is based on the rationale that FGF2 fused to the mouse IgG2α Fc 
domain can form a non-covalent complex with GFP fused to Protein A inside cells. 
Complex formation is mediated by the interacting domains IgG2α and Protein A and 
depends on the correct three-dimensional structure of both fusion proteins. If GFP-
Protein A would be detectable extracellularly, export of the complex would have been 
demonstrated. This, in turn, would establish that FGF2 is exported in a folded state 
because otherwise any protein-protein interactions would be lost. The system also 
addresses the question whether quality control means can apply during 
unconventional secretion. If correct folding is a prerequisite for non-classical export, 
release of non-functional proteins would be prevented. This would suggest that the 
cell is able to monitor correct folding of unconventional export cargo by an unknown 
mechanism and can reject proteins which do not fulfill quality control requirements. 
 
To generate model cell lines, the respective reporter constructs were cloned and 
verified by sequencing (see sections 2.2.15 and 3.2.1). The reporter constructs are 
organized in two ORFs separated by an IRES-element in the bicistronic expression 
vector pRTi. The transcription of the mRNA leads to translation of two distinct 
proteins, an IgG2α-containing FGF reporter molecule and GFP-Protein A. The 
IgG2α-containing reporter constructs were designed with FGF1, FGF2, FGF4-S (with 
a signal sequence) or no FGF moiety to analyze the folding state of FGF2 and FGF1 
during export and to generate control constructs which are classically secreted 
(FGF4-S) or not exported (no FGF moiety). All fusion constructs contain a nuclear 
export signal (NES) at the C-terminus to reduce nuclear localization as observed 
during the analysis of the DHFR system and to increase, in turn, the pool of cytosolic 
reporter molecules available for export. The cDNA constructs were introduced into 
CHOMCAT-TAM2 cells by retroviral transduction (Engling et al., 2002). As described 
when establishing the DHFR system, transduced cells were subjected to three 
rounds of FACS sorting to generate clonal cell lines expressing the reporter proteins 
in a doxicycline-dependent manner. The generated piggyback model cell lines were 
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characterized using Western blot analysis and flow cytometry. Additionally, a cell line 
expressing FGF2-GFP-NES was analyzed as a control. 
 
4.2.1 Characterization of Piggyback Model Cell Lines 
 
The Western blot analysis of cell lysates employing anti-mouse IgG and anti-GFP 
antibodies revealed that all reporter proteins are expressed in a doxicycline-
dependent manner. Furthermore, the expression of two distinct proteins from one 
mRNA is functional in the model cell lines (see section 3.2.2, Fig. 3.17). The IgG2α-
containing reporter proteins migrate in an SDS gel according to their calculated 
molecular masses as compared to a protein standard. An unexpected observation 
was that the FGF1- and FGF2-containing reporter proteins do not show the same 
migration behaviour although they are similar in size (see section 3.2.2, Fig. 3.17, 
panel A, lanes 2 and 4). This can be explained by the different amino acid 
compositions of the FGF moieties, which might influence the migration behaviour in 
the electric field during SDS-PAGE. When analyzing FGF4-S-IgG2α-NES additional 
bands migrating faster than the predominant one are detectable (see section 3.2.2, 
Fig. 3.17, panel A, lane 6). These bands are likely to represent glycosylated forms of 
the molecule. Since glycosylation is an ER- and Golgi-associated modification 
(Colley, 1997; Ernst and Prill, 2001; Helenius and Aebi, 2004; Rothman and Lodish, 
1977) this observation confirms that FGF4-S-IgG2α-NES enters the classical 
secretory pathway as expected. 
 
The analysis employing flow cytometry confirmed doxicycline-dependent expression 
of the various reporter proteins as detected by a strong increase of GFP-derived 
fluorescence upon addition of doxicycline (see section 3.2.3, Fig. 3.18, panels, A, C, 
E and G, grey versus green curves). To analyze export of the various FGF-containing 
reporter proteins, which is the basis for the subsequent analysis of co-export of the 
piggyback interaction partner GFP-Protein A, cells were processed employing 
externally added anti-mouse IgG antibodies. The analysis revealed that the FGF-
containing reporter constructs are exported to a significant extent and can be 
detected bound to the cell surface. The reporter construct IgG2α-NES which does 
not contain a FGF moiety is not detectable extracellularly. This demonstrates 
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specificity of the antibodies used because cell surface staining signals are directly 
dependent on an FGF moiety. As expected, FGF4-S-IgG2α-NES shows elevated cell 
surface staining levels as compared to the FGF1- and FGF2-containing reporter 
proteins since it is exported via the classical secretory pathway. When expression 
was induced the cell surface staining signal shifts to the upper limit of the detection 
range of the flow cytometer because the construct is exported in large amounts (see 
section 3.2.3, Fig. 3.18, panel F, green curve). 
 
Taken together, the characterization employing Western blot and FACS analysis 
showed that both interaction partners are expressed from a bicistronic mRNA as two 
distinct proteins in a doxicycline-dependent manner. Furthermore, constructs 
containing an FGF moiety are exported in the in vivo system and can be detected on 
the cell surface. 
 
4.2.2 Verification of Complex Formation Employing Biochemical 
Methods 
 
The association of FGF-containing reporter proteins and GFP-Protein A in non-
covalent complexes is a prerequisite for the piggyback export system to be 
functional. Therefore, experimental evidence had to be obtained to verify that the 
molecules do form cytoplasmic complexes. To analyze complex formation two 
independent biochemical methods were applied. 
 
For the analysis employing co-immunoprecipitation, cell free supernatants which 
were prepared without detergent to keep proteins under native conditions were 
incubated with Protein A-sepharose beads to allow binding of the reporter constructs 
mediated by the IgG2α domain. Additionally, beads decorated with anti-FGF2 
antibodies were employed. The analysis revealed that reporter proteins containing 
the IgG2α domain can be sedimented bound to Protein A-sepharose beads and that 
FGF1- and FGF2-IgG2α-NES can be recovered using anti-FGF2 antibodies (see 
section 3.2.5, Fig. 3.20, panel A). When analyzing the samples employing anti-GFP 
antibodies it could be shown that GFP-Protein A is efficiently co-purified with FGF1-, 
FGF2 and FGF4-S-IgG2α-NES (see section 3.2.5, Fig. 3.20, panel B). These 
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findings demonstrate that the reporter proteins do form cytoplasmic complexes. In 
the case of the reporter molecule IgG2α-NES, binding to Protein A-sepharose beads 
was verified but co-purification could not be observed (see section 3.2.5, Fig. 3.20, 
panel A and B, lane 10). Thus, complex formation could not be analyzed employing 
this experimental approach. On the other hand, this observation demonstrates 
specificity of the method as compared to the other reporter molecules because co-
purification must be due to complex formation and can not result from unspecific 
binding or be an experimental artefact. 
 
To confirm complex formation using an independent method, an FPLC gel filtration 
analysis was performed. Cell free supernatants prepared without detergent were 
separated according to molecular mass employing a superdex 200 size exclusion 
column. Superdex 200 beads retain molecules from 10 to 600 kDa on the column to 
various extents and, therefore, allow fractionation dependent on molecular mass. The 
fractionation of a marker protein mixture containing proteins with defined molecular 
masses was used as a standard to correlate retention on the column to molecular 
mass based on the elution profile (see section 3.2.6, Fig. 3.21, 3.22 and 3.23). 
Following standardization of the column, cell free supernatants of the piggyback 
model cell lines and FGF2-GFP-NES-expressing cells were separated using the 
FPLC system and the obtained fractions were analyzed by Western blot employing 
anti-mouse IgG and anti-GFP antibodies. In order to interpret the read-out of the 
experimental system the molecular masses of the putative complexes which could 
result from the potential oligomerization combinations were calculated (see section 
3.2.6, Fig 3.25). The Western blot analysis of FGF2-GFP-NES revealed that a peak 
of protein elution is detectable in fraction 22 which corresponds to a molecular mass 
of 90 kDa. This observation suggests that most reporter molecules are present in 
homodimers which have a calculated molecular mass of 92 kDa (see section 3.2.6, 
Fig. 3.24, panel A). 
The analysis of cell free supernatants obtained from FGF1- and FGF2-IgG2α-NES- 
expressing cells employing anti-mouse IgG antibodies showed that a shift of the 
elution-peak to fraction 18 occurs (see section 3.2.6, Fig. 3.24, panels B and D). 
Elution in this fraction corresponds to a molecular mass of 180 to 200 kDa, which 
matches the molecular mass of a heterotetramer consisting of two FGF-containing 
reporter molecules and two GFP-Protein A molecules. The observed shift of the 
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elution profile confirms that the complex between FGF1- or FGF2-IgG2α-NES and 
Protein A-GFP is formed. The same observation was made when analyzing FGF4-S-
IgG2α-NES-expressing cells (see section 3.2.6, Fig. 3.24, panel F). This is a rather 
unexpected finding since FGF4-S-IgG2α-NES is expected to enter the classical 
secretory pathway and should thereby be segregated from GFP-Protein A which 
does not contain a signal peptide. A possible explanation would be that complex 
formation occurs during the preparation of cell free supernatants. When the plasma 
membrane and the ER/Golgi system are disrupted the two interacting molecules are 
not segregated anymore and association might occur. Fractionation of supernatants 
of IgG2α-NES-expressing cells showed the highest amount of protein to elute in 
fraction 23 (see section 3.2.6, Fig. 3.24, panel H). This corresponds to a molecular 
mass of 60 to 80 kDa which is consistent with the formation of a heterodimeric 
complex expected to have a molecular mass of 73 kDa. This finding implies that the 
construct IgG2α-NES associates with GFP-Protein A as expected. 
The analysis of the interaction partner GFP-Protein A employing anti-GFP antibodies 
revealed that a large amount of protein is found in weight fractions 10, 12 and 14 
corresponding to high molecular complexes or aggregates (see section 3.2.6, Fig. 
3.24, panels C, E, G and I). These correspond to molecular mass of 600 kDa or more 
and are likely to represent protein aggregates which are not retained by superdex 
200 beads and elute in the exclusion volume. These high molecular weight 
aggregates might from during cell free supernatant preparation. Additionally, high 
amounts of protein were found in the low molecular weight fractions 24 and 26 (see 
section 3.2.6, Fig. 3.24, panels C, E, G and I). These fractions correspond to 
monomeric GFP-Protein A molecules with a molecular mass of 44 kDa not 
associated with any interaction partner. Most remarkably, the elution-peaks of the 
fusion proteins FGF1- FGF2-, FGF4-S-IgG2α-NES and IgG2α-NES and their 
respective interaction partner GFP-Protein A are not found to be similar. This is an 
unexpected finding since complex formation implies that both reporter molecules are 
present in the same fractions. The observation suggests that only a subpopulation of 
GFP-Protein A is involved in complex formation and that a large amount is present as 
free monomers or high molecular weight aggregates as observed. 
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In summary, the analysis employing co-purification and gel filtration revealed that the 
complexes consisting of IgG2α-containing reporter molecules and GFP-Protein A are 
formed to a significant extent. The interaction partner GFP-Protein A could be co-
purified although it can not bind to beads on its own. Furthermore, the elution profiles 
obtained by the gel filtration analysis suggest that the IgG2α-containing reporter 
molecules are found in fractions which correspond to the calculated molecular 
masses of the proposed complexes. These findings demonstrate that a stable 
association of the piggyback reporter molecules results in the formation of defined 
complexes. 
 
4.2.3 Analysis of the Folding State of FGF2 Employing Piggyback 
Export Analysis 
 
To analyze whether co-export of GFP-Protein A associated with FGF-containing 
reporter proteins occurs, the piggyback model cell lines were analyzed by flow 
cytometry and cell surface biotinylation. Additionally an immunoprecipitation analysis 
of the cell culture medium was employed to exclude unspecific release of the reporter 
molecules. 
 
The analysis by flow cytometry was performed using anti-mouse IgG and anti-GFP 
antibodies. The experiment was repeated three times to statistically evaluate the data 
obtained. When employing anti-mouse IgG antibodies no signal was observed for 
FGF2-GFP-NES-expressing cells since no IgG2α domain is present in this reporter 
construct. The analysis of FGF1-, FGF2 and FGF4-S-IgG2α-NES-expressing cells 
using the same antibodies showed that the reporter molecules are significantly 
exported (see section 3.2.7, Fig. 3.26, panels B, E, H, K and Fig. 3.27). As discussed 
in section 4.2.1, the FGF4-S-containing reporter construct is exported to a higher 
extent due to secretion via the classical secretory pathway as shown by the elevated 
cell surface signals. The reporter construct IgG2α-NES did not exhibit any cell 
surface staining demonstrating that it is not exported since it lacks an export-
mediating FGF domain. This finding together with the analysis of FGF2-GFP-NES 
export demonstrates specificity of the antibodies employed. 
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The analysis employing anti-GFP antibodies displayed a strong cell surface signal of 
the construct FGF2-GFP-NES showing efficient export. The analysis of the potential 
co-export of GFP-Protein A in association with FGF1-IgG2α-NES revealed a 
significant cell surface staining signal suggesting that export of the complex occurs 
(see section 3.2.7, Fig. 3.26, panel F and Fig. 3.28). The signal is not directly 
comparable to the cell surface signal of FGF2-GFP-NES. The expression levels as 
detected by GFP-fluorescence differ strongly when comparing the piggyback model 
cell lines and the cell line expressing FGF2-GFP-NES (see section 3.2.7, Fig. 3.26, 
GFP-fluorescence). For unknown reasons, proteins expressed upstream of the IRES 
element in the pRTi vector exhibit reduced expression levels as compared to proteins 
expressed of the downstream multiple cloning site. This contributes to a reduction of 
the amount of GFP-containing reporter proteins in the piggyback model cell lines. 
Nearly the same results were obtained when analyzing the reporter construct FGF2-
IgG2α-NES. The observed cell surface signals are lower as compared to the FGF1-
containing reporter construct but an increase of the signal in the presence of 
doxicycline is detectable (see section 3.2.7, Fig. 3.26, panel I and Fig.3.28). This 
shows that export of the complex FGF2-IgG2α-NES / GFP-Protein A occurs to a 
certain extent. An unexpected observation was made when analyzing FGF4-S-
IgG2α-NES. The cell line displays co-export although FGF4-S-IgG2α-NES is 
externalized via the classical secretory pathway and, therefore, should be segregated 
from the piggyback partner GFP-Protein A. For an unknown reason assembly into 
the complex seems to occur. The analysis of the reporter construct IgG2α-NES 
revealed that no co-export occurs. Cell surface staining signals are similar in induced 
and non-induced cells. Again, this demonstrates specificity of the read-out method 
and suggests that cell surface staining signals detected using anti-GFP antibodies 
might result from export of the complexes formed by the interacting molecules. 
However, the observations made when analyzing co-export in the model cell line 
expressing FGF4-S-IgG2α-NES allow the assumption that these low range cell 
surface signals could also result from unspecifically released GFP-Protein A which 
binds to FGF-containing reporter molecules associated with the cell surface. Taken 
together, the data are not consistent and co-export could not be verified to a 
significant extent, although a signal which is dependent on extracellular GFP-Protein 
A was detectable. 
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In order to employ an independent method, potential co-export was analyzed using a 
cell surface biotinylation assay. To label cell surface bound reporter molecules, 
induced cells were incubated with a membrane-impermeable biotinylation reagent. 
Biotinylated proteins which correspond to exported material were recovered from cell 
lysates employing streptavidin beads and compared to non-biotinylated proteins 
which represent intracellular material using a Western blot analysis. To distinguish 
between IgG2α-containing reporter proteins and co-exported GFP-Protein A the 
analysis was performed employing anti-mouse IgG and anti-GFP antibodies. The 
analysis of the reporter protein FGF2-GFP-NES revealed that export occurs to a 
significant extent as analyzed by anti-GFP antibodies. In the eluate from the 
streptavidin beads the reporter protein was detectable in high amounts. This fraction 
represents exported and, therefore, cell surface exposed material, which is 
accessible to the biotin reagent (see section 3.2.8, Fig 3.29, panel B, lanes 1 and 2). 
No signals could be observed when employing anti-mouse IgG antibodies which 
again demonstrates antibody specificity. The analysis of FGF1-IgG2α-NES using 
anti-mouse IgG antibodies revealed that only a small fraction of the IgG2α-containing 
reporter molecules seems to be exported as compared to the signal of the input 
sample. The same observation was made when analyzing co-export of GFP-Protein 
A employing anti-GFP antibodies (see section 3.2.8, Fig 3.29, panel A and B, lanes 3 
and 4). The analysis of the FGF2-containing reporter construct provided different 
evidence concerning the amounts of exported material. An intense signal of exported 
FGF2-IgG2α-NES and of co-exported GFP-Protein A could be observed (see section 
3.2.8, Fig 3.29, panel A and B, lanes 5 and 6). These findings suggest that the export 
of both interaction partners associated in a complex occurs more efficient as 
compared to the FGF1-containing reporter construct. The data obtained by the 
analysis of the FGF4-S-containing reporter construct showed lower signals with 
regard to the overall protein amount. Nevertheless, export of the IgG2α-containing 
reporter molecule and the GFP-containing interaction partner was detectable (see 
section 3.2.8, Fig 3.29, panel A and B, lanes 7 and 8). These observations are not 
consistent with the data obtained by FACS analysis especially when regarding the 
export efficiency of the construct FGF4-S-IgG2α-NES. The reporter construct IgG2α-
NES and the interaction partner GFP-Protein A showed no export in the biotinylation 
assay (see section 3.2.8, Fig 3.29, panel A and B, lanes 9 and 10). This again 
confirms the previously observed finding that export is dependent on an FGF moiety. 
Discussion  145 
 
 
 
To exclude unspecific release of the reporter molecule GFP-Protein A or inability of 
the complexes to bind to the cell surface, an immunoprecipitation analysis of cell 
culture medium was performed. Medium obtained from induced model cell lines was 
incubated with anti-GFP antibodies immobilized on sepharose-beads. Bound material 
was eluted and analyzed by Western blot employing anti-GFP antibodies. As a 
control different amounts of recombinant GFP were added to conditioned medium of 
CHOMCAT-TAM2 cells, which are not transfected with a reporter construct. The analysis 
revealed that no GFP-containing reporter molecules can be found in cell culture 
medium. Neither FGF2-GFP-NES nor the piggyback reporter construct expressing 
cell lines showed signals of GFP-containing reporter molecules whereas the control 
of recombinant GFP allowed detection of 6.25 ng of protein. These findings suggest 
that unspecific release does not seem to occur although it could be possible that a 
small population which is not detectable by this method is still released. Additionally, 
the assay does not analyze to which extent exported molecules which are not bound 
to the cell surface are prone to degradation. Therefore, unspecific release could 
occur to a certain extent but the reporter molecules are not detectable in the medium. 
 
The analysis of the piggyback export system revealed that GFP-Protein A seemed to 
be co-exported and was detectable on the cell surface to a certain extent. Compared 
on a qualitative basis the FACS-based analysis and the biotinylation assay showed 
that co-export occurs. However, when compared on a quantitative basis the data 
obtained by the two independent analysis methods are not fully consistent. The 
analysis by biotinylation suggests that FGF2-IgG2α-NES is exported most efficiently 
and that co-export of GFP-Protein A also occurs to a high extent. The analysis by 
flow cytometry showed that FGF4-S-IgG2α-NES exhibits the highest cell surface 
signal and FGF1-IgG2α-NES shows the most efficient co-export of GFP-Protein A as 
compared to the other piggyback constructs. These findings are not consistent within 
the two experimental approaches. Therefore, the biotinylation analysis was repeated 
three times but the results showed a high variation with regard to the amounts of 
proteins detected maybe due to the complicated experimental procedure (data not 
shown). These findings suggest that flow cytometry is more adequate to analyze co-
export of the piggyback analysis system. Nevertheless, the results obtained show 
that co-export of the piggyback interaction partner occurs although not to such an 
extent in order to make the experiments fully conclusive. 
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4.3 Concluding Remarks 
 
The aim of the present study was to analyze the folding state of FGF2 during 
unconventional secretion. Therefore, two experimental systems, namely the DHFR 
fusion protein system to prevent unfolding during membrane translocation and the 
piggyback export analysis system to investigate whether FGF2 is exported in a 
folded conformation, were employed. The DHFR system revealed that under 
conditions where unfolding is prevented FGF2 export is not affected. This suggests 
that FGF2 export does not seem to require unfolding (Backhaus et al., 2004). To 
overcome the limitations of the DHFR system a piggyback export analysis system 
was employed. The purpose was to address the question whether export of folded 
FGF2 can be mediated by the unconventional export machinery and to monitor the 
folding state of FGF2 during the actual export process. However, the data obtained 
were not fully conclusive. It could be shown that the complexes between the 
interacting molecules form as expected but the analysis of co-export did not provide 
consistent results. It is likely that co-export occurs to a certain extent but only a small 
amount of the interaction partner seems to be co-exported. These findings allow the 
proposal that FGF2 export might occur in folded state, especially when taking the 
evidence provided by the DHFR fusion protein analysis into account (Backhaus et al., 
2004). 
Additionally, the observations made have an impact on quality control issues during 
unconventional secretion. Since the cell possesses elaborate quality control 
mechanisms for the classical secretory pathway like ER-resident chaperones, the 
calnexin/calreticulin system and unfolded protein response (Helenius et al., 1997; 
Lyman and Schekman, 1996; Sidrauski and Walter, 1997) it is rather unlikely that 
there are no such mechanisms associated with unconventional secretory processes. 
A general mechanism could be to restrict export to correctly folded proteins which 
would provide a high level of quality control. Another system could involve specific 
cytosolic chaperones which bind to incorrectly folded molecules to retain them inside 
the cell comparable to the calnexin/calreticulin system in the ER (Tatu and Helenius, 
1997). 
Another hypothesis that is based on the export of folded molecules is that cell 
surface counter receptors, e.g. HSPGs, are directly involved in FGF2 plasma 
membrane translocation. Since the heparin binding site of FGF2 is comprised of 
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spatially separated amino acid residues in different loop regions of the molecule 
(Raman et al., 2003) folding into the correct three-dimensional structure is obligatory 
to form a functional binding site. Another finding supporting this view is that only 
correctly folded FGF2 can bind to heparin in vitro (Raman et al., 2003; Seddon et al., 
1991). It could be shown in our laboratory that a mutant CHO cell line deficient in 
HSPGs (Esko et al., 1985) does not export FGF2 (unpublished data of Christoph 
Zehe). Export could be rescued by co-cultivation with cells not deficient in HSPGs 
(unpublished data of Christoph Zehe) which demonstrates the involvement of HSPGs 
in FGF2 export and, in turn, requires correctly folded FGF2 molecules which are able 
to bind to heparan sulfates. Another finding concerning the heparin binding site and 
structural characteristics is that C-terminally truncated versions of FGF2 are impaired 
in both heparin binding and export (data of André Engling (PHD thesis) and 
Christoph Zehe). These findings are consistent with the hypothesis that HSPGs are 
involved in FGF2 export and that this process is restricted to correctly foldedcFGF2 
molecules. 
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Fig. 4.1 Schematic overview: Model of FGF2 export dependent on correctly folded molecules 
involving HSPGs. 
FGF2 = fibroblast growth factor 2, HSPG = heparan sulfate proteoglycan 
 
As depicted in Fig. 4.1 potential quality control mechanisms in unconventional 
secretion of FGF2 could be rejection of improperly folded or aggregated molecules 
by the translocation machinery. If binding to HSPGs, which, in that case, function as 
counter receptors, is necessary, incorrectly folded molecules could not enter the non-
classical export pathway. 
As proposed for galectin-1, counter receptors could act as a molecular trap which 
removes secreted molecules from the equilibrium between the intra- and extracellular 
pool of FGF2 (Seelenmeyer et al., 2005). Another possibility could be that they might 
exert a pulling force at the extracellular side of a putative translocation pore. In that 
case, HSPGs would actively contribute to the export process which was also 
proposed for counter receptors of galectin-1 (Seelenmeyer et al., 2005). Consistent 
with the proposed models, Schäfer et al. provided evidence for a direct plasma 
membrane translocation of FGF2. It could be shown in an in vitro assay which 
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reconstitutes FGF2 secretion by employing plasma membrane-derived inside-out 
vesicles that FGF2 and galectin-1 are selectively translocated in a time- and 
temperature-dependent manner (Schäfer et al., 2004). These findings suggest the 
existence of a plasma membrane-resident transporter which directly mediates 
translocation being consistent with the proposed models. 
Taken together, the data obtained by the two experimental systems presented in this 
study suggest that unconventional secretion of FGF2 does not require protein 
unfolding (Backhaus et al., 2004) and that non-classical export of FGF2 could 
depend on correctly folded cargo molecules to apply means of quality control to the 
unconventional secretory process. 
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6 Abbreviations 
 
αMEM α-modification of Minimal Essential Medium 
°C degrees celsius 
ABC ATP binding cassette 
APC allophycocyanin 
APS ammonium peroxo disulphate 
ATP adenosin triphosphate 
BFA brefeldin A 
bp basepairs 
CDB cell dissociation buffer 
cDNA complementary DNA 
CHO chinese hamster ovary (cells) 
CRD carbohydrate recognition domain 
C-terminal carboxy terminal 
ddH2O double destilled water 
DHFR dihydrofolate reductase 
DMSO dimethyl sulphoxide 
DNA desoxyribonucleic acid 
E.coli escherichia coli 
e.g. exempli gratia 
ECL enhanced chemoluminescence 
ECM extracellular matrix 
EDTA ethylenediaminetetraacetic acid 
En2 engrailed 2 
ER endoplasmatic reticulum 
et al. et altera 
EtBr ethidium bromide 
EtOH ethanol 
FACS fluorescence activated cell sorting 
FCS fetal calf serum 
FGF1 fibroblast growth factor 1 
FGF2 fibroblast growth factor 2 
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FGF4-S fibroblast growth factor 4 with a classical signal sequence 
FGFR fibroblast growth factor receptor 
FV foamy virus 
g gravitation 
Gal-1 galectin-1 
GFP green fluorescent protein 
GTP guanosine triphosphate 
h hour 
HASPB hydrophilic acylated surface protein B 
HCl hydrochlorid acid 
HEK human endothelial kidney (cells) 
HIV human immunodeficiency virus 
HMGB high mobility group protein 
HRP horse raddish peroxidase 
HSPG heparan sulfate proteoglycans 
ICE interleukin converting enzyme 
IgG immunoglobulin G 
IgG2α immunoglobulin 2 α 
IL interleukin 
IRES internal ribosome entry site 
kDa kilo Dalton 
M Molar 
mA milliampere 
MAP microtubule associated protein 
MCAT murine cationic amino acid transporter 
MCS multiple cloning site 
mg milligramme 
MIF migration inhibtory factor 
min minute 
ml milliliter 
mM millimolar 
mRNA messenger RNA 
MTS mitochondrial targeting sequence 
NaCl natrium chloride 
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NES nuclear export signal 
ng nanogramm 
NLS nuclear localization signal 
nm nanometer 
NSF N-ethyl-maleimid sensitive factor 
OD optical density 
ORF open reading frame 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PE phycoerythrin 
pH -log10 [H+] 
PKC proteinkinase C 
PVDF polyvinyliden fluoride 
RNA ribonucleic acid 
SDS sodium dodecyl sulfate 
SNAP soluble NSF attachment protein 
SNARE soluble NSF attachment protein receptor 
SRP signal recognition particle 
Taq thermus aquaticus 
Tat HIV transactivator protein 
TEMED N,N;N´,N´-tetramethylethylenediamine 
Tris tris [hydroxymethyl] aminoethane 
Tween 20 polyoxethylene sorbitane monolaureate 
u units (enzyme activity) 
uPA urokinase-type plasminogen activator 
V volt 
v/v volume per volume ratio 
VEGF vascular endothelian growth factor 
w/v weight per volume ratio 
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Something unknown is doing we don't know what. 
 
Sir Arthur Eddington (1882 - 1944) 
 
 
 
 
 
 
 
The important thing is not to stop questioning. 
 
Albert Einstein (1879 - 1955) 
 
